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3 Summary 
Eukaryotes and bacteria are known to utilize the shikimate pathway for 
synthesizing aromatic amino acids (AroAAs). Of the 17 enzymes involved in the 
well-studied E. coli pathway, haloarchaea possess only 13 recognizable homologs, 
and these cover the steps necessary to convert 3-dehydroquinate (DHQ) to AroAAs. 
No homologs were found for the initial reactions in the pathway responsible for the 
biosynthesis of DHQ, suggesting that haloarchaea use a non-canonical pathway for 
biosynthesis of AroAAs.  
 To assign function to all individual genes of this de novo biosynthesis pathway in 
H. salinarum, a number of strategies were employed, including targeted mutations of 
the proposed first three genes, nutrient requirements, phenotypes, AroAAs uptake 
assays, enzyme activities of the purified gene products, and global examination of 
AroAAs-related genes using a genome-wide DNA microarray for H. salinarum.  
In summary, the DNA microarray data provided solid evidence to support the 
function of all 13 gene homologues that are required downstream to DHQ. These 
were differentially expressed when AroAAs were omitted from the growth media. In 
addition, ORFs involved in specific and unspecific AroAAs transport systems were 
found to be strongly regulated including the E. coli aroP homolog, as well as 
dppA3B3C3D3F3 operon (ABC transporter) and various Na+-dependent transporters. 
Finally, the transcription regulators TrmB (OE3018F) and TBPe (OE4146F) were 
strongly regulated when AroAAs were added to the growth media, while LrpA2 
(OE2776F) was regulated when AroAAs were omitted from the growth media.   
It was hypothesized that the first three steps of the de novo AroAAs pathway were 
catalyzed by ORFs OE1472F, OE1475F and OE1477R, respectively, based on 
sequence similarity to M. jannaschii, and genomic context. These predictions were 
tested by determining the role of these ORFs both in vivo and in vitro.  
Several lines of evidence indicated that ORF OE1472F has a role in the AroAAs 
biosynthesis pathway: (1) genetically disturbing ORF OE1472F resulted in an 
auxotrophic mutant that required AroAAs for growth. (2) the purified recombinant 
protein specified by this ORF exhibits aldolase activity in the catabolic direction, and 
uses the phosphate sugar F-1,6-P as substrate. This might indicates that the ORF is 
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involved in the formation of DKFP, which is one of the precursors in the pathway. 
Nevertheless, the aldol like condensation between a hydroxyacetone fragment of 
DKFP with ASA needs to be tested. (3) this ORF was part of the trp operon identified 
in H. salinarum, which was transcriptionally regulated by AroAAs in the medium. (4) 
alignment with the transaldolase from M. jannaschii (which has known 3D structure) 
allowed OE1472F to be classified as an archaeal-type aldolase class 1A 
(transaldolase), supporting the possibility of this ORF catalyzing the first step in the 
de novo pathway.  
The role of the second ORF in the de novo pathway was confirmed by the 
phenotype of an insertion mutant OE1475F::pMG501, which showed reduced ability 
to grow without AroAAs. In the presence of AroAAs it could grow as well as WT, 
confirming that this ORF specifies a protein that is important for AroAAs 
biosynthesis.  
The predicted enzymatic function of the protein encoded by the 3rd ORF, 
OE1477R, was demonstrated in vitro. The purified gene product of ORF OE1477R 
could remove water molecule from DHQ to form 3- dehydroshikimate, demonstrating 
it is a 3-dehydroquinate dehydratase type I enzyme (EC 4.2.1.10). Deletion of the 
ORF resulted in AroAAs auxotrophy. This mutant utilized only low concentrations of 
Phe when growing on synthetic medium supplemented with only AroAAs, while the 
presence of AroAAs plus either DHQ or shikimate induced the uptake of Phe.  
Together, the data for these three ORFs showed that, as predicted, they catalyze 
three consecutive enzymatic reactions responsible for the production of DHQ in the 
de novo pathway of AroAAs in H. salinarum. 
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4 Introduction 
4.1 The three domains of life  
The classification of cellular life has changed several times over the last 60 years 
as more information accumulated about cellular structure biology and genetics. In the 
late 1970s the classification of life was radically revised by Woese et al., (Woese and 
Fox, 1977; Woese et al., 1990) who found evidence for a previously unknown group 
of single-celled organisms, which were so different from the known bacteria that they 
required classification at the highest level of division. The distinctiveness of archaea 
was supported by 16S rRNA gene sequence, then later by phylogenies based on a 
number of proteins (such as elongation factors EF-1/Tu and EF-2/G, RNA polymerase 
subunits II and III and ATPases type F and V, (Gogarten et al., 1989; Iwabe et al., 
1989; Puhler et al., 1989). The later studies also predicted that the root of the tree lay 
between the Bacteria lineage on the one side, and lineage leading to Archaea and 
Eukarya on the other (figure #1), indicating that Archaea were more related to 
Eukarya than to Bacteria. Apart from sequence data, all Archaea show a biochemical 
characteristic of major significance, the cell composition of the membrane. Unlike 
eubacterial and eukaryotic lipids, which usually consist of fatty acids that are linked to 
glycerol by ester bonds, archaeal membrane lipids are chemically very different, 
being composed of isoprenyl glycerol ethers (Gambacorta et al., 1994). Above the 
lipid linker, the archaeal cell is surrounded either by a proteinaceous surface layer (S-
layer), or a rigid cell wall sacculus formed by polymers like pseudomurein or 
heteropolysaccharide, or nothing at all (Kandler, 1994). These and other data 
underpinned Woese’s original 1977 proposal to split the prokaryotes into two distinct 
kingdoms (later Domains), the Bacteria and the Archaea (Woese et al., 1990). In the 
past few years, with the sequencing of complete genomes from numerous archaea (see 
Genome OnLine database at http://genomesonline.org/index2.htm), an enormous 
amount of data has become available that has been used to critically examine the 
evolutionary relationships among various organisms. These studies have confirmed 
the three-domain proposal, and it is now generally accepted that life is classified into 
three domains: Bacteria, Archaea, Eukarya. 
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The domain Archaea comprises 4 phyla (previously kingdoms) as seen in figure 
#1: Korarchaeota, Nanoarchaeota, Crenarchaeota and Euryarchaeota. Euryarchaeota 
unite a diverse group of archaea characterized by their ability to generate methane 
(methanogens) or by their growth in extreme habitats with high salt concentrations 
(extreme Halophiles) or at high (hyperthermophilic) and low (psychrophilic) 
temperatures. In contrast, crenarchaeota comprise almost exclusively 
hyperthermophilic species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 1
 
: The rRNA tree of life (Allers, 2005). Molecular phylogeny clearly distinguishes 
Archaea as a distinct domain of life independent from Bacteria and Eukarya. 
4.2 Diversity and unity 
As indicated by the tree of life (figure #1) the Archaea show a closer relationship 
to eukaryotes than to Bacteria.  However, Archaea are prokaryotic in cell architecture. 
They are single-celled, contain no nucleus or other eukaryotic organelles, are of 
approximately the same size as most Bacteria, have circular DNA genomes, have 
genes organized into operons, and use pathways such as energy conservation and 
biosynthesis that are similar to Bacteria (Allers, 2005). In contrast, their information-
processing machinery such as RNA polymerase, resemble their eukaryotic 
counterparts, although they are far simpler in structure (Allers, 2005).  
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Genome sequence comparisons revealed that Archaea might have acquired many 
of their genes by horizontal gene transfer (Koonin et al., 2001), seen especially in 
metabolically diverse methanogenic and halophilic archaea which cohabit with 
bacteria, and from which they may have acquired many genes for novel metabolic 
functions (Deppenmeier et al., 2002; Rosenshine et al., 1989).  In particular, the 
haloarchaea appear to have evolved from the anaerobic methanogen lineage (figure 
#1), and must have recruited many genes for aerobic metabolism (see next section). 
A perplexing issue arising from genome sequence data is that as much as 50% of 
the annotated archaeal genes have no identifiable functions. In many cases, metabolic 
pathways show gaps where no gene homologues can be found by sequence 
comparison, but functional homologues are presumably present among the 
complement of hypothetical proteins. For example, central pathways such as the 
pentose-phosphate pathway and shikimate pathway (Allers, 2005; Falb et al., 2008; 
Gonzalez et al., 2008).    
4.3 Metabolism of halophilic archaea  
Members of the family Halobacteriaceae are commonly referred to as extremely 
halophilic archaea, or halobacteria. Currently, 28 genera of this family are recognized 
and include members isolated from salt lakes, soda lakes (high pH), saltern 
crystallizer ponds, salty soils and salted foods (NCBI taxonomy website: 
http://www.ncbi.nlm.nih.gov/sites/entrez). Haloarchaea thrive in extremely saline 
environments (up to 4.5M NaCl) and share physiological adaptations such as acidic 
proteins that can function at the high internal salt concentrations found in the 
cytoplasm. Surprisingly, the nutritional demands and metabolic pathways were found 
to vary considerably among diffrent haloarchaeal species (for review see (Falb et al., 
2008)).  
H. salinarum, like other haloarchaea requires high salt concentrations for growth. 
It is an aerobic hetrotroph that degrades carbon sources such as amino acids, glycerol 
and organic acids via the TCA cycle (Ghosh and Sonawat, 1998) using oxygen as 
terminal electron acceptor (Schafer et al., 1996). Due to low the solubility of oxygen 
in salt-saturated brines, it easily becomes a limiting factor for respiration, and 
alternative terminal acceptors, such as DMSO and to some extent fumarate, have been 
reported to be utilized (Oren, 1991; Oren and Truper, 1990). H. salinarum employs 
                                                                                                                   Introduction 
 10 
two further modes of energy conservation under anaerobic condition. First, it is able 
of photophosphorylate using the light-driven proton pump bacteriorhodopsin, building 
up a proton motive force for ATP generation (Oesterhelt, 1988). As a second 
possibility, H. salinarum is able to ferment arginine via the arginine deaminase 
pathway (Dundas and Halvorson, 1966; Ruepp and Soppa, 1996). 
The metabolic diversity of halophilic archaea was investigated at genomic level 
through systematic metabolic reconstruction and comparative analysis of H. 
salinarum, H. marismortui, H. walsbyi and the haloalkaliphile N. pharaonis (for 
review see (Falb et al., 2008; Gonzalez et al., 2008)). The metabolic reconstruction 
showed that in spite their common hypersaline environments, halophilic archaea are 
surprisingly different in their nutritional demands. For example, while N. pharaonis 
can synthesis all amino acids de novo (Falb et al., 2005), H. salinarum has reduced 
capabilities to synthesize amino acid and therefore requires 5 amino acids in order to 
grow in synthetic medium (Grey and Fitt, 1976; Oesterhelt and Krippahl, 1973). 
Specifically, H. salinarum lacks gene clusters for valine, leucine, isoleucine, lysine, 
and arginine synthesis (supplementary material S2 in (Falb et al., 2008)). 
Furthermore, the predicted set of essential amino acids (lysine, methionine, valine, 
leucine and isoleucine) fits well to the set of amino acids that can be sensed by H. 
salinarum, except for lysine, which is not an attractant signal, and cysteine which is 
sensed by BasT (Kokoeva et al., 2002).   
The metabolic reconstruction by Falb et al., (Falb et al., 2008; Gonzalez et al., 
2008)), also revealed some interesting metabolic pathways different to bacteria. For 
example, the biosynthesis of ribose-5-phosphate (R5P), the precursor of 
ribonucleotides, is usually synthesized through the pentose phosphate pathway (PPP). 
However,  from the reconstruction of the PPP in H. salinarum it was observed that H. 
salinarum lacks the non-oxidative branch, and possesses only two enzymes of the 
oxidative branch. Those two enzymes constitute the final steps in producing ribulose-
5-phosphate.  The absence of the non-oxidative branch of the PPP pathway also 
results in the absence of the pathway intermediate, erythrose-4-phosphate, which is 
one of the precursors of aromatic amino acids (AroAAs) biosynthesis in bacteria, 
known as the shikimate pathway.   
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4.3.1 Shikimate pathway of aromatic amino acids (AroAAs) 
biosynthesis 
In E. coli, phenylalanine, tyrosine, and tryptophan are synthesised by a common 
pathway, the shikimate pathway, as depicted in figure #2. The pathway derives its 
name from Illicium religiosum (in Japanese, shikimi-no-ki) from which shikimic acid 
was first isolated in 1885. The initial step is the condensation of phosphoenolpyruvate 
(PEP, a glycolytic intermediate) with erythrose-4-phosphate (E-4-P, a pentose 
phosphate pathway intermediate). The resulting C7 open-chain sugar loses its 
phosphoryl group and cyclises to 3-dehydroquinate (DHQ). Dehydration then yields 
3-dehydroshikimate (DHS), which is reduced by NADPH to shikimate.  A second 
molecule of phosphoenolpyruvate then condenses with 5-phosposhikimate to give an 
intermediate that loses its phosphoryl group, yielding chorismate. Chorismate is the 
precursor for either prephenate, or anthranilate.  
Figure # 2
http://www.chem.qmul.ac.uk/iubmb/enzyme
: The synthesis of chorismate in E. coli.  (Modified from IUBMB Enzyme 
Nomenclature website, ). The end products 
derived from the precursor chorismate are marked in blue boxes. The seven steps necessary to 
convert the precursors to chorismate are numbered in red. In fungi, such as Saccharomyces 
cerevisiae, steps 2-6 are catalyzed by the pentafunctional enzyme denoted AROM (Banerji et 
al., 1993; Charles et al., 1986). 
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In the prephenate branch (figure #3), a mutase converts chorismate into 
prephenate, the immediate precursor of the aromatic ring of phenylalanine and 
tyrosine. Dehydration and decarboxylation yields phenylpyruvate. Alternatively, 
prephenate can be oxidatively decarboxylated to yield p-hydroxyphenylpyruvate. 
These α-keto acids are then transaminated to yield phenylalanine and tyrosine. 
 
 
 
 
 
 
 
 
 
 
Figure # 3
http://sandwalk.blogspot.com/2007/03/how-cells-make-tryptophan-phenylalan ine 
.html
: The synthesis of phenylalanine and tyrosine from chorismate (The prephenate 
branch). (
).  
 
 
In the anthranilate branch (figure #4), chorismate acquires an amino group from 
the side chain of glutamine to form anthranilate. Anthranilate then condenses with 
phosphoribosyl-pyrophosphate (PRPP), an activated form of ribose phosphate. PRPP 
is also a key intermediate in the synthesis of histidine, purine nucleotides, and 
pyrimidine nucleotides. The C-1 atom of ribose-5-phosphate becomes bound to the 
nitrogen atom of the anthranilate in a reaction that is driven by the hydrolysis of 
pyrophosphate. The ribose moiety of phosphoribosylanthranilate undergoes 
rearrangement to yield 1-(o-carboxyphenylamino)-1-deoxyribulose 5-phosphate. This 
intermediate is dehydrated and decarboxylated to form indole-3-glycerol phosphate. 
Finally, indole-3-glycerol phosphate reacts with serine to form tryptophan. The 
glycerol phosphate side chain of indole-3-glycerol phosphate is replaced by the 
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carbon skeleton and amino acid group of serine. This reaction is catalysed by 
tryptophan synthase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 4
http://www.chem.qmul.ac.uk/iubmb/enzyme
: The synthesis of tryptophan from chorismate (anthranilate branch). From IUBMB 
Enzyme Nomenclature website, .  
 
 
4.3.2 Pathway reconstruction from genomic data 
The seven enzymatic steps in the chorismate pathway have been extensively 
studied in E. coli, and the corresponding genes have been identified (Pittard, 1996). 
All of the participating enzymes, including shikimate kinase, are conserved in a broad 
range of organisms, such as bacteria, yeast and plants.  
In 1996, the first archaeal genome sequence was published, that of the 
methanogenic archaeon Methanocaldococcus jannaschii (M.j) (Bult et al., 1996). In 
this organism, the genes for the first two steps of the chorismate pathway and for 
shikimate kinase (the fifth step) appeared to be missing. Selkov et al. (Selkov, 1997) 
even declared that the pathway starts from DHQ. Attempts to identify the gene 
encoding shikimate kinase using similarity to known examples of this enzyme yielded 
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no plausible candidates in any of the archaeal genomes so far sequenced (Daugherty 
et al., 2001).  
In the case of the missing archaeal shikimate kinase gene, the problem was 
approached on basis of reconstruction of metabolic pathways and analysis of gene 
clustering on the chromosome. Daugherty et al., (Daugherty et al., 2001) 
reconstructed the chorismate pathway from the genomic data as known for E. coli 
(figure #5), using more than 50 complete and partial microbial genomes. From the 
data presented in figure #5 one can see that the chorismate pathway is remarkably 
conserved over broad range of organisms, and homologs of all seven genes could be 
easily identified by sequence comparison. As summarized in figure #5, most 
prokaryotes possess either all of the genes (for example: B. subtilis and A. fulgidus), 
or none (for example: T. pallidum and P.horikoshii) and this is consistent with their 
growth requirements (Gonzalez et al., 1998). The missing archaeal shikimate kinase 
was identified by Daugherty et al., (Daugherty et al., 2001), and verified 
experimentally by purification of the enzyme and determination of its kinetic 
parameters. Moreover, its orthologs in other archaea have been pointed out 
(Daugherty et al., 2001), figure#5).  
 
Figure # 5: Reconstruction of the first steps in shikimate pathway in bacteria and archaea. 
The reconstruction was done using genomic data and chromosomal clustering of chorismate 
biosynthesis genes. Gene names shown in italic are those of E. coli. Modified from 
(Daugherty et al., 2001). The EC number of the first enzyme in the pathway has been changed 
to EC 2.5.1.54, and not as indicated in the figure above. Black boxes within a genome row 
represent proximity on the chromosome. 
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4.3.2.1 Shikimate pathway in Methanocaldococcus and Methanococcus 
Although the chromosomal clustering approach proved to be useful in identifying 
the shikimate kinase in M. jannaschii, it failed to identify the first two genes in the 
pathway. This is most likely because a different pathway for the formation of DHQ is 
used, which is consistent with labelling studies of M. jannaschii showing that E-4-P is 
not the precursor of chorismate. Since the enzymes for the two steps preceding and 
the two steps following the phosphoylation of shikimate are present in all archaea, a 
complete pathway for synthesis of aromatic amino acid most likely exists, and so 
needs to be identified.  
In 2004 White (White, 2004) reported that 6-deoxy-5-ketofructose 1-phosphate 
(DKFP) and L-aspartate semialdehyde (ASA) were precursors to DHQ. He 
demonstrated that DKFP supplies a hydroxyacetone moiety which, via a transaldolase 
reaction, undergoes an aldol condensation with ASA (figure #6). White has 
demonstrated that the recombinant protein product of M. jannaschii ORF MJ0400 
catalyzes the transaldolase reaction while the recombinant protein product of ORF 
MJ1249 was responsible for the oxidative deamination and the cyclization reactions. 
Enzymatic function was demonstrated in vitro by quantifying the DHQ generated 
when the recombinant protein products of both these ORFs were incubated with 
DKFP and ASA (table #2 (White, 2004)). Addition of the individual proteins 
produced no product (0.012 nmole), whereas the mixture of the two proteins produced 
7 nmole DHQ. The production of DHQ was greatly stimulated (330 nmole) when 
NAD was added. From the data presented, White estimated the specific activity of the 
MJ0400 enzyme was > 860 nmole/min/mg protein (White, 2004). 
The in vivo function of the ORFs suggested by White (White, 2004) for the early 
steps in the novel pathway for the biosynthesis of AroAAs in M. jannaschii, were 
characterized both biochemically and genetically in M. maripaludis (Porat et al., 
2006). Strong evidence was found to support the in vivo role of DKFP in this 
pathway. Firstly, phenylalanine was found to be labelled after the incorporation of 
labelled acetate. Secondly, a mutant with a deletion of the first ORF (aroA′, 
corresponding to MJ0400) required AroAAs for growth. Complementation with this 
gene restored the WT phenotype. Unexpectedly, deletion of the second ORF (aroB′, 
corresponding to MJ1249) did not convert the strain to auxotrophy, suggesting this 
gene was not required for AroAAs biosynthesis. Although the bioinformatic analysis 
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supports the role of this gene, it might be that there is another, unidentified enzyme 
that is able to perform the same function. Since there are no other ORFs homologous 
to aroB′, the proposed second enzyme is unrelated.    
 
Figure # 6
 
: The alternative pathway for the biosynthesis of AroAAs in M. jannaschii as 
suggested by White (White, 2004). 
4.3.2.2 The Shikimate pathway in Haloarchaea 
Several lines of circumstantial evidence indicate that haloarchaea possess a novel 
pathway for the early steps of AroAAs biosynthesis. First, in the archaeal domain, the 
oxidative pentose phosphate pathway (PPP), as seen in figure #7, does not appear to 
be present. The genes for most of this pathway cannot be detected in archaeal 
genomes (indicated in red), including those responsible for the production of E-4-P. 
Unless there is an alternative pathway for production of E-4-P, it can not be used as 
the precursor of the AroAAs pathway (step 1 in figure #2).  
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Figure # 7
 
: The pentose phosphate pathway (PPP) in H. salinarum, the source of E-4-P. The 
enzymes for which genes cannot be found are indicated in red. Based on the experimental 
results of Dr. Daniela Breckau.   
 
Second, homologues for all 13 genes necessary to convert DHQ to AroAAs are 
present in all sequenced haloarchaeal genomes, indicating that downstream to DHQ, 
the canonical pathway for synthesis of AroAAs takes place, as shown in figure #8.  
Third, attempts to identify the genes encoding the first two steps using sequence 
similarity to known enzymes yielded no plausible candidates in any of the archaeal 
genomes (www.halolex.mpg.de), which indicates that as yet unidentified and non-
orthologous enzymes are likely to span these early steps.  
Fourth, in M. jannaschii, ORFs MJ40400 and MJ1249 have been shown to play a 
role in the alternative pathway of DHQ biosynthesis (White, 2004). Homologues, 
displaying high levels of sequence similarity (31-44%), are encoded in haloarchaea 
genomes, as seen in table #1.  
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Figure # 8
 
: Homologues ORFs of H. salinarum downstream of DHQ. Green represents the 
ORFs in the chorismate pathway starting from DHQ, pink- the ORFs of the tryptophan 
branch, blue- the ORFs in the phenylalanine branch, and red- the ORFs  in the tyrosine 
branch. 
 
While some haloarchaea have single homologues of M. jannaschii genes, H.  
salinarum and N. pharaonis each have two homologs of MJ0400 (aroA′). ORFs 
OE2019F and OE1472F were annotated as fructose bisphosphate aldolase I and II, 
respectively. Examination of the gene organization in H. salinarum and N. pharaonis, 
show that OE1472F and NP3160A are linked to their respective trpCBA operons 
(figure #9), indicating that they are likely to be involved in the trp pathway, while 
OE2019F and NP1594A, respectively, are involved in gluconeogensis. However, in 
M. jannaschii and M. maripaludis, the homologs to aroA′ are not linked to the genes 
of tryptophan biosynthesis (Porat et al., 2006). ORF OE1475F was annotated as 
conserved protein (www.halolex.mpg.de). 
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Table # 1
 
: Homologs for the M. jannaschii ORFs MJ0400 and MJ1294. 31-44% amino acid 
identity was found. 
 
Fructose  
bisphosphate aldolase  
EC 4.1.2.13 
3- dehydroquinate  
synthase  
EC 4.2.3.4 
M. jannaschii MJ0400 MJ1249 
H. salinarum OE1472F, OE2019F OE1475F 
N. pharaonis NP3160A, NP1594A NP2238A 
Haloarcula marismortui rrnAC1881 rrnAC1879 
Haloquadratum walsbyi HQ1156A HQ1155A 
 
 
 
 
 
 
 
 
Figure # 9
 
: ORFs OE1472F and NP3160A relative to the trpCBA operon in H. salinarum 
and N. pharaonis, respectively. The corresponding genes in the trp operon have the same 
color. The % of amino acid identity to M. jannaschii ORF MJ0400 is indicated in parenthesis. 
Note that the linker between trpA and OE1472F or NP3160A do not contain a putative TATA 
box. 
 
The genomic contexts of all ORFs involved in the de novo pathway of AroAAs 
biosynthesis pathway in H. salinarum are represented in the figures 10 and 11 below.  
Figure # 10, illustrates the ORFs responsible for the conversion of the precursors to 
chorismate. As explained above, several lines of circumstantial evidence indicates that 
haloarchaea possess a novel pathway for the early steps of AroAAs biosynthesis. 
These early steps are assumed to be responsible for the production of DHQ, using 
ORFs OE1472F and OE1475F (marked with red circles), homologs of ORFs in M.  
jannaschii (White, 2004). ORF OE1477R represents the first step for which a 
homolog has been identified (figure #11A-B). The genomic contexts of the ORFs 
responsible for the conversion of DHQ to chorismate are represented in figure #10C-
E. 
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In figure #11, F-I represents the ORFs assigned for the tryptophan, tyrosine and 
phenylalanine branches, respectively. Figure #11J, on the other hand illustrates the 
genomic context of ORF OE2019F, homolog to OE1472F (see table #1). 
 
Figure # 10
 
: The genomic context of ORFs involved in the conversion of the precursors to 
chorismate. A-B: ORFs assigned to convert the precursors to DHQ. The first and second 
ORFs (marked in red circles) are homologs to M. jannaschii ORFs (White, 2004) and part of 
the non canonical part of the pathway. ORF OE1477R is the 3rd ORF discussed in this thesis. 
C-D: ORFs needed to convert DHQ to chorismate. The numbers represent the positions of the 
ORFs in the chromosomal DNA of H. salinarum. CHY- conserved hypothetical protein, HY- 
hypothetical protein. The locations and directions of open reading frames are indicated by 
arrows. 
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Figure # 11
 
: The genomic context of the ORFs involved in the conversion of chorismate to 
tryptophan, tyrosine and phenylalanine. F-G: the tryptophan branch, H- the tyrosine branch, 
I-the phenylalanine branch. J- the genomic context of ORF OE2019F, homolog to OE1472F. 
The numbers represent the positions of the ORFs in the chromosomal DNA of H. salinarum. 
CHY- conserved hypothetical protein. The locations and directions of open reading frames 
are indicated by arrows. 
4.3.2.3 Postulating de novo pathway in Haloarchaea 
On the basis of the evidence presented above, ORFs OE1472F and OE1475F, were 
proposed as candidates for the first two steps in the biosynthesis of AroAAs in 
haloarchaea. This was consistent with the pathway suggested by White for M. 
jannaschii (White, 2004), and provided a testable hypothesis: that haloarchaea 
homologous would catalyse the same reactions as those shown experimentally for  M. 
jannaschii. 
The first step would then be predicted to be an aldol like condensation between HA 
(hydroxyacetone) moiety of DKFP (6-deoxy-5-ketofructose 1-phosphate) to ASA 
(aspartate semialdehyde), using the enzyme specified by ORF OE1472F. 
Hydroxpyruvaldehyde phosphate (HPAP) would be released and compound I formed. 
In the second stage, oxidative deamination and the cyclization using ORF OE1475F is 
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predicated to form DHQ. From this stage on, the canonical pathway can be used for 
the biosynthesis of AroAAs. 
  
 
 
 
 
 
 
 
 
  
Figure # 12
 
: Initial steps in the de novo pathway of AroAAs biosynthesis in haloarchaea 
according to (White, 2004). ASA- L-aspartate semialdehyde, DKFP-6-deoxy-5-ketofructose 
1-phosphate. 
4.4 Enzyme classification 
The enzymes relevant to the first three steps in the predicted pathway are 
aldolase/transaldolase, dehydroquinate synthase, and dehydroquinate dehydratase, 
enzymes specified by ORFs OE1472F, OE1475F and OE1477R, respectively. 
4.4.1 Aldolases EC 4.1.2.13 
Aldolase is an enzyme which is capable of cleaving fructose 1-phosphate to form 
glyceraldehyde 3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP). The 
reaction is reversible and part of glycolysis. 
Two distinct classes of aldolases are found in nature, which differ in their 
molecular properties and mechanisms (Rutter, 1964a). Class I aldolases, as 
represented by rabbit muscle aldolase, catalyses the cleavage of FBP through a 
covalently bound intermediate. The intermediate is stabilized by a Schiff base formed 
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between the substrate and an active site residue of the enzyme, Lys237. Enzymes 
which are part of this class are inactivated by borohydride (NaBH4) (Rutter, 1964b). 
Class II aldolases, represented by yeast aldolase, depend on divalent metal ions to 
stabilize the carbanion intermediate, and are inhibited by EDTA (Lebherz and Rutter, 
1969).   
Early studies of extreme halophiles described the distribution of class I and II 
aldolases in various haloarchaea. Their activity was measured in cell-free extracts in 
the presence of EDTA or NaBH4 (Altekar W., 1987). These studies showed that the 
H. salinarum, H. volcanii and H. mediterranei enzymes exhibit the properties of class 
II aldolase (i.e. their activities were metal dependent), while the aldolase of H. 
vallismortis was classified as a class I enzyme, due to inactivation by NaBH4.  
Although class I and II aldolase activities have been demonstrated in archaea (Altekar 
W., 1987; Dhar and Altekar, 1986; Fuchs et al., 1983; Krishnan and Altekar, 1991; 
Schafer and Schonheit, 1992), no genes encoding classical class I and II enzymes 
have been identified in any of the sequenced archaeal genomes, suggesting that 
archaea possess a novel type of aldolase. In 1998, Thomson et al., (Thomson et al., 
1998) described a new type of FBP aldolase in E. coli, which belongs to the class I 
family. Although it uses a Schiff-base mechanism, its shows only low sequence 
similarity to other members of this class. This aldolase was originally misannotated in 
the E. coli genome as dehydrin (DhnA). Homologs were identified in archaea, as seen 
in the multiple alignments done by Siebers et al., (Siebers et al., 2001). Remarkably, 
M. jannaschii, A. fulgidus, H. salinarum NRC-1 and H. salinarum each possess two 
paralogous genes of this family, while Pyrococcus furiosus and Aeropyrum pernix 
each possess one gene. The enzymes from Pyrococcus furiosus and Aeropyrum pernix 
(Siebers et al., 2001) were expressed in E. coli, and showed preferred substrate 
specificity for FBP in the catabolic direction and exhibited metal-independent class I 
aldolase activity via a Schiff-base mechanism. Consequently, class I aldolases were 
grouped into two different sequence families, one with only eukaryotic members and 
one with both bacterial and archaeal members. The latter were designated class IA 
aldolase (DhnA family), possessing a catalytic lysine residue (Lys237) (Siebers et 
al., 2001; Thomson et al., 1998). 
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4.4.2 Dehydroquinate synthase EC 4.6.1.3 
This enzyme catalyses the conversion of 3-deoxy-D-arabino-heptulosonate 7-
phosphate to 3-dehydroquinate (DHQ) in the shikimate pathway of bacteria and 
eukaryotes (see figure #2, second step). The overall reaction is complex and involves 
alcohol oxidation, phosphate elimination, carbonyl reduction, ring opening and 
intermolecular aldol condensation, in a single active site (Srinivasan et al., 1963; 
Widlanski et al., 1989). In prokaryotes, the enzyme is encoded by a single function 
gene, aroB (Bentley, 1990).  In some eukaryotes such as Neurospora crassa, 
Aspergillus nidulans and Saccharomyces cerevisiae, dehydroquinate synthase is 
produced as part of the pentafunctional AROM protein which catalyse steps 2-6 
(figure #2) (Banerji et al., 1993; Charles et al., 1986). 
ORF OE1475F in H. salinarum was annotated as a conserved hypothetical protein 
but displayed a 41% sequence similarity to MJ1294 from M. jannaschii. The latter 
enzyme has shown to be responsible for the synthesis of DHQ in the de novo pathway 
of AroAAs in M. jannaschii (White, 2004).  
4.4.3 dehydroquinate dehydratase EC 4.2.1.10 
A 3-dehydroquinate dehydratase is an enzyme that catalyzes the dehydration of 3-
dehydroquinate (DHQ) to form 3-dehydroshikimate (DHS) while releasing a water 
molecule. This enzymatic reaction is the 3rd step in the shikimate pathway (figure #2, 
3rd step).  
Two distinct types of 3-dehydroquinate dehydratase are found in nature which 
catalyze the same overall reaction but are unrelated at the sequence level and utilize 
completely different mechanisms (Gourley et al., 1999). Both enzyme types function 
as part of the shikimate pathway but while type I is found in archaea, plants and some 
bacteria, type II is found in bacteria and fungi. 3-dehydroquinate dehydratase from the 
bacterium Salmonella typhimurium was the first type I enzyme-product complex to be 
crystallized and its structure solved to 2.1Å resolution (Gourley et al., 1999; Lee et 
al., 2002). In 2004, the structure of another type I enzyme from Staphylococcus 
aureus was solved (Nichols et al., 2004), showing that type I enzymes belong to the 
(βα)8-barrel fold superfamily. 
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ORF OE1477R (aroD) in H. salinarum was annotated as a 3-dehydroquinate 
dehydratase, and predicted to be responsible for the formation of DHS.  
4.5 Microarray analysis 
The aromatic amino acids phenylalanine, tyrosine and tryptophan are synthesized 
in E. coli via the shikimate pathway, a well-studied and widely conserved biosynthetic 
pathway that involves 17 enzymes, and multiple levels of regulation (Bentley, 1990; 
Knaggs, 1999; Pittard, 1996). When analysing similar pathways in novel 
microorganisms, particularly those with non-canonical enzymatic steps such as 
haloarchaea, a number of strategies need to be considered. At the transcriptional level 
one might use traditional methods for detecting gene expression changes such as 
Northen blotting or differential RNA display, which allow analysis of only one or few 
genes at a time. DNA microarrays on the other hand are a much more powerful tool 
for studying genome-wide differential gene expression. Microarrays allow high 
throughput, parallelism, speed and automation and by encompassing the whole 
genome it eliminates bias associated with preselecting a subset of genes believed to be 
involved in certain cellular event. Nonetheless, microarray experiments produce 
voluminous datasets which are frequently difficult to analyse and can lead to 
confusing hypotheses and conclusions (Dharmadi and Gonzalez, 2004). 
DNA Microarrays were developed in the early nineties of the last century and have 
been used successfully to study gene expression in many organisms, including plants 
(Aharoni, 2001), pathogen-infected hosts (Diehn and Relman, 2001), humans (Kurella 
et al., 2001), and bacteria, such as Bacillus subtilis and E. coli (Eymann et al., 2002; 
Laub et al., 2000; Rohlin, 2002; Ye et al., 2000). Until 2001, no genome-wide 
transcriptome analysis had been performed on any archaeal species, and only one 
example was published using an array based on 271 ORFs from the 
hyperthermophilic archaeon Pyrococcus furiosus (Schut et al., 2001). In recent years, 
DNA microarrays of archaeal species have become an important tool for studying 
complex biological processes, such as understanding the regulatory network 
underlying the biochemical pathways for phototropy in H. salinarum NCR-1 strain 
(array based on 2413 ORFs (Baliga et al., 2002)). Microarrays were used as well to 
investigate chromosome replication in the hyperthermophilic acidophiles S. 
acidocaldarius and S. solfataricus using arrays based on 1,914 and 2,488 ORFs, 
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respectively (Lundgren et al., 2004). In 2006, the genome-wide DNA microarray 
(1722 ORFs) made of Methanococcus maripaludis was published, which validated 
proteomic data by microarray and RT-PCR (Xia et al., 2006). This was followed by a 
publication from Twellmeyer et al., (Twellmeyer et al., 2007)which established the 
first genome-wide DNA microarray of H. salinarum R1 (2774 ORFs). This array has 
been used to analyse the transcriptional differences between cells grown under 
aerobic and phototrophic conditions (Twellmeyer et al., 2007), the phosphate-
dependent gene expression in H. salinarum (Wende et al., 2009), the global and 
specific transcriptional regulatory effects of Lrp-like proteins in H. salinarum 
(Schwaiger, 2010), and the AroAAs-related genes of the shikimate pathway (this 
study).   
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4.6 Objectives 
The pathway leading to the biosynthesis of aromatic amino acids, known as the 
shikimate pathway, is well understood in both, Eukaryotes and Bacteria, where the 
genes, enzymes and the reactions, for each step have been intensively studied 
(Daugherty et al., 2001; Pittard, 1996). This pathway is critical for growth as, in 
addition to the biosynthesis of AroAAs, it is the source of p-aminobenzoic acid (the 
precursor of folic acid), and p-hydroxybenzoic acid, the precursor of the quinones, 
which are members of the electron transport chain. Analysis of the haloarchaeal 
genomes has failed to identify the first two genes in this pathway, but from studies on 
the euryachaeota M.  jannaschii (White, 2004), a pathway in haloarchaea can be 
postulated. This proposed non-canonical pathway is the subject of this investigation in 
Halobacterium salinarum, with the aims to provide genetic and biochemical evidence 
for the full de novo pathway of aromatic amino acids in haloarchaea.  
 
The specific objectives related to verifying the proposed pathway were:    
1) The construction of mutants of each of the first three genes: OE1472F, 
OE1475F and OE1477R (figure #10A-B). Deletion of these genes would be 
expected to convert H. salinarum to aromatic amino acid auxotrophy. 
2) Determining the phenotypes of these mutants including nutrient requirements, 
growth rates and their ability to import AroAAs from the medium. 
3) Assessing the differential gene expression of all assigned genes for the 
AroAAs biosynthesis pathway using a DNA microarray of H. salinarum. 
4) Expression and purification of the gene products of OE1472F, OE1477R and 
OE2019F in order to examine their enzymatic activities. 
5) Developing the relevant biological assays to determine the activities, kinetics 
and substrate specificities of the purified OE1472F, OE1477R and OE2019F 
proteins. 
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5 Materials and Methods  
5.1 Materials  
5.1.1 Chemicals 
All chemicals used in this study were purchased from Sigma-Aldrich, Merck, or 
Riedel de Haen at the highest grade available. Exceptions are listed below: 
BactoTM agar    Difco, Detroit, MI, USA 
BactoTM trypton    Difco, Detroit, MI, USA 
BactoTM yeast extract    Difco, Detroit, MI, USA 
BMA SeakemTM LE agarose    Biozym, Hess. Oldendorf, Germany 
disodium3-(4-methoxyspiro{1,2-
dioxetane-2,3’-(5- hloro)tricycle 
[3.3.1.13,17] decan}4-yl) phenyl 
phosphate (CSPD) 
   Roche Diagnostics, Mannheim, Germany 
DIG-11-dUTP    Roche Diagnostics, Mannheim, Germany 
DNA ladder 1Kb    Invitrogen, Karlsruhe, Germany 
Polyethylene glycol (PEG600)    Sigma Aldrich, St. Louis, USA 
HisTrap HP-1ml    GE Healthcare, Freiburg, Germany 
Albumin, bovine fraction V    SERVA Electrophoresis GmbH, Heidelberg, Germany 
 
 
5.1.2 Kits and Enzymes 
All restriction enzymes were purchased from New England Biolabs, Beverly, MI, 
USA. Other enzymes or kits used in this study are listed below: 
ABI PRISM BIG DYETM Cycle Sequencing  
Ready Reaction Kit 
Applied Biosystems, Foster City, CA, USA 
BCA Reagent Assay Pierce, Rockford, IL, USA 
DIG-11-dUTP Boehringer Mannheim Biochemicals 
LA Taq Polymerase TaKaRa Bio Inc, Japan 
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QIAprepTM Spin Miniprep Kit Qiagen, Hilden, Germany 
QIAquickTM Gel Extraction Kit Qiagen, Hilden, Germany 
Wizard® SV Gel and PCR Clean Up System Promega, Madison Wisconsin, USA 
ECL Plus Western blot Detection system  GE Healthcare, Freiburg, Germany 
5.1.3 Media, Buffers and Stock solutions  
5.1.3.1 Media 
Media were prepared with distilled water and sterilized in an autoclave, with the 
exception of the synthetic medium where sterilization was achieved by filtration. For 
plates, 15g of Bacto-Agar were added to 1 liter of medium in a 2 liter flask. 
Antibiotics were added to the medium after it cooled down to ~60°C. Before 
autoclaving, the pH was adjusted to pH=7.0, when necessary.  
LB medium  for E. coli  
 
 
 
 
 
 
 
 „Halo medium“ for Halobacterium salinarum (Oesterhelt, 1983) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Per 1 liter 
Bacto-Tryptone 10g 
Yeast extract 5g 
NaCl 10g 
 Per 1 liter 
NaCl 250g 
MgSO4 x 7H2O 20g 
Na3-citrate x 2H20 3g 
KCl 2g 
Oxoid-Peptone 10g 
pH adjusted to 7-7.2 with NaOH 
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Synthetic medium for Halobacterium salinarum + 1.1mM AroAAs  
(Modified from (Oesterhelt, 1983)) 
 
Solution 1
 
: The substances were dissolved in 800ml of distilled water, and the pH 
was adjusted to pH =7.0 with 1M NaOH. 
 
MW 
(g/mole) 
Amount 
(g) 
Final 
concentration 
*(mM) 
NaCl 58.44 235 3904.1 
MgSO4 x 7H2O 246.48 20 78.78 
KCl 74.55 2 26.05 
KNO3 101.11 0.1 0.96 
Na3-citrate x 2H20 294.1 0.5 1.65 
Glycerol 92.09 
20ml of  
50%(W/V) 
109 
800ml of this solution was used for  
preparing 1.03 liter medium 
 
 
Solution 2
 
: The substances were dissolved in 100ml of distilled water, and 
autoclaved.  
 
MW 
(g/mole) 
Amount 
(g) 
Final 
concentration 
* (mM) 
KH2PO4 136.09 2.86 0.408 
K2HPO4 x 3H20 228.19 6.62 0.563 
2ml of this stock solution was used for  
preparing 1.03 liter medium 
 
 
 
Solution 3: The trace elements were dissolved one after the other in ~80 ml distilled 
water which contained 4 drops of 25% HCl. After all the substances were dissolved, 
the final volume was adjusted to 100ml. 
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MW 
(g/mole) 
Amount 
(g) 
Final 
concentration 
* (µM) 
CuSO4 x 5H2O 249.68 0.005 0.1944 
FeCl2 x 4H2O 198.81 0.23 11.23 
MnSO4 x H2O 169 0.03 1.723 
ZnSO4 x 7H2O 287.54 0.044 1.485 
Na2MoO4 x 2H2O 241.95 0.024 0.963 
CoCl2 x 6H20 237.93 0.024 0.979 
1ml of this stock solution was used for  
preparing 1.03 liter medium 
 
 
Solution 4
 
: The amino acids were dissolved in 750ml distilled water, and filter 
sterilized. 
 
MW 
(g/mole) 
Amount 
(g) 
Final 
concentration 
* (mM) 
L-Arg 174.2 2 2.23 
L-Ile 131.18 2.2 3.26 
L-Leu 131.18 4 5.92 
L-Lys-HCl 182.65 1.25 1.33 
L-Thr 119.12 2.5 4.08 
L-Ser 105.9 3.05 5.64 
L-Ala 89.09 1.11 2.42 
L-Gly 75.07 0.38 0.98 
L-Pro 115.13 0.52 0.88 
L-Asp 133.1 2 2.92 
L-Glu 147.13 6.62 9 
150ml of this stock solution was used for  
preparing 1.03 liter medium 
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Solution 5
1.41g Tyr (MW=181.19g/mole) were dissolved in 49ml 1M HCl. The total volume 
was adjusted to 282ml with distilled water. 
: L-Tyr, 27.59mM stock solution 
41ml of this stock solution was used to prepare 1.03liter solution with 1.1mM Tyr. 
 
Solution 6
 
: Vitamins were dissolved in 10ml distilled water, and sterilized by 
filtration. 
 
MW  
(g/mole) 
Amount 
(g) 
Final 
concentration 
* (µM) 
Thiamine 337.3 0.1 14.39 
Folic acid 441.4 0.1 11 
Biotin 244.31 0.01 1.99 
0.5ml of this stock solution was used for  
preparing 1.03 liter medium 
This solution was added last after the pH was 
adjusted to 7.0 
 
 
Solution 7
2 g Met (MW= 149.21g/mole) were dissolved in 100ml distilled water with ~ 1 drop 
of 1M NaOH. The final pH=6.85. 
: L-Met, 134.04mM stock solution 
10ml of this stock solution was used to prepare 1.03 liter solution with 1.3mM Met. 
 
Solution 8
4.956g Phe (MW=165.19 g/mole) were added to ~150ml distilled water with 4 drops 
of 1N NaOH. Phe was added gradually. After all the Phe had dissolved, the total 
volume was adjusted to 200ml.  
: L-Phe, 150mM stock solution 
7.55ml of this stock solution was used to prepare 1.03 liter solution with 1.1mM Phe. 
 
Solution 9
1.37g Trp (MW=204.23 g/mole) were dissolved in ~30ml distilled water with 9ml 1M 
HCl. When all the Trp had dissolved, the volume was adjusted to 50ml and filter 
sterilized. 8.45ml of this stock solution was used to prepare 1.03liter solution with 
1.1mM Trp. 
: L-Trp, 134mM stock solution 
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Solution 1
 
0: Val was dissolved in 100ml distilled water.  
MW  
(g/mole) 
Amount 
(g) 
 
* (mM) 
L-Val 117.15 2.93 2.428 
10ml of this stock solution was used for  
preparing 1.03 liter medium 
 
* The concentration in each table is the final concentration in 1.03 liter medium 
 
 
M205 medium for Natronomonase pharaonis (according to DSMZ http://www.dsmz.de)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.3.2 Buffers 
 Basal salt solution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Per 1 liter 
Casamino acids 15g 
Na3-citrate x 2H20 3.0g 
Glutamic acid 2.5g 
MgSO4 x 7H2O 2.5g 
KCl 2.0g 
NaCl 250.0g 
pH adjusted to 8.7-8.8 with 
20% sterilized Na2CO3 
Reagent 
Amounts 
(g) 
Final 
concentration 
NaCl 250 4.278M 
MgCl2 x 7H2O 20 0.081M 
Na3-citrate x 2H20 3 0.01M 
KCl 2 0.0268M 
H2O to 1liter  
pH adjusted to  7-7.2 with NaOH 
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Buffers for NiNTa column  
The amounts of the compounds are calculated for 1 liter buffer. The pH of all buffers 
was adjusted to pH=8.0. 
 
Buffer/compounds NaH2PO4 x H2O NaCl KCl Imidazole 
NP  (Binding buffer) 
6.9g 
(50mM) 
17.54g 
(300mM) 
-------- -------- 
NPI20 (Wash buffer) 
6.9g 
(50mM) 
17.54g 
(300mM) 
-------- 
1.36g 
(20mM) 
NPI250 (Elution buffer) 
6.9g 
(50mM) 
17.54g 
(300mM) 
-------- 
17.02g 
(250mM) 
NP-KCl (Binding buffer) 
6.9g 
(50mM) 
-------- 
74.55 
(1M) 
-------- 
NPI20-KCl (Wash buffer) 
6.9g 
(50mM) 
-------- 
74.55 
(1M) 
1.36g 
(20mM) 
NPI250-KCl (Elution buffer) 
6.9g 
(50mM) 
-------- 
74.55 
(1M) 
17.02g 
(250mM) 
 
 
5.1.3.3 Antibiotics 
Antibiotics 
Stock** 
(mg/ml) 
Solvent 
Per 
 liter 
Final 
concentration 
Ampicillin (Amp) 100 H2O 1ml 100µg/ml 
Chloramphenicol (Chlor) 34 H2O 1ml 34µg/ml 
Novobiocin (Nov) 20 H2O 1ml 20µg/ml 
Mevinolin (Mev)* 10 EtOH 1ml 10µg/ml 
 
* Mevinolin (MKevinacorTM): 6 tablets were ground to a powder, and mixed with total 
volume of 12ml EtOH. The mixture was stirred well for 10min at RT and then centrifuged 
(15min, 4000rpm). The supernatant was collected and filtered (0.45µM). Aliquots were stored 
at -20°C. 
 
** Aliquots of the stock solutions were stored at (-20°C), until use. 
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5.1.4 Strains, Vectors and Oligonucleotides 
5.1.4.1 Strains 
Strain Genotype or Phenotype Source or reference 
E. coli 
ElectroMax DH10B 
F-mcrA (mrr-hsdRMS-mcrBC), O80lacZ∆M15, 
∆lacX74, recA1, endA1,ara∆139, ∆(ara, leu7697) , 
galU, galkλ, rpsL, mupG,  
Invitrogen 
(Electrocomp
etent) 
ElectroMax StbI4 
mBcrA ∆(mcrBC-hsdRMS-mrr), recA1, 
endA1,gyrA96, gal-, thi-, supE44λ-, relA1, ∆lac-
proAB)/F’ proAB+ , lacIqZ∆M15, Tn10(TetR) 
Invitrogen 
(Electrocomp
etent) 
One 
Shot®TOP10Electrocomp™ 
F-mcrA∆(mrr-hsdRMS-mcrBC), φ80lacZ∆M15 
∆lacX74recA1, araD139∆(ara-leu)7697 galU galK 
rpsL(StrR)endA1 nupG 
Invitrogen 
(Electrocomp
etent) 
H. salinarum 
R1 BR+, HR+, SRI+, SRII+, Car+, Rub+, Ret+, Vac- (Stoeckenius et al., 1979) 
R1, ∆OE1477R R1 derivative with ∆OE1477R, BR
+, HR+, SRI+, 
SRII+, Car+, Rub+, Ret+, Vac- This study 
R1,OE1475F::pMG501 R1 derivative with OE1475F::pMG501, BR
+, HR+, 
SRI+, SRII+, Car+, Rub+, Ret+, Vac- This study 
R1, OE1471F:: Terminator 
R1 derivative with OE1471F:: Terminator (No 
promoter/terminator for OE1472F), BR+, HR+, 
SRI+, SRII+, Car+, Rub+, Ret+, Vac- 
This study 
N. pharaonis 
WT  
 
Strain 2160 http://www.dsmz.de  
(Falb et al., 
2005; 
Kamekura et 
al., 1997; 
Soliman and 
Truper, 1982; 
Tindall et al., 
1984) 
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5.1.4.2 Plasmids  
Name Relevant description Source 
Plasmids for H. salinarum 
pUS-Mev 6.3Kbp; H. salinarum shuttle vector; Amp
R, MevR, 
bop 
(Pfeiffer et al., 1999; 
Schweiger, 1996) 
pWL-102 10.5Kbp; H. salinarum shuttle vector; AmpR, MevR (Lam and Doolittle, 1989) 
pBPH-M 6.06Kbp; H. salinarum shuttle vector; Amp
R, MevR, 
bop promoter, OE3349F as integration site, 7xHis (Besir, 2001) 
pMG550 
6.832Kbp; H. salinarum shuttle vector; AmpR, 
MevR, bop promoter, OE3349F as integration site, 
OE1472F, 7xHis, parental plasmid - pBPH-M 
This study 
pMG650 
7.198Kbp; H. salinarum shuttle vector; AmpR, 
MevR, bop promoter, OE3349F as integration site, 
OE1475F, 7xHis, parental plasmid - pBPH-M 
This study 
pMG750 
6.715Kbp; H. salinarum shuttle vector; AmpR, 
MevR, bop promoter, OE3349F as integration site, 
OE1477R, 7xHis, parental plasmid - pBPH-M 
This study 
pMKK100 7.2Kbp; H. salinarum shuttle vector; Amp
R, MevR, 
BgaH (Koch and Oesterhelt, 2005) 
pMG501 
7.777Kbp; H. salinarum shuttle vector; AmpR, 
MevR, BgaH, 509bp of OE1471F (trpA), modified 
terminator of FlgA, parental plasmid -pMKK100 
This study 
pMG601 
7.729Kbp; H. salinarum shuttle vector; AmpR, 
MevR, BgaH, 500bp of middle OE1475F,  parental 
plasmid -pMKK100 
This study 
pMG500 
8.185Kbp; H. salinarum shuttle vector; AmpR, 
MevR, BgaH, flanking regions of OE1472F, 
parental plasmid -pMKK100 
This study 
pMG600 
8.184Kbp; H. salinarum shuttle vector; AmpR, 
MevR, BgaH, flanking regions of OE1475F, 
parental plasmid -pMKK100 
This study 
pMG700 
7.213Kbp; H. salinarum shuttle vector; AmpR, 
MevR, BgaH, flanking regions of OE1477R, 
parental plasmid -pMKK100 
This study 
pET22b(+) 5.49Kbp; E. coli expression vector; AmpR, 6xHis Novogen 
pMG560 6.165Kbp; E. coli expression vector; Amp
R,  
OE1472F, 6xHis, parental plasmid - pET22b(+) This study 
pMG760 6.048Kbp; E. coli expression vector; Amp
R,  
OE1477R, 6xHis, parental plasmid - pET22b(+) This study 
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pMG860 6.159Kbp; E. coli expression vector; Amp
R,  
OE2019F, 6xHis, parental plasmid - pET22b(+) This study 
Plasmids for N. pharaonis 
pUS-Mev 6.3Kbp; H. salinarum shuttle vector; Amp
R, MevR, 
bop 
(Pfeiffer et al., 1999; 
Schweiger, 1996) 
pMKK100 7.2Kbp; H. salinarum shuttle vector; Amp
R, MevR, 
BgaH (Koch and Oesterhelt, 2005) 
pNB102 
9.1Kbp, N. pharaonis shuttle vector, AmpR, MevR, 
colE1.ori, pNB101 (ori of N. pharaonis strain 
AS7091, 2.5Kbp) 
(Zhou et al., 2004a; Zhou et 
al., 2004b) 
pMG100 
8.84Kbp, N. pharaonis shuttle vector, pNB101 (ori 
of N. pharaonis strain AS7091, 2.5Kbp), AmpR, 
MevR, and bop gene from pUS-Mev plasmid.  
This study 
pMG200 
9.751Kbp, N. pharaonis shuttle vector, pNB101 (ori 
of N. pharaonis strain AS7091, 2.5Kbp), AmpR, 
MevR, and BgaH gene from pMKK100 plasmid.  
This study 
5.1.4.3 Oligonucleotides 
All oligonucleotides used in this study were ordered from Metabion International 
AG (www.mymetabion.com). For the list of oligonucleotides used in this study, see 
appendix section 8.3 table #19. 
5.2 Microbiological methods 
5.2.1 Cultivation of E. coli 
For the isolation of vector DNA, E.coli was cultivated in LB medium in 4.5ml or 
50ml cultures inoculated at 37°C, 245rpm. Where appropriate, the LB medium was 
supplemented with antibiotics. For expression of proteins in E.coli, 1 liter volumes of 
LB medium (in 5 liter flasks) were inoculated with an overnight pre-culture and 
incubated at 37°C, 245rpm.   
5.2.2 Cultivation of H. salinarum and N. pharaonis 
Cultures were grown aerobically in the dark at 40°C and with constant shaking 
(100rpm). Cultivation of H. salinarum was carried out in 10ml medium (25ml flask), 
35ml medium (100ml flask) or 1liter medium (2liter flask), and were inoculated with 
pre-cultures at rates of 1/50, 1/35 or 1/29 of the culture volume, respectively. Cell 
                                                                                                  Materials and Methods 
 38 
growth was monitored by measuring optical density at 600nm (OD600) in a 
spectrophotometer. In anaerobically grown cultures, the growth rate of the cells was 
monitored by light scattering of the culture using a Klett photometer. 
Cultures of N. pharaonis were grown aerobically in the dark at 40°C and with 
constant shaking (100rpm), in 37ml medium (100ml flask). Cell growth was 
monitored by measuring optical density at 600nm (OD600) in a spectrophotometer. To 
check the affect of Bacitracin (Merck) and protease (from Streptomyces griseus, 
Biochemika, cat#81748) on cell morphology, both were added to the growing 
medium in different concentrations. 
5.3 Molecular biological methods 
5.3.1 Transformation of E. coli 
5.3.1.1 Preparation of chemically-competent cells 
A single XL-10 colony from an LB plate was used to inoculate 25ml LB medium, 
and this was incubated at 37°C, 250rpm for 7.5h. This was used was used to inoculate 
two 1liter flasks, each containing 250ml of SOB medium (Super Optimal Broth used 
for initial growth). The first flask received 10ml of the starter culture, and the second 
received 4ml of the starter culture. The two 1liter flasks were incubated at 22°C, 
150rpm. 
The following morning, growth of the cultures was monitored every 45min until 
one of the flasks reached OD600=0.5-0.55. Then the culture vessel was transferred to 
an ice-water bath for 10min. Cells were harvested by centrifugation at 2500g, 10min 
at 4°C (Sorvall rotor).  The medium was poured off, and the inverted centrifuge bottle 
was left on a stack of paper towels for 2min, to remove any drops of remaining 
medium.  
The pellet was resuspended gently in 80ml of ice cold transformation buffer, and 
the cells were harvested by centrifugation at 2500g, 10min at 4°C (Sorvall rotor). The 
medium was decanted, and the centrifuge bottle again allowed to drain on a stack of 
paper towels for 2min, to remove any drops of remaining medium. The pellet was 
resuspended in 20ml of ice cold transformation buffer, 1.5ml of DMSO added, and 
the bacterial suspension mixed by swirling followed by 10min incubation on ice. 50µl 
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aliquots of the suspension were dispensed into chilled, sterile microcentrifuge tubes. 
The competent cells were immediately snap-frozen by immersing the tightly closed 
tubes in a bath of liquid nitrogen. The tubes were stored at -70°C until needed. 
The transformation efficiency of chemically competent cells was measured, and found 
to be 6.5x106 CFU/µg plasmid.  
SOB medium (Super Optimal Broth) 
 
 
 
 
 
Powders were dissolved in 950ml water, and 10ml of 250mM KCl solution [1.86g of 
KCl in 100ml deionized water] was added and the pH adjusted pH=7.0 with 5N 
NaOH. The volume was made to 1liter with deionized water, and the medium 
sterilized by autoclaving (20min at 15psi). Just before use, 5ml of a sterile solution of 
2M MgCl2 [19g of MgCl2 in 90ml of deionized water] was added.  
Transformation buffer 
a) Preparation of 0.5M PIPES [piperazine-1,2-bis(2-ethanesulfonic acid)] (pH 6.7): 
15.1g of PIPES was dissolved in 80ml of pure water (Milli-Q), and the pH of the 
solution adjusted to 6.7 with 5M KOH. The volume was made to 100ml and the 
solution sterilized by filtration (0.45µm pore size), and divided into 20ml aliquots and 
stored at -20°C. 
b) Transformation buffer was prepared by dissolving all of the solutes listed below in 
800ml of MiliQ water, and then the volume adjusted to 1 liter. The solution was 
sterilized by filtration (0.45µm pore size), divided into 100ml aliquots and stored at -
20°C. 
 
 
Per 1 liter 
(g) 
Bacto-Tryptone 20 
Yeast extract 5 
NaCl 0.5 
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 Transformation buffer 
 
 
 
 
 
 
 
 
 
5.3.1.2 Transformation of chemically-competent cells 
A tube of competent cells was removed from the -70°C freezer, and thawed by 
holding the tube in the palm of the hand, then transferred immediately to ice for 
10min. Up to 25ng of DNA per 50µl competent cells was used, then the tubes were 
swirled gently several times, and stored on ice for additional 20min. The tube 
(competent cells+DNA) was transferred to a rack placed in a preheated 42°C 
circulating water bath for exactly 90 seconds, and immediately incubated on ice for 
2min. 800µl of LB was added, and the mixture incubated for 1h, 37°C, 250rpm. 0.5-
5µl of transformation mixture was plated on LB medium plates with appropriate 
antibiotics.    
5.3.1.3 Transformation of electro-competent cells 
20µl of electro competent cells was thawed on ice and 1-2µl of DNA was added to 
the cells, and mixed by gently tapping the tube. The cells/DNA mixture was pipetted 
carefully into a chilled 0.1cm cuvette. The cuvette was gently tapped to remove air 
bubbles, then electroporated in a Gene PulserTM (Biorad, Munich Germany) using the 
following settings: 2.0KV, 200Ω, 25µF. A typical time constants were 3.9msecond. 
Immediately after electroporation, 1ml of SOC medium (glucose-rich SOB medium 
containing 20 mM glucose, see 5.3.1.1) was added to the cuvette, and the mixture was 
transferred into a 15ml snap-cap tube, and incubated at 37°C, 250rpm for 1h. 0.5-5µl 
Reagent 
Amounts  
pre  liter 
(g) 
Final  
concentration 
MnCl2 x 4H2O 10.88 55mM 
CaCl2 x 2H2O 2.20 15mM 
KCl 18.65 250mM 
PIPES (0.5M pH 6.7) 20ml  10mM 
H2O to  1 liter  
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(in the case of plasmid propagation) or 50µl-200µl (in case of ligation reactions) was 
spread on selective plates.   
5.3.2 Transformation of H. salinarum  
Transformation of H. salinarum was performed according to the PEG method 
(Cline, 1987; Cline et al., 1989) with minor modifications. 1.5ml of culture (OD600 
0.6-0.8) was centrifuged (5min 16000g, RT) and the supernatant removed. Residual 
medium was removed after additional centrifugation (1min, 16000g, RT) using a 
pipette. The cell pellet was then gently resuspended in 150µl spheroplasting solution 
(SPH). To produce spheroplasts, 30µl of 0.25M EDTA (pH 8.0 in SPH solution) was 
added and the mixture was incubated for 5min at RT. Then 10µl of DNA (in SPH 
solution, ~1µg DNA) was added and the mixture incubated at RT for 5min. 190µl of 
60%PEG600 (in SPH solution), was added to the tube, followed by rapid mixing of the 
contents to prevent lysis of the cells due to high local concentration of PEG600. After 
20min incubation at RT, 1ml of Halo medium+15% sucrose was added to the tube in 
order to dilute the PEG. The mixture was centrifuged for 2min, 16000g at RT, and the 
supernatant removed. After an additional centrifugation (1min, 16000g, RT), residual 
medium was removed by a micropipette.  Finally, the pellet was resuspended gently 
with 1ml of Halo medium+15% sucrose and incubated at 37°C, 250rpm for 12-16h to 
allow the cells to restore their S-layer.  
Most of the plasmids in this study contained the reporter gene BgaH (coding for 
the halophilic galactosidase BgaH, from Haloferax lucentense, (Holmes and Dyall-
Smith, 2000; Patenge et al., 2000), therefore, before spreading the transformation 
mixture, the plates which contained 10µg/ml Mev, were smeared with X-gal (150µl of 
20mg/ml, followed by 30min incubation under the hood). After cell spreading, the 
plates were incubated at 40°C in a closed transparent box with ~10ml water to prevent 
the plates from drying out. Usually, transformants became visible after 10-14 days.  
Similar protocol was used for N. pharaonis with the following changes: the SPH 
buffer contained 2M Betaine, cells were recovered in M205 medium with either 15% 
sucrose or 2M Betaine, and cells were plated on M205 plates with 10µg/ml Mev. 
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Unbuffered SPH solution 
 
 
 
 
 
 
 
 
 
 
The solution was sterilized by filtration and stored at 4°C until use. 
 
5.3.3 Transformation of N. pharaonis  
5.3.3.1 PEG method 
The PEG method was similar to the one described for H. salinarum (section 5.3.2) 
but with the with the following changes for N. pharaonis: the SPH buffer contained 
2M Betaine; cells were recovered in M205 medium with either 15% sucrose or 2M 
Betaine; and cells were plated on M205 plates with 10µg/ml Mev. 
5.3.3.2 Electroporation 
Cells grown in M205 medium (OD600nm 0.5-0.7), were centrifuged (2min, 10000g, 
RT) and the supernatant was discarded. The cells were centrifuged again to remove 
residual medium and the pellet was resuspended with 4.3M Betaine (Fluka, 
cat#14300) in 50mM Tris HCl pH 8.7. Plasmid DNA was added to the cell 
suspensions and the tubes were incubated in RT for 10min. The mixture was 
electroporated (25µF, 1.5KV, different resistance, see appendix table #20). Cells were 
recovered in 800µl M205 medium with 15% sucrose or 2M Betaine (14-16h, 37°C, 
100rpm). The cells were centrifuge and the pellet resuspended in 100µl supernatant, 
then the cells were plated on M205 plates+10µg/ml Mev. 
5.3.3.3 Gun particle 
1.5-3x108 cells/ml of E. coli, N. pharaonis and H. salinarum were plated on LB, 
halo medium and M205 medium plates, respectively, and then incubated at 37°C (14 
days for haloarchaea and o.n for E. coli).  
Reagent 
Amounts  
(per 100ml) 
Final  
concentration 
NaCl 11.7g 2M 
KCl 2.5ml of 1M 25mM 
Sucrose  15g 15% (w/v) 
H2O to 100ml  
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The microcarriers (either M5 Tungsten or gold particles) were prepared one day 
before the bombardment, and coated with DNA on the day of the bombardment. The 
microcarriers were coated according to Bio-Rad recommended protocol ((Kikkert, 
1993). 500µg of microcarriers were used per bombardment, based on the method of 
Sanford et al., (Sanford et al., 1993).  
0.625µg DNA was use for each bombardment event. The Biolistic®PDS-100/He 
device (Bio-Rad) was used (Kikkert, 1993), using helium pressure was 1100psi, gap 
distance (i.e. the distance between the helium source and the flying disk) of  1cm, and 
target distance (i.e. the distance between the partical launch site and target cell) of 
6cm. Cells were stamped to selective plates (10µg/ml Mev) and colonies were visible 
after 8 weeks. 
5.3.4 Preparation of genomic DNA from H. salinarum 
300µl of culture in the stationary phase (~ OD600 =1) was centrifuged for 2min 
16000g at RT. The supernatant was discarded and the pellet recentrifuged (1min, 
16000g, RT) to remove residual medium. Cells were lysed with 200µl sterile 
autoclaved H2O (bi- distilled). The crude DNA, without further purification, was 
stored at 4°C.   
5.3.5 Isolation of plasmid DNA from E. coli 
Single colonies of E.coli transformants were picked from LB agar plates 
containing antibiotic. Cells were grown overnight (37°C, 250rpm) in 4.5ml LB 
medium with antibiotics and harvested by centrifugation (15min, 3200rpm, 4°C). 
Plasmid isolation was performed with QIAprep Spin Miniprep Kit (Qiagen), 
according to the manufacturer’s detailed guide. Elution was done with 50µl of EB 
buffer (10mM Tris HCl, pH 8.5).  
5.3.6 Agarose gel electrophoresis 
Horizontal agarose gels slabs were used for analysis and separation of PCR 
products. The gel was prepared by melting the agarose with TAEx1 (running buffer). 
After the gel had solidified, the DNA samples were mixed with sample buffer and 
pipeted into the wells. For Southern blots, 1.5µg of genomic DNA per digest was used 
for each well, while 0.1µg of digested plasmid (used as controls for the specificity of 
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the labeled probes) were loaded into each well. 1Kb DNA MW ladder (Life 
Technologies Inc) was used as the size standard. The DNA pattern was visualized by 
staining the gel for 15min in 0.1mg/ml ethidium bromide followed by washing for 
15min in H2O and illumination by UV light at 302nm. 
 50 x TAE 
 
 
 
 
 
 
 
Sample buffer 
 
 
 
 
 
 
 
5.3.7 Isolation of DNA from preparative agarose gels 
Preparative gels (1-2.5%), were performed for purification of PCR products and 
the products of endonuclease digests. The isolation of DNA fragments was carried out 
using the Wizard®SV Gel and PCR Clean-Up System kit (Promega), according to the 
protocol of the manufacture. 
Reagent 
Amounts  
(per 1 liter) 
Final  
concentration 
Tris base 242g  2M 
Acetic acid 57.1ml 0.997M  
EDTA (disodium salt) 18.61g 50mM 
H2O to 1liter  
The pH was adjusted to 8.0 using acetic acid 
Reagent Amounts/ volumes  
Final  
concentration 
Sucrose 50g 50% 
0.5M EDTA (disodium salt) 20µl 0.1mM 
Bromophenolblue 10mg 0.1% (w/v) 
10% SDS 1ml  0.1% (w/v) 
H2O to 100ml  
pH was adjusted to 7.0 with NaOH 
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5.3.8 Determination of DNA concentration 
DNA concentration was determined by analytic agarose gel electrophoresis. A 1µl 
volume of each DNA sample was loaded onto a gel that included 10µl of an 
appropriate DNA ladder. The concentration of the individual bands in the ladder 
allowed estimation of the DNA concentration. Alternatively, the concentration was 
determined using a NanoDrop®ND-1000 spectrophotometer (NanoDrop) using 1-5µl 
sample, measuring the absorbance at 260 and 280nm. The concentration of the DNA 
sample was calculated using an extinction coefficient of 50ng/ml (dsDNA) and 
33ng/ml for single-stranded DNA (ssDNA).    
5.3.9 Sequencing of DNA 
An ABI PRISM BigDye Terminator Cycle Sequencing Kit (Applied Bioscience, 
Foster City, CA, USA) was used for sequencing. The Terminator Ready Reaction Mix 
contained labeled ddNTP’s (BigDye terminator), dNTP’s mixture, AmpliTaq DNA 
polymerase and MgCl2 in Tris HCl pH 9.0.  Usually 2-3µl of mini-prep DNA was 
added as template before the reaction mixture was applied to the thermo-cycler. The 
product of the sequencing reaction was diluted 1:2 with 10µl H20 (bi-distilled) or 
0.4% SDS and sent to the in-house core facility to generate the DNA sequences 
chromatograms. These were analysed using the program BioEdit (Hall, 1999). 
Sequencing reaction 
1µl reaction mix (enzyme, dNTP’s) 
1µl buffer 
2µl 5M Betaine 
2-3µl DNA after mini prep 
2µl 5pmole/µl primer 
to 10µl H2O 
 
5.3.10 Polymerase chain reaction (PCR) 
Depending on the aim of the PCR, either Taq polymerase or the proof-reading 
polymerase LA taq were used. These were added to the reaction mixture immediately 
before starting the PCR.  
 
Thermocycler steps 
96°C  DNA melting 
30 
cycles 
60°C Annealing and elongation 
4°C Pause  
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Transformant colonies were screened for gene deletions by direct colony PCR using 
primers targeting the flanking regions of the particular genes. The PCR mixture was 
prepared as a master mix, and then 10µl volumes were transferred into individual 
PCR tubes. Colonies were picked by sterile toothpick, restreaked on plates and 
subsequently rolled in the reaction mix (10µl).  
Taq polymerase in colony PCR 
 
 
 
* The colony PCR procedure was used for initial screening. The presence of the dyes did not 
interfere with the amplification. Candidates for deletion mutants were further checked using 
LA Taq polymerase.  
 
PCR Temperature profile  
step Temperature & Time  cycles 
Initial denaturation 94°C, 4min x1 
Denaturation 94°C, 30sec 
x 39 
Annealing Tm+4°C, 40sec 
Elongation 72°C, X min**  x1 
Final elongation 72°C, 10min  
** The times needed for the elongation step were adjusted according to the product length, 
using the formula: 1min per 1Kbp.   
 
Reaction mixture 
Thermopol buffer (x10) 1µl 
Forward/reverse primer (5pmole/µl) 1µl 
dNTP’s (1.25mM each) 0.8µl 
DMSO 0.4µl 
Taq polymerase (5U/µl) 0.2µl 
SBx5 for colony PCR          2µl 
DNA from 1 colony  
H2O (bidis, autoclaved) to 10µl 
Stock SBx5 * 
5.8ml Glycerol (stock 86% V/V) 
3.8ml ddH2O 
100µl of Bromophenol blue  
(saturated solution) 
100µl xylen cyanol  
(saturated solution) 
200µl 1M TrisHCl pH 7.2 
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LA taq polymerase  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
** The times needed for the elongation step were adjusted according to the product length, 
using the formula: 1min per 1Kbp.   
 
5.3.10.1 Ligation of DNA fragments  
Ligation reactions were performed with ~100ng DNA, 1U of T4 DNA ligase 
(Invitrogen), 2µl of reaction buffer (x5) in total volume of 10µl. Before the reaction, 
the concentrations of the insert and vector were determined either by agarose gel 
electrophoresis or a Nanodrop spectrophotometer. Inserts and vectors with compatible 
cohesive ends were usually incubated in molar ratios of 4:1 to 2:1 overnight at 10°C.  
Reaction mixture 
LA Taq buffer II (x10) (Mg2+ plus) 5µl 
Forward/reverse primer (5pmole/µl) 5µl each 
dNTP’s (1.25mM each) 8µl 
DMSO 1µl 
Taq polymerase (5U/µl) 0.25µl 
Genomic DNA (5.3.3)        1-2µl 
H2O (bidis, autoclaved) to 50µl 
PCR Temperature profile 
step Temperature  
& Time  
cycles 
Initial  
denaturation 
95°C, 6min 
 
Denaturation 95°C, 1min 
x 24 
Annealing Tm+4°C, 40sec 
Elongation 72°C,  X min**  
Final elongation 72°C, 7min  
                                                                                                  Materials and Methods 
 48 
5.3.10.2 Digestion of DNA by restriction endonucleases 
A typical digestion reaction (40µl) contained 4µl (40-80U) of restriction enzyme, 
and 4µl of the corresponding 10x reaction buffer (as recommended by the 
manufacture). The concentrations of DNA were determined either by agarose gel 
electrophoresis or by Nanodrop spectrophotometer, to 10µg of vector and 0.12-0.38µg 
of insert.  
5.3.10.3 ORFs OE1472F, OE1475F, OE1477R, and OE2019F from H. 
salinarum 
For homologous overexpression, the genes OE1472F, OE1475F and OE1477R 
(http://halolex.mpg.de) were amplified by a one step PCR, using the proofreading 
DNA polymerase LA-Taq, genomic DNA from H. salinarum strain R1 as a template, 
and the primers listed in appendix table #18, (pMG550, pMG650, and pMG750, 
respectively). The entire ORF’s were amplified, but without a stop codon, then 
digested with HindIII and BamHI and subcloned into the E. coli-H. salinarum shuttle 
vector pBPH-M. The pBPH-M vector contains an inducible bop promoter at the 5′ 
end of the cloned gene, and a 7xHis C-terminal purification tag followed by a stop 
codon. Selection is via a MevR marker, and part of OE3349F is present to allow 
integration into the chromosome. 
For heterologous overexpression, the genes OE1472F, OE1475F, OE1477R and 
OE2019F were amplified by PCR using the proofreading DNA polymerase LA-Taq, 
genomic DNA from H. salinarum strain R1 as a template, and the primers listed in 
appendix table#18, (pMG560, pMG660, pMG760, and pMG860, respectively). The 
genes (without the stop codon) were amplified, digested with NdeI and XhoI and 
subcloned into a similarly treated pET22b(+) expression vector.  
5.3.10.4 Plasmids for gene deletion 
Single, in-frame deletions were achieved by homologous recombination using 
“suicide plasmids” carrying the flanking regions of each gene. The upstream (US) and 
downstream (DS) regions of the target genes were amplified separately by PCR 
(~500bp each) and specific restriction sites were introduced at each end. BamHI and 
PstI sites were introduced at the 3’ end and 5’ end (respectively) of the US region. 
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PstI and HindIII sites were introduced at the 3’ end and 5’ end (respectively) of the 
DS region, as seen in the figure #13A- B below.  
 
 
 
 
 
 
Figure # 13
 
: The construction of gene deletion vector. The US (I) and DS (II) regions of a 
specific gene (A) were amplified with restriction sites using primers P1+P2, and P3+P4, 
respectively (B), then US (I) and DS (II) regions were ligated after cleavage with PstI (C).  
   The US and DS amplified sequences were purified from a 1% preparative 
agarose gels (figure #14A), then cleaved with PstI and ligated to each other using T4 
DNA ligase. The overnight ligation was followed by PCR using the ligated US+DS 
regions as template with primers P1 and P4. 
 
 
 
 
 
 
Figure # 14
 
: A - A preparative agarose gel with US (lane 1,2) and DS (lane 3,4) regions after 
amplification by PCR. B- Analytical 1% agarose gel of ligated US+DS sequences after PCR 
amplification using P1 and P4 as primers. The positions of MW size marker bands are 
indicated at the right of each panel (in bp). 1% agarose gel. 
The PCR amplified US+DS regions (figure #14B) of each gene were purified, and 
then ligated into pCR 2.1-TOPO vector. Positive candidates were chosen according to 
the size of the inserts obtained after the cleavage with EcoRI. A correct construct will 
give fragments of 3.9Kbp, and ~1Kbp, as seen in figure #15 below. 
                                                                                                  Materials and Methods 
 50 
 
 
 
 
 
 
Figure # 15
 
: EcoRI-digested plasmids from independently picked transformants after TOPO 
cloning (lanes 2-11). Correct clones contain 3.9Kbp, and 1Kbp fragments. MW markers are 
shown in lanes 1 and 12 (in bp), 1% agarose gel. 
   The constructs shown in lanes 3-9 (figure #15) were sequenced and confirmed to 
have the correct sequence. One of these was selected, cleaved by BamHI and HindIII, 
separated on a 1% preparative agarose gel, and the 1031bp cloned fragment purified.  
   The plasmid pMKK100, which was used as backbone, was cleaved as well with 
BamHI and HindIII and dephosphorylated. The purified, cleaved US+DS regions 
were ligated into the dephosphorylated and cleaved pMKK100 vector. The ligated 
DNA was introduced into competent E. coli XL-10 cells. Transformed colonies 
carrying plasmids containing the US+DS regions were identified by electrophoresis of 
plasmid extracts, similar to the example shown in figure #15. The correct construct 
was chosen according to the cleavage pattern of the purified plasmid with BamHI and 
HindIII. Correct constructs show a ~1Kbp fragment (the insert) and a ~7.1Kbp 
fragment (the vector pMKK100).   
   The plasmids used for in-frame ORF deletions, contained the US+DS regions of 
OE1472F, OE1475F and OE1477R, respectively. In addition, each plasmid contained 
AmpR, and MevR regions as selection markers, and the BgaH gene as the reporter 
gene for blue/ red screening, as seen in the figure #16. 
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Figure # 16
 
: Diagrammatic map illustrating the plasmids pMG500, pMG600, and pMG700. 
The plasmids were used to generate single in-frame deletions of OE1472F, OE1475F and 
OE1477R, respectively. 
5.3.10.4.1 Blue/red screening of transformant colonies  
The gene deletion plasmids directed at ORFs OE1472F, OE1475F and OE1477R, 
were introduced into H. salinarum R1 cells using the PEG method (materials and 
methods section 5.3.2), and plated on complex medium containing mevinolin (Mev) 
and X-gal. A successful first cross-over event would produce blue colored 
transformants colonies. During the first cross-over, the complete plasmid would 
integrate into the genome via homologous recombination between either the upstream 
region (US) or the downstream region (DS) on the plasmid and the corresponding 
region in the genome. Thus, positive transformants would be resistant to mevinolin 
and develop a blue color on plates containing X-gal.  
Blue colored transformants were then transferred into medium without Mev, which 
allowed a second cross-over event to take place, excising the plasmid together with its 
Mevinolin-resistance and β-galactosidase genes from the genome. Even after several 
generations, second cross-over events occur only in small fraction of cells. On plates 
containing X-gal without Mevinolin, cells which had undergone a second cross-over 
were identified based on their red color (due to bacteriorhodopsin and 
bacterioruberin) in contrast to blue colonies that still contained the plasmid. As the 
second cross-over can occur in two ways (figure #17), deletion of the target gene is 
expected to occur in only ≤50% of the red colonies.  
While two successive cross-over events between the same homologous regions 
(i.e. two US or two DS cross-over events) would lead to restoration of the parental 
genotype, an US cross-over followed by a DS cross-over (or vice versa) would lead to 
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deletion of the target gene. After the second cross-over event, the target gene bounded 
by the flanking regions will be eliminated and replaced by the direct fusion of the 
flanking regions as present on the plasmid. Gene deletions were verified by PCR 
analysis and Southern blot.  
 
 
 
 
 
 
 
 
 
 
 
Figure # 17:
 
 Schematic illustration of the first and second cross-over events. The plasmid 
contains the fused upstream (US) and downstream (DS) regions of the target gene. The first 
cross-over is exemplified by a cross-over of the US region in the plasmid and US in the 
genome, but can also occur between the DS regions. If the second cross over occurs between 
the US region again (A), the genotype of the parent strain is restored. If the second cross-over 
occurs between the DS regions (B), the target gene is deleted. Diagram prepared by Dr. 
Wilfried Staudinger 
 
5.3.10.5 Southern blot analysis 
1.5µg of chromosomal DNA from WT and gene deletion candidates, were cleaved 
with a restriction enzyme, and the DNA fragments separated on a 1% agarose gel. The 
gel was vacuum-blotted onto a nylon membrane (Hybond-N, Amersham), using 
essentially the method of Southern (Southern, 1975). For size determination of the 
DNA fragments, digoxigenin-labeled DNA molecular marker VIII (Roche diagnostic, 
Mannheim, Germany) was included on the gel. All gel pretreatment steps, such 
depurination, denaturation and neutralization were done as recommended by Southern 
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(Southern, 1975).  After UV-crosslinking the DNA to the membrane, all further steps, 
including prehybridzation, hybridization, washing and chemiluminesecent detection 
with CSPD, were performed according to the manufacturers recommendations (Roche 
diagnostic, Mannheim, Germany).  
Probes for hybridization were generated by incorporation of digoxigenin-labeled 
dUTP in a PCR, using DIG labeling mix Plus (Roche). Two 500bp labeled probes were 
designed to hybridize to the up-stream region of the gene and to the internal region of 
the corresponding gene.  
5.3.11 Microarrays 
5.3.11.1 Microarray design 
The microarray was designed as described by Twellmeyer et al., (Twellmeyer et 
al., 2007 119). Each γ - amino-silane coated CMT-GAPS-II glass slide was spotted 
with five replicates of 2774 DNA probes, manufactured as described by Twellmeyer 
et al., (Twellmeyer et al., 2007). 
5.3.11.2 Isolation of total RNA 
9ml cultures of H. salinarum R1, grown in different media and to different 
OD600nm, were harvested by centrifugation (5min, 8000rpm, 4°C). The pellet was 
resuspended with 6ml of peqGOLD RNApure (peqLAB Biotechnology, Erlangen, 
Germany), and the mixture was frozen in liquid nitrogen and stored at -80°C. Total 
RNA was extracted using chloroform/phenol extractions, washing with 75% EtOH 
and finally the RNA dissolved in 100µl DEPC-treated water. The RNA was DNase 
treated with DNAase kit DNA-free (Ambion, Huntington, United Kingdom) and the 
absence of DNA was confirmed by a PCR using LA Taq,  primers P1 and P2 for ORF 
OE1472F (500bp, appendix table #18), 35 cycles and RNA before and after digestion 
as templates (figure #18A). The quality of the DNA-free total RNA was assessed by 
1% denaturating agarose gel in TBE buffer. Intact total RNA run on a denaturating 
gel will have sharp, clear 23S and 16S rRNA bands (figure #15B). The concentration 
of intact total RNA was determined using NanoDrop®ND-1000 spectrophotometer 
(NanoDrop). The concentration of the RNA sample was calculated using the formula 
1OD260nm=40ng/ml ssRNA.   
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Figure # 18
 
: Examples of RNA preparations. A- 1% agarose gel in TAE buffer with 4 
isolated RNA samples before and after 1st and 2nd DNA digest. Lanes 6 and 12 are positive 
controls, Chromosomal DNA of R1. The MW markers are shown in lanes 1 and 17 (in bp). B-
1% denaturating agarose gel in TBE buffer with 4 RNA samples after 2nd DNAse digestion. 
 
10xTBE buffer  
 
 
 
 
 
 
 
1% denaturating agarose gel in TBE buffer 
To 100ml 1% agarose gel in TBE buffer (after melting and cooling down) add 0.236g 
guanidine thiocyanate (MW=118g/mole, final concentration, 20mM). 
RNA samples  
RNA samples were diluted 1/10 with DEPC-treated water, the SB was added, and the mixture 
was heated to 75°C for 5 min and immediately loaded on the gel and electrophoresed. 
5.3.11.3 Microarray analysis 
Adapted cultures of H. salinarum were grown in synthetic medium with or without 
AroAAs, and cells were harvested by centrifugation at OD600nm=0.2 and 0.58, 
respectively. Additionally, the deletion strain ∆OE1477R and WT H. salinarum were 
Reagent 
Amounts  
(per 1liter) 
Final  
concentration 
Tris base 108g  0.89mM 
Boric acid 55g 0.889mM  
0.5M EDTA pH=8.0 in DEPC water 40ml 2mM 
DEPC-water to 1liter  
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grown in synthetic medium supplemented with 1.1mM AroAAs+1.1mM Shikimate. 
RNA was isolated from cell samples as described above. 
3µg of total RNA was reversed transcribed into cy5 or Cy3-labled cDNA using a 
CyScribe first-strand cDNA synthesis kit with random nonamer primers and 
Cy5/Cys3-dUTP (Amersham Biosciences, Freiburg, Germany). RNA was removed 
by alkaline hydrolysis, and the cDNA purified and concentrated as described by 
Zaigler et al., (Zaigler et al., 2003). After prehybridization, labeled cDNA was 
pipetted onto the microarray which was then sealed in hybridization chamber for 
overnight at 64°C. The microarrays were washed and dried by centrifugation (5min, 
1500rpm), as described by (Zaigler et al., 2003). Labeled cDNA from cells grown 
with AroAAs was hybridized with labeled cDNA from cells grown without AroAAs 
(in two different OD’s). Additionally, labeled cDNA from R1 grown with AroAAs 
and shikimate was hybridized with labeled cDNA from mutant ∆OE1477R grown in 
the same medium (in two different OD’s). 
Hybbridized microarray slides were scanned for Cy5 and Cy3 florescence signals 
using a   GenePix 4000B scanner (Biozym Seientific GmbH, Hessisch Oldendrof, 
Germany). Image processing was done with GenePix Pro 6 (Biozym Scientific 
GmbH) and the florescence values were processed in the R environment using a 
program written by G. Welzl (Twellmeyer et al., 2007). Significant gene regulations 
were identified by a one-sample t-test as implemented in the TIGR MultiExperiment 
viewer (Saeed et al., 2003). A gene was considered to be significantly regulated if the 
regulation factor was three fold or higher, and the calculated P value of the regulated 
gene was P <0.001. 
5.3.12 RT-PCR 
1µg total RNA was reversed transcribed with 400ng random hexamer primer and 
50U of Reverse-iTTM RTase Blend (ABgene House, UK). Quantitative PCRs were 
performed in Bio-Rad iCycler MyiQ™ single-color Real-time PCR detection system 
using a SYBR green PCR master mix kit (from AB Applied biosystems). The final 
reaction volume was 25µl with 0.5µl of the reverse transcription reaction serving as 
template. Primers were designed with Primer3 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and were used at a final 
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concentration of 0.92 pmole/µl (see appendix table #18 for the sequence of the 
primers).  
Transcript level differences were calculated by a relative quantification approach 
using an internal standard gene, OE1160R, which encodes ribosomal protein L10.eR. 
For all calculations, the mean-Ct of 2 replicate reactions per primer pair was used. 
5.4 Protein Methods 
5.4.1 SDS-PAGE of proteins 
The SDS-polyacrylamide gel electrophoresis system used in this study essentially 
followed the method of Laemmli (Laemmli, 1970; Schagger and von Jagow, 1987). 
Protein samples, at a concentration of 10µg/ml (determined by BCA method), were 
mixed with sample buffer, boiled for 10min at 95°C, followed by 5min centrifugation 
(16000g, RT), and the supernatant loaded into the wells. In addition to this, E.coli cell 
lysates were sonicated (5min in sonication bath) before the centrifugation. The protein 
samples were loaded on ready-to-use 4-12% NuPAGE®Novex®Bis-Tris Mini Gels 
(Invitrogen), with running buffer (MES SDS running buffer) prepared according to 
the manufacturer’s recommendation. Running conditions: 10min at 100V constant 
voltage, followed by ~55min at 200V constant voltage.  5µl of prestained protein 
marker (PageRuler, Fermentas) was also loaded. Electrophoresis was stopped when 
the lower band in the marker reached the bottom of the gel. The gel was stained for 
25min with Coomassie Blue and protein bands were visualized after the gel was 
subsequently treated with destaining solution. 
0.5M Tris-HCl pH 6.8 
5xSDS-PAGE sample buffer 
10% glycerol 
2.3% (w/v) SDS 
5% DTT 
0.1% bromophenyl blue 
Coomassie blue R-250 
Staining solution 
Destaining solution 
125ml Isopropanol 
(1liter) 
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100ml Acetic acid 
775ml RO water 
5.4.2 Western blot analysis 
Protein samples were separated on SDS-PAGE as described above but with two 
differences: 1µg of protein was separated, and only 3µl of the prestained marker was 
used. The protein bands from the polyacrylamide gel were transferred onto a PVDF 
membrane (ImnobilonTM-P, Millipore, 0.45µm pore size) for immunodetection. The 
transfer method was based on the semidry electrobloting system using an XCell II 
Blot Module (Invitrogen). Transfers were performed for 2h, RT, 170mA, 25V. The 
membrane was incubated with blocking reagent overnight at 4°C. 
His-tagged proteins were detected using the ECL Plus Western blot Detection 
system (GE Healthcare). The membrane was incubated with mouse anti-His Tag 
monoclonal IgG1 antibody (diluted 1:2500 in 3%BSA in TBST) for 1h at RT with 
slow shaking. Unbound antibody was removed by washing (3x20ml TBST) followed 
by a second series of washes (3x25ml 3%BSA in TBST, for 10min each at RT). Then 
the membrane was incubated with horseradish peroxidase (HRP)-conjugated goat 
anti-mouse IgG (diluted 1:12500 in 3%BSA in TBST) for 1h at RT. Unbound 
secondary antibody was removed by washing in 3x20ml TBST followed by 3x25ml 
TBST, for 10min each at RT. The membrane was treated with 1ml of detection 
reagent mixture for 1min. After draining off the excess reagent, the membrane was 
covered with plastic wrap and exposed to x-ray film for 30sec up to 2min.   
Semi dry blotting buffer
25mM Tris (3.03g) 
:  
192mM Glycine (14.4g) 
20% (v/v) methanol 
To 1liter with pure water 
The pH of the solution was 8.3.   
100mM TrisHCl 
10xTBST buffer, pH 7.4 
1.5M NaCl 
2% (w/v) Triton X100 
3% (w/v) BSA in 200ml TBST (for one blot) 
Blocking solution 
                                                                                                  Materials and Methods 
 58 
5.4.3 Determination of protein concentration 
The concentration of the protein was analyzed by the BCA Protein Assay 
according to the protocol of the manufacture (Pierce), using Bovine serum albumin 
(BSA) to generate a standard curve.  
5.4.4 EasyXpress protein Synthesis Kit (Qiagen)  
Following the manufacturer’s recommendations, 0.6µg of each plasmid was mixed 
with E. coli extract and the reaction mixture incubated at 37°C for 1h, shaking at 
500rpm. The in-vitro expression was analyzed both by SDS-PAGE and Western blot.   
5.4.5 Expression and purification of OE1472F, OE1475F and 
OE1477R from R1 
E. coli DH3-Rosetta (Invitrogen) was used as host strain for the expression 
plasmids: OE1472F-His C-6xhis/ pET22b(+), OE1477R-His C-6xhis/ pET22b(+), and 
OE2019F-His C-6xhis/ pET22b(+), respectively. Cells from single colonies were 
inoculated into 50ml of LB with antibiotics and incubated overnight, 37°C, 250rpm. 
These were used to inoculate 1liter LB (with antibiotics) in 5liter flasks, giving an 
initial cell density of 0.1OD600nm. The cells were induced with 1mM IPTG for 3h 
(37°C, 200rpm), after the OD600nm reached ~ 0.6. The cells were harvested by 
centrifugation (4000rpm, 40min, and 4°C). The cell pellet from each 2 liter culture 
was stored at -70°C until further use.  
Before purification on NiNTa affinity column, the cell pellet was thawed on ice 
and resuspended with 50ml NP buffer containing DNAase. PMSF 
(Phenylmethylsulfonyl fluoride) in 2-propanol was added to the suspension to a final 
concentration of 0.2mM and the cells were lysed using a French press (2 passages, 
1000psi). After centrifugation at 40000rpm, 40min, 4°C (Ti50), the resulting 
supernatant was diluted to a final volume of 250ml with NP buffer. The NiNTa 
column (HisTrpTMHP) was equilibrated with NP buffer, and the bound fraction eluted 
with a step gradient between NPI200 and NPI250.  
For homologous overexpression of OE1472F, OE1475F and OE1477R, the 
recombinant vectors OE1472F-His C-7xhis/pBPH-M, OE1475F-His C-7xhis/pBPH-M and 
OE1477R-His C-7xhis/pBPH-M, were introduced into H. salinarum R1 cells using the 
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PEG method. The cells were plated on Halo medium plates containing 10µg/ml Mev, 
and transformants were grown up in 35ml Halo medium +10µg/ml Mev. These 
cultures were used to prepare total DNA, which was used to identify colonies that 
contained the plasmid. 1liter of halo medium+10µg/ml Mev was inoculated, and the 
cells were harvested by centrifugation (7200rpm, 20min, 4°C). The cell pellet was 
resuspended in 3ml 3.4M KCl+10mM NaCl+25mM Tris HCl pH 7.2. The cells were 
lysed by sonication (till ~90% of the cells were broken), DNAase was added and the 
solution was mixed 30min at RT, shaking. After centrifugation (45000rpm, 1h, 12°C, 
TI50), the concentration of total proteins in the cell-free extract was determined by the 
BCA protein assay (Pierce). 
5.4.6 N-terminal sequencing 
N-terminal sequencing by the Edman degradation method was performed by the 
core facility in the Institute. Proteins were either sequenced from solution of from 
PVDF membranes as solid support. 
5.4.7 Amino acid analysis 
200µl samples were taken from cultures of R1 and deletion strains cultures grown 
in various media, at different time points (~5 points per growing curve). The samples 
were centrifuged (5min, 16000g, RT), and the supernatant from each time point was 
divided into two tubes. The supernatants were stored at -20°C until all samples were 
collected. Amino acid analysis was done by Mr. Wolfgang Strasshofer from the core 
facility, using an Amino Acid Analyzer (Biotronik LC3000). The data in figures #31, 
38 and 41 represents aggregate data from 3-4 cultures that were prepared and 
processed separately. 
5.4.8 Activity assays 
5.4.8.1 Aldolase activity using a coupled enzyme assay 
The activity of commercial Aldolase (Sigma) was measured using the coupled 
enzyme assay suggested by the manufacturer. The coupled assay involved 3 enzymes: 
Aldolase (from rabbit muscle) which cleaves F-1,6-P into DHAP and GAP; 
Trioesphosphate Isomerase (TIM, EC 5.3.1.1), which is responsible for the 
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isomerasation of GAP to DHAP; and Glyerophosphate Dehydrogenase (GDH, 
EC1.1.1.8), which reacts with DHAP in the presence of NADH as cofactor, as seen 
below:   
F-1,6-P   +   H2O        GAP   +   DHAP 
GAP      DHAP 
2 DHAP + 2NADH     2 Glycerophosphate +  2NAD+ 
 
In a 1.0 ml reaction mix, the final concentrations were 84mM Tris, 1.92mM F-1,6-
P, 0.15mM NADH, 1.67U GDH, 16.7U TIM, and 14.84mU Aldolase. The activity 
was measured at room temperature following the decrease in the absorbance (340nm) 
when Aldolase was added to the reaction mixture. The slope of the graph 
(∆A(340nm)/min) was used for calculating the specific activity of the Aldolase. The 
extinction coefficient of NADH used for the calculation was 6.22mM-1 x cm-1. One 
unit will convert 1.0µmole of F-1,6-P to DHAP and GAP per minute at pH 7.2 at RT. 
5.4.8.2 Colorimetric assay of Aldolase 
Aldolase activity was assayed by the colorimetric procedure of Silbley and 
Lehninger (Sibley, 1949) with some modifications. Activity was assayed in a 0.5ml 
reaction mixture in the presence of 2M KCl with 78.7mM Tris HCl (pH=7.2), 1mM 
Cysteine, 0.5mM FeCl2, 56µM hydrazine sulfate (in 50mM Tris HCl pH=7.2), and 
1.2µM F-1,6-P, as substrate. The reaction (37°C, 30min) was terminated with 2ml of 
10% TCA, and the chromogens developed were read at 540nm. Blank tubes contained 
1.2µM F-1,6-P, which was added after the addition of TCA. Aldolase activity was 
expressed as µmoles DHAP formed/mg protein/30min at 37°C.  
5.4.8.3 3-Dehydroquinate dehydratase 
The activity of 3-dehydroquinate dehydratase was assayed by monitoring the 
formation of 3-dehydroshikimate (DHS) at 234nm (ε=12x103 M-1cm-1) at RT. The 
standard assay mixture (1ml) contained 2.625M KCl+43.75mM Tris-HCl pH=7.2, 
10mM 3-dehydroquinate (DHQ, synthesized by Mr. Jurgen Musiol) (Bottomley et al., 
1996).   
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5.4.8.4 LC-MS  
The enzyme activity of recombinant proteins was measured after derivatization of 
the reaction products and subsequent analysis by LC-MS. ~51µg enzyme in 3M KCl 
+50mM Tris HCl pH=7.2 were mixed with 2.5mM F-1,6-P or 2.5mM DKFP and 
2.5mM ASA, in a total volume of 60µl, and incubated at 37°C for 30min or o.n. For 
the derivatization, 2mM o-(-4-nitrobenzyl)-hydroxylamin-hydrochlorid (NBHA) in 
MeOH was added, in a final volume of 150µl. The mixture was centrifuged (5min, 
16000g) and the supernatant was incubated for 1h at 60°C.  
Up to 10µl of the derivatized mixture was loaded on a C18 reverse phase column 
(25°C, flow-250µl/min). Derivatized reactants and products were eluted with ACN ( 
2min 10% ACN, 28min gradient from 10%-30%, 5min 70% ACN, 2min 90% ACN, 
11min 10% ACN), and monitoring was at 210nm and 254nm.  
The activity of commercial Aldolase was measured using LC-MS. 16.7U/ml TIM, 
1.92mM F-1,6-P, 14.84Mu/ml Aldolase in 84mM Tris-HCl pH=7.2 in total volume of 
60µl were incubated at 37°C, for 30min. The derivatization with NBHA, and the 
elution was done as described above. The samples were measured by Mrs. Lissy 
Weyher-Stingl 
5.4.8.5 GC-MS 
A two-step derivatization of the samples was used to aid the identification of 
reactants and products. The first step was methoximation of the carbonyl group with 
freshly prepared methoxyamin in pyridin. The second step was derivatization with 
TMS or TBS (Macherey Nagel) to form the corresponding derivatives.  
Briefly, the desired volume of sample was dried down using a Spedi-vac, and then 
resuspended in 10µl of freshly prepared methoxyamin (20mg in 1ml pyridine, 
MW=83.52g/mole). The mixture was stirred for 90min at 30°C and 900rpm. 90µl of 
TMS or TBS were added to each sample, and the tubes were mixed for a further 
30min, 900rpm at 37°C (for TMS) or 75°C (for TBS). 30µl of the derivatized sample 
was transferred to a glass vial. 1µl of the derivatized sample was injected to the GC-
MS, eluting with step gradient of temperature. GC-MS was carried out using a 
TermoQuest gas chromatograph (TraceGC) equipped with a Rtx-5Sil MS 
W/Integra-Guard ™ column (Restek, 30mx0.25mmx0.25µm) that was directly 
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connected to a ion trap mass spectrometer (Polaris Q from Finnigen). The injection 
volume was 1µl at a carrier gas flow of 1.2ml/min helium with a splitless injector.  
The initial oven temperature of 60°C was maintained for 2min and then raised to 
120°C at 8°C/min. Several temperature gradient were used including raising the 
temperature to 155°C at 6°C/min and maintaining the temperature for 5min, than 
raising the temperature to 250°C at 10°C/min for 12min, and finally raising the 
temperature to 300°C at 15°C/min and maintaining the temperature for 3min. Mass 
spectra were analyzed in the rang of 60-750 atom mass units. MS data were processed 
using the program Xcalibure. 
The samples were both derivatized and measured by Mrs. Sigrid Bauer. 
5.5 Synthesis 
Numerous compounds used in this thesis were synthesized by Mr. Jurgen Musiol. 
Among them were: ASA (L-aspartate semialdehyde), DKFP (6-deoxy-5-ketofructose 
1-phosphate), DHQ (3- dehydroquinate) and HPAP- hydroxpyruvaldehyde 
phosphate. 
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6 Results  
6.1 Mutations of key ORFs in AroAAs biosynthesis 
pathway  
In the proposed pathway of aromatic amino acids (AroAAs) synthesis, seen in 
figure #19, the first three steps are catalyzed by enzymes encoded by ORF’s 
OE1472F, OE1475F, and OE1477R, respectively. Deletion of these genes should 
convert H. salinarum to aromatic amino acid auxotrophy, and may lead to the build 
up of precursor metabolites. This was tested by the construction and analysis of 
mutant strains deleted in each of the three genes. In the first step, the phenotype of the 
WT strain was tested and then plasmids were engineered to enable in-frame deletion 
or insertion mutants of the target genes. 
Figure # 19
 
: The proposed pathway of AroAAs biosynthesis in H. salinarum. The first three 
steps of the pathway are shown along with the H. salinarum ORFs (in red) believed to specify 
required enzymes. The number of enzymes needed for synthesis of the later intermediates is 
indicated above the arrows.  
6.1.1 H. salinarum strain R1 can grow without AroAAs 
   The ability of R1 to grow in synthetic medium with and without AroAAs was 
determined by monitoring the growth of R1 after adaptation to synthetic medium with 
different concentrations of AroAAs. The results are presented in figure #20.  
The addition of AroAAs to the synthetic medium improved the growth rate of H. 
salinarum R1. In synthetic medium with 1.1mM AroAAs the generation time (Gn) 
was two fold higher than without AroAAs (11.8±0.26h and 23.8±0.3h, respectively). 
No difference in the Gn time was seen when the synthetic medium was supplemented 
with 1.1mM, 0.11mM or 0.011mM AroAAs (Gn=11.8±0.26h, 11.7±0.02h and 
11.4±0.16h, respectively). Together, the data indicate the following: (1) WT can 
uptake one or more of the supplied AroAAs (figures #31, 38 and 41), (2) growth 
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stimulation only requires low concentrations of AroAAs, (3) 1.1mM AroAAs was a 
reasonable level to use in the supplemented media, and (4) while a WT strain can 
clearly grow without AroAAs, deletion strains are expected to be auxotrophic for 
AroAAs supplementation 
Figure # 20
 
: Growth of R1 in synthetic medium with different concentrations of AroAAs. 
The cell grow in 35ml, 40°C, 100rpm, in the dark. Points represent the average absorbance at 
each time point. Vertical error bars represent the standard deviation.   
 
6.1.2 Construction of mutants deleted for genes OE1472F, 
OE1475F and OE1477R 
6.1.2.1 Plasmids for gene deletions 
   Single, in-frame deletions of ORF’s OE1472F, OE1475F and OE1477R (figure 
#19) were attempted by recombination using integration plasmids carrying flanking 
regions of each gene. Flanking regions were amplified separately by PCR, ligated to 
each other, cloned into plasmid pMKK100 (figure #21A, B and C, respectively), and 
the plasmid introduced into E. coli. Transformed E. coli colonies were screened for 
plasmid containing the correct insert by restriction with BamHI and HindIII (figure # 
21D, lane 4).  As seen in figure #21C, the final constructs contained AmpR and MevR 
markers, and the BgaH gene as the reporter gene for blue/ red screening, but no 
replication genes for haloarchaea. 
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Figure # 21
  
: Constructing plasmids for in-frame deletion. A- Illustration of the flanking US 
(I) and DS (II) regions of a specific gene with introduced restriction sites at each end. B- 
Illustration of the ligated flanking regions which were introduced to a plasmid. C- General 
map to illustrate the plasmids used for in-frame deletions of ORF’s OE1472F, OE1475F and 
OE1477R. D- Example of a 1% agarose gel of purified plasmids from E. coli transformants 
after BamHI+HindIII digestion. Fragments of ~ 1Kbp and ~7Kbp are seen for the positive 
candidates. MW markers are shown in lanes 1 and 8 (in bp). 
6.1.2.2 Selection and screening of deletion strains 
The conditions needed for selecting and screening of deletion strains after 
transformation of the suicide plasmids into R1 needed to be considered carefully for 
the following reasons. Firstly, deletion of these genes should convert H. salinarum to 
aromatic amino acid auxotrophy, requiring the synthetic medium to be supplemented 
with AroAAs. Secondly, chorismate is a precursor of two additional pathways (figure 
#22): (a) the production of menaquinone (MQ), which is the mobile carrier of 
electrons in the respiratory chain, and (b) the production of tetrahydrofolate (THF), 
which is converted to several other folate coenzymes that are involved in biosynthesis 
of amino acids, nucleotides and coenzyme A. This means that THF (or a precursor for 
THF) would also be predicted to be required by such mutants. In addition, to 
overcome the dependence upon the respiration chain, cells could be grown 
anaerobically. Fortunately, R1 is photosynthetic. It can synthesise bacteriorhodopsin 
as a light driven proton pump. This generates a proton motive force that is utilized for 
ATP synthesis (reviewed by (Oesterhelt, 1998)). 
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Therefore, the synthetic medium used for recovery of deletion mutants was 
supplemented with 4-aminobenzoic acid (ABZA, a precursor for THF), 1.1mM 
AroAAs and 1.1mM DHQ. Cells were grown anaerobically under strong illumination. 
 
 
 
 
Figure # 22
http://www.genome.ad.jp/kegg/pathway/map/map00400.html
: The precursor of AroAAs, menaquione (MQ) and tetrahydrofolate (THF). 
Modified diagram from GenomeNet Database resources (KEGG), H. salinarum map 00400 
( ) 
 
6.1.2.2.1 Mutants could not be recovered by anaerobic growth under 
white light  
 Strain R1 was transformed with suicide plasmids designed to create in-frame 
deletion of OE1472F, OE1475F and OE1477R. MevR transformants with integrated 
plasmids were recovered on selective plates and screened for the presence of the 
BgaH gene. MevR and BgaH+ transformants were then grown anaerobically in 8ml 
volume sealed glass tubes (40°C, 100rpm, figure #23B) containing 4ml of synthetic 
medium with 1.1mM AroAAs + 1.1mM DHQ and 0.5mM ABZA (SM + AroAAs + 
DHQ+ABZA) without drug selection, to allow further recombination to eliminate the 
target genes, leaving  only the flanking regions. Cultures were inoculated into fresh 
medium after the turbidity had reached ~50 klett units, for a total of three passages.  
The growth of the recombinant strains after the 3rd transfer was recorded and plotted 
(figure #23A). As controls, the anaerobic growth of R1 in a complex medium and in 
synthetic medium with 1.1mM AroAAs was also recorded. The generation time (Gn) 
of R1 in synthetic medium was 13.07h. The strains that had been transformed with 
plasmids targeting ORFs OE1472F, OE1475F and OE1477R, had Gn times of 12.54h, 
7.44h and 5.45h, respectively.    
Although the tubes were not flushed with N2, the growth conditions rapidly 
become anaerobic because the inoculum (2 Klett unit in 4 ml medium) consumes all 
the O2 in the medium within 17h (the consumption rate of O2 is 0.63µmole O2/day x 
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Klett, solubility of O2 in high salt medium is 25µM O2, Loccedie Mansueto, data not 
published). Furthermore, the tubes were sealed tightly with a screw capped lid.  
 
 
 
 
 
 
 
Figure # 23
 
: The anaerobic growth of adapted H. salinarum cells in sealed glass tubes. A- 
The growth curves after 3rd transfer into synthetic medium+1.1mM AroAAs+1.1mM 
DHQ+0.5mM 4 aminobenzoic acid ,at 40°C, 100rpm in sealed glass tubes. Cells grew up to a 
density of 50 Klett units. B- The tubes in duplicates used for the anaerobic growth under 
white light. 1-R1, 2-OE1472F:pMG500, 3- OE1475F:pMG600, and 4-OE1477R:pMG700, 
respectively. 
To differentiate between WT and deletion strains, the adapted anaerobic cultures 
were plated on supplemented synthetic medium plates (SM + AroAAs + 
DHQ+ABZA) containing X-gal but without Mevinolin. Cells that had undergone a 
second cross over and eliminated the target gene would also have eliminated the 
BgaH gene and so would have a red color phenotype (due to bacteriorhodopsin and 
bacterioruberin) on X-gal plates. Blue colonies would be strains that still retained the 
plasmid. Synthetic medium plates with 1.1mM AroAAs, 1.1mM DHQ and 0.5mM 
ABZA were inoculated with adapted anaerobic cultures from the glass tubes and 
incubated in anaerobic chambers, under white light, as seen in figure # 24. 
The temperature in the sealed anaerobic chambers was regulated to 37°C using 
circulating water reservoir at the same temperature. The air in the chambers was 
removed by flushing the chambers with N2, and sealing them, so there was no possible 
exchange of air with the outside. Each chamber contained a colored indicator to detect 
oxygen. Trace amounts of oxygen were removed by the included Gas Pak, which 
produced CO2+ H2 when the O2 in the chamber reacted with sodium borohydride, 
sodium bicarbonate and citric acid tablets in the Gas Pak. The oxygen indicator 
remained white during the experiment (i.e. no oxygen present). 
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Figure # 24
 
: The anaerobic chambers used to differentiate WT from deletion strains grown 
on synthetic medium plates with 1.1mM AroAAs+1.1mM DHQ+0.5mM ABZA, at 37°C, 
under white light. (Oesterhelt, 1982). 
As a growth control, WT cells were plated on both complex medium and synthetic 
medium with 1.1mM AroAAs and incubated in the same chambers. Colonies of WT 
were visible on plates after 9 weeks in the anaerobic chambers. However, only two 
colonies of grew after 7 months of incubation, most probably WT. Those colonies did 
not re-grow when subcultured into liquid medium under anaerobic condition in sealed 
glass tubes (figure #23B), so there was no possibility to check whether the cells were 
WT or recombinant strain. Nonetheless the experiment was not successful, so 
recovery under aerobic conditions was attempted.   
6.1.2.2.2 Recovery of deletion mutants by aerobic growth in the dark  
   Next, attempts to obtain knockout strains were done using aerobic growth in 
synthetic medium supplemented with 1.1mM AroAAs and 1.1mM DHQ 
(SM+AroAAs+DHQ). Assuming that DHQ can be taken up by cells from the 
medium, the production of chorismate was expected to support the production of 
AroAAs, MQ and THF in mutants lacking ORFs OE1472F, OE1475F and OE1477R 
(figure #22).    
Strain R1, after transformation with plasmids pMG500, pMG600 and pMG700, 
were plated on complex medium plates containing mevinolin (Mev) and X-gal. 
Mixture of cells with the BgaH+ phenotype (via homologous recombination of the 
plasmid) were subcultured into 10ml of fresh medium (in 25ml flask, 40°C, 100rpm, 
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dark) for a total of three passages. The growth of the recombinant strains after the 3rd 
transfer was recorded and plotted as seen in figure #25.  
 
 
 
 
 
 
 
 
 
 
Figure # 25
 
 : The growth of recombinants in synthetic medium+1.1mM AroAAs+1.1mM 
DHQ. Conditions: 40°C, 100rpm, aerobic. The initial OD presented in the graph was 
calculated.   
 
 
The adapted cells from liquid medium were plated on synthetic medium plates 
which contained 1.1mM AroAAs, 1.1mM DHQ and X-gal but without mevinolin. 
The plates were incubated at 37°C for 20 days. BgaH+ and BgaH- colonies were 
obtained for all three gene deletion constructs. The BgaH+ phenotype indicated strains 
where the plasmids were still integrated into the chromosome, while the red 
phenotype indicated either a WT strain or a deletion strain. The strains with the BgaH- 
phenotype were tested by colony PCR and Southern blot hybridization, to distinguish 
WT from the desired deletion strain. 
6.1.3 In vivo mutation analysis   
6.1.3.1 Deletion mutant ∆OE1477R 
6.1.3.1.1 PCR analysis to confirm the deletion in ∆OE1477R 
   BgaH- colonies were screened by PCR to confirm the in-frame deletion of 
OE1477R. Two sets of colony PCR reactions were performed. The first PCR used 
primers P1+P4 to differentiate WT from a deletion candidate. In a WT strain, a full 
length PCR fragment of 1.69Kbp was expected, while in a potential deletion 
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candidate, only a 1Kbp fragment would be amplified (the length of the flanking 
regions). A second PCR reaction used primers P5+P4, in which WT amplification 
would generate a 1.2Kbp product, while no product would be expected in a deletion 
strain.  
PCRs using primers P1+P4 are shown in figure #26B lanes 2, 4, and 6, 
respectively. WT DNA gave the expected product (1.69Kbp), while a 1Kbp fragment 
was amplified from the potential deletion candidates #3 and #11 (figure #26B, lanes 4 
and 6, respectively). Note that in strain #11 (lane 6) two additional bands are seen and 
one of them has the same size as WT (lane 2). PCRs using primers P5+P4 are shown 
in lanes 3, 5, 7, respectively, only WT DNA gave a product. According to colony 
PCR analysis, both colonies are potential deletion candidates, and they were further 
analysed by Southern blot hybridization.     
 
 
 
 
 
 
 
 
Figure # 26
 
:  PCR analysis of potential ∆OE1477R strain. A- The relative position of the 
primers used to confirm the deletion of ORF OE1477R. B-1% agarose gel of 1st PCR reaction 
using primers P1+P4 and total DNA from WT, strain #3, and strain #11 (lanes 2,4,6, 
respectively). 2nd PCR reaction using primers P5+P4 and DNA of WT, clone #3, and clone 
#11 (lanes 3,5,7, respectively). MW markers are shown in lanes 1 and 8 (in bp). 
 
6.1.3.1.2 Southern blot analysis  
   To verify the deletion of OE1477R in the potential deletion candidates (strain # 3 
and 11), a Southern blot analysis was performed. Total DNA was isolated from liquid 
cultures (SM+AroAAs+Shikimate+ABZA) of each strain, digested with SacI, 
separated on a 1% agarose gel, and transferred to a membrane. Two DIG labeled 
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probes were used: one for the flanking region of OE1477R, and a second for the gene 
itself. In the WT strain, the probe for the flanking region should detect a 1.7Kbp 
fragment, while a shorter fragment is expected (0.98Kbp) in a deletion candidate. The 
probe for the gene should detect a 1.7Kbp fragment in the WT strain and nothing in a 
deletion strain.  
As shown in figure #27A, strains #3 and #11 produced a 0.98Kbp band when a 
DIG labeled probe of the flanking region of OE1477R was used (figure #27A).  
Nevertheless, only in strain #3 was the gene deleted entirely, as seen from figure 
#27B (lane 3), since no complementary DNA segment was detected when using DIG 
labeled probe for the gene itself. In strain #11, a 1.7Kbp fragment was detected with 
the gene probe, indicating that it is a mixture of WT cells and a deletion strain. 
Controls in the Southern blot included DNA from plasmid pMG700 (which 
contains the flanking regions of OE1477R) and plasmid pMG750 (which contains the 
gene OE1477R). As expected, the DNA segment of pMG700 was detected only when 
using DIG labeled probe for the flanking region (figure #27A, lane 5), while the DNA 
segment of pMG750 was detected only when using DIG labeled probe for the gene 
(figure #27B, lane 6). 
 
 
 
 
 
 
 
 
Figure # 27
 
:  Southern blot analysis of WT vs. deletion strains.  Lane 1: SacI digested DNA 
from WT, lane 2: DIG VII size marker (in bp), lane 3: SacI digested DNA from deletion 
strain #3, lane 4: SacI digested DNA from deletion strain #11, lane 5: HindIII digested 
pMG700, lane 6: HindIII digested pMG750. A- Hybridization with a DIG labeled probe of 
the US flanking region of OE1477R. B- Hybridization with a DIG labeled probe of part of the 
gene.  
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6.1.3.1.3 Phenotype of the ∆OE1477R strain  
   In order to check the phenotype of the ∆OE1477R mutant, strain #3 was grown 
in synthetic medium with 1.1mM AroAAs and 1.1mM shikimate and plated on 
synthetic medium with or without AroAAs. If OE1477R is part of the AroAAs 
biosynthesis pathway, this strain should be auxotrophic for AroAAs, and will not be 
able to grow in synthetic medium without AroAAs. As seen in figure #28, the 
∆OE1477R mutant was unable to grow on plate without AroAAs, even after 28 days 
incubation, while WT cells did not grow well under the same conditions but growth 
was clearly visible (lower right panel). As a control for the viability of the cells and to 
demonstrate that the deletion strain is able to grow on those plates, cells were grown 
in liquid synthetic medium supplemented with AroAAs and shikimate, and plated as 
well (left and middle panels of figure #25).  
 
 
 
 
 
 
Figure # 28
 
: Phenotype of ∆OE1477R compared to WT, growing on plates. Cells were 
grown in liquid synthetic medium supplemented with 1.1mM AroAAs and 1.1mM shikimate 
until OD600nm=1.565, and 1.315 (deletion and WT, respectively) (40°C, 100rpm). Cells were 
washed with basal salt before diluting 1/10-3 and spotting 3µl from each dilution on plates 
containing AroAAs+shikimate, only AroAAs and without AroAAs . 
Next, the average Gn of the deletion ∆OE1477R strain #3 was measured after 
inoculation into liquid synthetic medium supplemented as follows: (1) 1.1mM 
AroAAs, (2) synthetic medium without AroAAs, (3) AroAAs +DHQ, and AroAAs + 
Shikimate (4). As shown in figure #29B, the deletion strain ∆OE1477R was not 
capable of growing without AroAAs in the medium, but could grow at half the rate of 
the WT when supplemented with AroAAs. In order for the deletion strain to grow as 
well as the WT the synthetic medium needed to be supplemented with 1.1mM 
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AroAAs and either 1.1mM DHQ or 1.1mM Shikimate (figure # 29C and D, 
respectively).  
Figure # 29
 
: The growth of ∆OE1477R in supplemented synthetic medium. The growth of 
WT (  ) and ∆OE1477R(  ) in synthetic medium with 1.1mM AroAAs (A), without AroAAs 
(B), with 1.1mM AroAAs +1.1mM DHQ (C), and with 1.1mM AroAAs + 1.1mM Shikimate 
(D). The inoculum was washed with basal salt solution, before resuspending in the 
appropriate medium. The numbers at the top left are average Gn times. The cells were grown 
in 25ml flasks containing 10ml medium, at 40°C, 100rpm.  
Both, deletion and WT strains had similar average Gn times when grown in 
synthetic medium with AroAAs + Shikimate (figure # 29D), suggesting that the 
enzyme encoded by OE1477R acts on a substrate upstream to Shikimate, since 
Shikimate was able to compensate for the loss of the gene.  
Additionally, the ability of the deletion strain to grow in synthetic medium with 
AroAAs + DHQ (figure #29C) as well as in medium containing only DHQ (figure 
#30B), indicate that the gene product of OE1477R acts on a substrate upstream to 
DHQ, which is not in agreement to the reconstructed pathway (figure #19). This 
discrepancy can be explained by the reaction presumably catalyzed by OE1477R, 
either synthesis of DHQ or dehydration of DHQ (figure #30A). If the former is true 
than DHQ is expected to compensate for the loss of the gene, as demonstrated by the 
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growth of the mutant in synthetic medium supplemented with AroAAs + DHQ (figure 
#29C). If the later is true the cells have been fed with both DHQ and DHS. The later 
was examined in more details by LC-MS. The two possible sources for DHS are 
contamination in DHQ or spontaneous release of water molecule when DHQ was 
incubated at 37°C during the growth of the cells. In either case there was a need to 
determine the amount of DHS available to the cells.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 30
 
: A- Biosynthesis of DHS. The numbers in the figure refer to the enzymes: (1) 3-
dehydroquinate synthase (EC 4.6.1.3), and (2) 3-dehydroquinase dehydratase (EC 4.2.1.10). 
B- Growth requirements of ∆OE1477R mutant (  ) and WT (  ). The inoculum was washed 
with basal salt solution before resuspending in synthetic medium supplemented with either 
DHQ or shikimate. Cells were grown in 25ml flasks containing 10ml medium, at 40°C, 
100rpm.  
 
As seen in table # 2, 0.4% DHS was detected after derivatization of DHQ. One can 
not distinguish between contamination in DHQ with DHS or formation of DHS 
during the derivatization procedure. In either case the concentration of DHS is low. 
On the other hand, when incubating DHQ for 1h at 37°C, 3% of DHS were formed. 
No increase in the formation of DHS was observed when DHQ was incubated for 23h 
at the same temperature, indicating that the reaction either achieved equilibrium 
(although, water being bad nucleophile most likely will not attack double boned), or 
out of the total percentage of DHS formed most of it is been transformed to other 
                                                                                                                             Results 
 75 
intermediate leaving 3% of DHS. In either of the explanation when feeding the cells 
with DHQ we were also providing at least 3% of DHS. The 3% of DHS corresponds 
to 0.033mM DHS, meaning 0.2mM DHS per OD (0.033mM DHS/0.159OD, 
figure#30B). As shown by Gonzalez et al., (figure #4 in (Gonzalez et al., 2009)), only 
0.1mM Phe/OD is needed for biomass (whether integrated into proteins or as free 
metabolites), demonstrating that by feeding the cells with DHQ containing 3% of 
DHS, the cells can grow.    
 
Table # 2
  
: Detection DHS formed under different conditions 
(1) Pre-treatment 
(2) Detection (%) 
DHQ DHS 
no pre-incubation 99.6 0.4 
90°C, 1h in 0.1M HCl 76 24 
37°C, 1h 97 3 
37°C, 23h 97 3 
 
(1)- 2.5mM DHQ in 1.75M KCl+29mM Tris-HCl was pretreated before derivatization, 
according the conditions specified in the table. 
 
(2)- Derivatization was carried out at 60°C for 1h, using 2mM NBHA [O-(4-nitrobenzyl) 
hydroxylamine hydrochloride] in MeOH. The derivatized compounded were separated on 
C18 column using ACN. DHQ eluted after 15min and DHS after 20.2min. The % represents 
area detected at 254nm.   
 
6.1.3.1.4 Aromatic amino acid analysis of the ∆OE1477R mutant 
The concentrations of aromatic amino acids, phenylalanine (Phe) and tyrosine 
(Tyr) were measured in the medium of cultures grown in different synthetic media 
supplemented with AroAAs, Shikimate, DHQ, and combinations of these. Media 
were inoculated with either R1 or the deletion strain ∆OE1477R, and the 
concentrations of Phe and Tyr from three biological repeats (represented by the 
symbols circles, triangles and diamonds) at different time points during the growth, 
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were plotted as shown in figure #31. The experimentally measured concentrations 
were modeled (represented by the dash lines, done by Dr. Orland Gonzalez) which 
allowed the calculation of uptake rates of Phe and Tyr in different supplemented 
media.   
No significant differences were observed in the extracellular concentration of Tyr 
between cultures of the WT and deletion strain, in either of the synthetic media 
(figure 31B, D and E, table #2). Moreover, no difference in the deletion strain, in 
either the extracellular concentration or the uptake rate of Phe (table #3), was 
observed in synthetic media containing AroAAs+Shikimate or AroAAs+DHQ (figure 
#31C and E), while a significant difference was seen in the concentration of Phe in 
synthetic medium supplemented only with AroAAs (figure #31A). In the case of the 
WT, the Phe levels decreases steadily after 2 days of growth (OD600=0.514), while in 
the mutant ∆OE1477R the concentration of Phe remained steady during the growth. 
The uptake rate of the R1 strain was 9.2 nmole Phe OD-1ml-1h-1, while no uptake was 
seen in ∆OE1477R grown in the same medium (table #3), unless either DHQ or 
shikimate were added to the medium in addition to AroAAs.  
 
Table # 3
 
: Uptake rates of Phe and Tyr by R1 and ∆OE1477R. Cells grow in supplemented 
synthetic media. The uptake rates were calculated from the corresponding model stimulations. 
Synthetic media 
supplemented with 
Phe (nmole OD-1 ml-1 h-1) Tyr (nmole OD-1 ml-1 h-1) 
R1 ∆OE1477R R1 ∆OE1477R 
+AroAAs 9.2 0 0.6 0 
+AroAAs+Shikimate 8.7 7.5 0 0 
+AroAAs+DHQ 12.5 9.4 0.6 0 
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Figure # 31
 
: Phe and Tyr consumption during the growth of WT and mutant 
∆OE1477R. The experimental data for Phe (left panel, A, B, and C) and Tyr (right 
panel, D, E and F) are shown using circles, triangles and diamonds (representing 
biological repeats) , red for WT and blue for the mutant. Error bars represent the 
deviation of the average.  Simulations curves are shown using dashed lines, red for 
WT, and blue for ∆OE1477R. The uptake rates were calculated from the 
corresponding model stimulations. Note that small differences in the concentration of 
AroAAs are hard to detect, therefore low uptake rats need to be carefully addressed. 
Nevertheless, the differences in the trends between WT and deletion strain are more 
trustworthy. Done by Dr. Orland Gonzalez. 
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6.1.3.1.5 DHQ uptake by H. salinarum and ∆OE1477R  
DHQ in the supernatants of late exponential phase cultures of R1 and ∆OE1477R, 
grown in synthetic medium with 1.1mM AroAAs and 1.1mM DHQ (figure #32A), 
was derivatized using the method discussed in materials and methods. The 
concentration of DHQ in the medium was calculated using derivatized DHQ.  
The data confirm uptake of DHQ from the medium by both WT and mutant 
∆OE1477R. As shown in table #2, DHQ is in equilibrium with DHS. The DHS can be 
used by the mutant to be converted to AroAAs. 
Figure # 32
 
: Growth of R1 and ∆OE1477R in medium supplemented with AroAAs +DHQ. 
A-growth curves of R1 (  ) and ∆OE1477R (  ), respectively. Cells were grown in 25ml flasks 
containing 10ml medium, at 40°C, 100rpm. B-calibration curve of derivatized DHQ. 
 
 
Table # 4
 
 : Concentration of DHQ in the medium after the growth of R1 and ∆OE1477R in 
synthetic medium with 1.1mM AroAAs and 1.1mM DHQ. 
 OD600nm mM DHQ % DHQ used 
R1 1.22 0.728 42 
∆OE1477R 1.54 0.265 79 
Blank (1)  1.245  
 
(1) Synthetic medium with 1.1mM AroAAs and 1.1mM DHQ 
 
 
6.1.3.2 ORFs OE1472F and OE1475F were disturbed by insertions 
Attempts to obtain deletion strains of OE1472F and OE1475F were not successful, 
even when using the conditions that allowed the isolation of ∆OE1477R i.e., aerobic 
growth in synthetic medium supplemented with 1.1mM AroAAs and 1.1mM DHQ, or 
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1.1mM AroAAs+1.1mM Shikimate + 0.5mM 4-aminobenzoate. While colonies 
displaying a BgaH- phenotypes were obtained after culturing the primary 
transformants in medium without mevinolin, PCR analyses revealed that these were 
genotypically WT, indicating the second cross-over had only restored the WT 
genotype. 
 Looking at the genomic context of OE1472F and OE1475F (figure #33), it was 
possible that complete deletion of these genes might interfere with expression of 
nearby genes. As seen in figure #33, deletion of OE1472F, could disturb the trpCBA 
operon, or OE1474R (CHY), while deletion of OE1475F might interfere with the 
transcription of OE1476R and OE1477R (which most probably form an operon). 
Therefore, instead of full deletions, the target genes were disturbed by insertions, with 
the aim of obtaining mutants showing reduced activity of the corresponding enzymes. 
 
Figure # 33
 
: Schematic representation of annotated ORFs in H. salinarum R1 genome 
(genome coordinates 230688-237094bp) 
6.1.3.3 Insertion mutant OE1471F:: pMG501  
   Four ORF’s are included in the trp operon (figure #34) OE1469F (trpC), 
OE1470F (trpB), OE1471F (trpA) and OE1472F. By introducing a transcription 
terminator sequence at the 3’ end of the gene OE1471F (trpA), transcription of 
OE1472F would be reduced but the upstream genes should not be affected.     
500bp of the 3’ end of OE1471F were amplified by PCR and ligated to a 55bp long 
sequence containing the terminator of the flgA operon.  The resulting 583bp fragment 
was amplified by PCR using LA Taq polymerase, purified from a preparative 1% 
agarose gel, cloned into TOPO vector and sequenced to confirm that no errors had 
been introduced. It was then subcloned into pMKK100, generating plasmid pMG501, 
which contained AmpR, MevR markers and BgaH as a reporter gene. pMG501 was 
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introduced into strain R1, and transformants were recovered on complex medium 
plates with Mev and Xgal. Colonies were screened by PCR to confirm the in-frame 
integration of the terminator using the primers indicated in figure #34 (green arrows). 
In-frame integration should show a 1566bp fragment, whereas the WT sequence 
should not generate a product. As shown in figure #35A, all transformants had 
integrated the plasmid pMG501. PCR controls included chromosomal DNA from the 
WT, and plasmid pMG501. As expected, no product was amplified from WT DNA, 
while plasmid DNA gave a strong band. To exclude the possibility that pMG501 
could survive in R1 without integration into the chromosome (although pMG501 did 
not contain a replication ori for haloarchaea), a second PCR was performed using the 
primers indicated in figure #34 (red arrows). In-frame integration should give a 
2209bp fragment, while no product is expected for the WT. As shown in figure #35B, 
plasmid pMG501 was found to be integrated in all transformants tested. Controls in 
the PCR included chromosomal DNA from the WT strain, and plasmid pMG501. As 
expected no amplification was visible when using WT or plasmid DNA.   
 
 
 
 
 
 
 
 
Figure # 34: Schematic representations of the single cross-over event between the 
chromosomal DNA of R1 and pMG501. Arrows indicate the relative positions of the primers 
used.  
Transformation 
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Figure # 35
 
: PCR analysis of cells transformed with pMG501 using A - primers P1 and P2 
(green arrows), and B- primers P3 and P2 (red arrows). Lanes 1 and 14: MW markers (in bp). 
The templates used in the PCRs were, lane2: Chromosomal DNA of R1, lane 3: plasmid 
pMG501, lanes 4-13- transformed colonies. !% agarose gel. 
6.1.3.3.1 Transcription level of ORF OE1472F was reduced in the mutant  
The expression of OE1472F in OE1471F::pMG501 mutant was compared to the 
WT strain. Both were cultivated in synthetic medium without AroAAs. The transcript 
level differences were calculated by a relative quantification approach using an 
internal standard gene, OE1160R (ribosomal protein L10.eR). As seen in figure# 36, 
the expression of OE1472F in the mutant strain was down-regulated 4.7 fold and 44 
fold when the culture was harvested at OD600nm=0.4 and 1.0, respectively. The down- 
regulation indicates that integration of pMG501 into the chromosomal DNA of R1 
(figure #35) had indeed reduced the transcription level of OE1472F. This mutant was 
then analysed for its ability to grow with and without AroAAs. 
 
Figure # 36
 
: Transcription levels of 
ORF OE1472F in mutant 
OE1471F::pMG501 at OD600nm=0.4 
and 1.0. Results were obtained using 
RT-qPCR. 
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6.1.3.3.2 Phenotype of OE1471F::pMG501 mutant  
Introduction of the upstream terminator was shown to reduce or completely block 
transcription of OE1472F and, if OE1472F is part of the AroAAs biosynthesis 
pathway, the mutant should grow poorly or not at all in media lacking AroAAs.   
The phenotype of OE1471F::pMG501 was tested after inoculation of the mutant 
strain into synthetic medium with and without AroAAs, or into synthetic medium 
supplemented with 1.1mM AroAAs and either 1.1mM Shikimate or 1.1mM DHQ.  
After each growth the genotype was conformed by PCR.  
Figure # 37
 
: Growth requirements of WT (  ) and mutant OE1471F::pMG501 (  ) in 
synthetic media supplemented with A-AroAAs, B-without AroAAs, C-
AroAAs+DHQ, and D-AroAAs+Shikimate. The inoculum was washed with basal salt 
solution before resuspending in the appropriate medium. The numbers at the top left are 
average Gn times. Cells were grown in 25ml flasks containing 10ml medium, at 40°C, 
100rpm.  
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As seen in figure#37A, C and D, similar average Gn times were obtained for both 
WT and the mutant when grown in media with AroAAs, and in media with AroAAs 
and either DHQ or Shikimate. But in media without AroAAs, the mutant 
OE1471F::pMG501 grows at about half the rate of WT cells (figure #37B). Together, 
the data indicate a reduced ability to synthesis AroAAs, and this is alleviated by 
supplementation of the medium with AroAAs. It also suggests that either transcription 
of OE1472F was not completely blocked by the integrated terminator, or that another 
gene in H. salinarum (possibly OE2019F, see introduction table #1) can complement, 
to a limited extent, for the loss of OE1472F.   
6.1.3.3.3 Utilization of Phe and Tyr by the OE1471F::pMG501 mutant 
 The extracellular concentrations of Phe and Tyr were measured in cultures grown 
in different synthetic media supplemented with AroAAs, Shikimate, DHQ, and 
combinations of these. Media were inoculated with either R1 or the 
OE1471F::pMG501 mutant. The extracellular concentrations of Phe and Tyr (figure 
#38) were measured three times (represented by the symbols circles, triangles and 
diamonds) from three independent cultures. The experimentally measured changes in 
Phe and Tyr concentrations were modeled (represented by the dash line) which 
allowed the calculation of uptake rates in different supplemented media (table #5, 
done by Dr. Orland Gonzalez). Note that small differences in the concentration of 
AroAAs are hard to detect, therefore low uptake rats need to be carefully addressed. 
Nevertheless, the differences in the trends between WT and deletion strain are more 
trustworthy. 
 
Table # 5
 
: Uptake rates of Phe and Tyr by R1 and OE1471F::pMG501. Cells grow in 
supplemented synthetic media. The uptake rates were calculated from the corresponding 
model stimulations. 
Synthetic media 
supplemented with 
Phe  (nmole OD-1 ml-1 h-1) Tyr (nmole OD-1 ml-1 h-1) 
R1 OE1471F::pMG501 R1 OE1471F::pMG501 
+AroAAs 11.5 7.5 0.9 0.2 
+AroAAs+Shikimate 9.6 5.2 1.5 0 
+AroAAs+DHQ 13.8 11.8 2.0 2.6 
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Figure # 38
 
: Phe and Tyr consumption during the growth of WT and mutant 
OE1471F::pMG501. The experimental data for Phe (left panel, A, B, and C) and Tyr (right 
panel, D, E and F) are shown using circles, triangles and diamonds, red for WT and blue for 
the mutant. Error bars represent one standard deviation. Simulations curves are shown using 
dashed lines, red for WT, and blue for mutant OE1471F::pMG501. The uptake rates were 
calculated from the corresponding model simulations. Done by Dr. Orland Gonzalez. 
 
As seen in figure #38D-F, the concentration of Tyr remained constant in all media 
for both the WT and mutant strains. The extracellular concentration of Phe on the 
other hand, decreased over time, in different media (Figure #38A-C, table#5), 
indicating uptake of Phe by both WT and the OE1471F::pMG501 mutant. From the 
data presented in table #5, the uptake rate of Phe by OE1471F::pMG501 was 30-45% 
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lower than that of the WT in synthetic medium supplemented with either AroAAs, or 
AroAAs with shikimate. No differences in the uptake rates were seen in synthetic 
medium supplemented with AroAAs + DHQ. 
6.1.3.4 Insertion mutant OE1475F:: pMG601  
The central part OE1475F was amplified by PCR, sequenced and cloned in 
pMKK100, to obtain the integration vector pMG601. It contained the AmpR, MevR 
markers and the reporter gene BgaH for red/blue screening. Successful integration of 
this plasmid into the R1 chromosome would slice OE1475F into two pieces, separated 
by plasmid sequences (figure #39A). As shown in the figure #39A, the insertion is 
likely to block expression of a functional enzyme, although about 2/3 of the ORF 
could still be transcribed via the natural promoter. 
pMG601 was introduced into R1 cells and 9 transformants were analysed by PCR 
to verify the single cross-over integration of pMG601. The PCR was designed using 
one primer which anneals to the beginning of the gene (which is in the chromosomal 
DNA) and a second primer that targets the MevR marker in the plasmid (figure#39A, 
green arrows). A 1.8Kbp fragment is expected after the integration of pMG601. PCR 
controls included chromosomal DNA from the WT, and DNA from plasmid pMG601. 
As shown in figure #39B, a 1.8Kbp fragment was amplified in all 9 transformants, 
indicating they contained pMG601 integrated into the correct site of the R1 
chromosome.   
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Figure # 39
 
: A- Schematic representations of the single crossover event with pMG601. B-
The expected genotype of the mutant after transformation. The length (in bp) of the sliced 
gene is indicated. C-1% agarose gel of PCR products from chromosomal DNA of R1 (lane 2), 
and chromosomal DNA from 9 BgH+ colonies after integration of pMG601 into R1 (lane 3-
11), MW marker is shown in lane 1 (in bp). The percentages r See the text for details of the 
primers used. 
 
6.1.3.4.1 Phenotype of OE1475F::pMG601 mutant 
To test whether ORF OE1475F plays a role in the AroAAs biosynthesis pathway, 
the growth of the mutant OE1475F::pMG601 was investigated in synthetic medium 
alone, or supplemented with 1.1mM AroAAs, and either 1.1mM Shikimate or 1.1mM 
DHQ. The mutant OE1475F::pMG601 could grow on synthetic medium with only 
1.1mM AroAAs, as indicated form the average Gn times recorded for both mutant 
and WT (figure #40A). However, the growth rate of the mutant was about half that of 
the WT in synthetic medium without AroAAs (figure #40B), indicating that ORF 
OE1475F play a role in AroAAs biosynthesis pathway. Both the mutant and the WT 
grow equally well in synthetic medium supplemented with AroAAs and either 
shikimate or DHQ (figure #40C-D). The genotype of the WT and the mutant strains 
was confirmed by PCRs. 
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Figure # 40
 
: Growth requirements of mutant OE1475F::pMG601 (  ) and WT (  ). The cells 
were grown in 25ml flasks containing 10ml medium, at 40°C, 100rpm. A- synthetic medium 
with 1.1mM AroAAs, B- synthetic medium without AroAAs, C-synthetic medium with 
1.1mM AroAAs +1.1mM DHQ, and D- synthetic medium with 1.1mM AroAAs +1.1mM 
Shikimate. The cells used for inoculation of C were from synthetic medium with 1.1mM 
AroAAs. The numbers at the top left are average Gn times. The inoculum was washed with 
basal salt, before resuspending in the appropriate medium.   
 
6.1.3.4.2 Utilization of Phe and Tyr by OE1475F::pMG601 mutant 
As described in the previous section, the effect of medium supplemented with 
AroAAs, or AroAAs with shikimate on the growth of the OE1475F::pMG601 mutant, 
indicated it was able to take up AroAAs and use them for growth. To establish that 
uptake was occurring, the extracellular concentrations of Phe and Tyr were measured 
during the growth. Amino acid measurements were preformed three times 
(represented by the symbols circles, triangles and diamonds) from three independent 
cultures. The experimentally measured concentrations were modeled (represented by 
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the dash line) which allowed the calculation of uptake rates of Phe and Tyr in 
different supplemented media (Done by Dr. Orland Gonzalez).   
As seen in figure #41D-F, no significant difference in the concentration of Tyr was 
seen during the growth of either the WT or the mutant. A decrease in the extracellular 
concentration of Phe was seen in synthetic medium supplemented with either 
AroAAs+shikimate or AroAAs+DHQ, for both WT and mutant OE1475F::pMG601 
(figure #41B,C). No change in the concentration of Phe was observed in mutant 
OE1475F::pMG601 grown in synthetic medium supplemented with only AroAAs. 
From the data presented in table #6, the uptake of the mutant grown in synthetic 
medium supplemented only with AroAAs, was 12% (1.3nmole Phe OD-1 ml-1 h-1) of 
the uptake rate of the WT grown in the same media. Note that small differences in the 
concentration of AroAAs are hard to detect, therefore low uptake rats need to be 
carefully addressed. Nevertheless, the differences in the trends between WT and 
deletion strain are more trustworthy.  
 
Table # 6
 
: Uptake rates of Phe and Tyr by R1 and OE1475F::pMG601. Cells grow in 
supplemented synthetic media. The uptake rates were calculated from the corresponding 
model stimulations. 
Synthetic media 
supplemented with 
Phe (nmole OD-1 ml-1 h-1) Tyr  (nmole OD-1 ml-1 h-1) 
R1 OE1475F::pMG601 R1 OE1471F::pMG501 
+AroAAs 10.8 1.3 0 0 
+AroAAs+Shikimate 9.1 12.2 0 0 
+AroAAs+DHQ 11.9 16.5 2.9 4.2 
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Figure # 41
 
: Phe and Tyr consumption data during the growth of WT and mutant 
OE1475F::pMG601. The experimental data for Phe (left panel, A, B, and C) and Tyr (right 
panel, D, E and F) are shown using circles, triangles and diamonds, red for WT and blue for 
the mutant. Error bars represent one standard deviation.  Simulations curves are shown using 
dashed lines, red for WT, and blue for mutant OE1475F::pMG601. Note the different time 
scales in the left panel. The uptake rates were calculated from the corresponding model 
simulations. Done by Dr. Orland Gonzalez. 
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6.2 Genome-wide transcriptional studies (microarray)  
Regulation of gene expression is essential for normal growth, replication of cells, 
and for adaptation to changes in the environment. By expressing certain genes only 
when necessary, cells conserve both energy and resources. To study the differential 
gene expression of all assigned genes for the biosynthesis of AroAAs, a DNA 
microarray covering 3072 ORFs of H. salinarum R1 was used (Twellmeyer et al., 
2007). This was expected to assist in identifying the pathways of AroAAs production, 
as well as shed a light on associated regulatory or metabolic genes. 
In the first series of experiments (see below), cell samples of H. salinarum grown 
in synthetic medium with and without AroAAs were taken at two different growth 
phases (OD600nm=0.2, and 0.58). RNA was isolated and used to prepare cDNA. The 
cDNA from cells grown in medium without AroAAs (at specific OD) was compared 
to the cDNA prepared from cells grown in medium with AroAAs on a DNA 
microarray. In the second series of experiments (section 6.2.1.6), the cDNA prepared 
from WT cells was compared to cDNA of mutant ∆OE1477R (aroD, 3rd gene in the 
pathway, see figure #19) both grown in synthetic medium with AroAAs and 
shikimate. In all experiments, the criterion, which was used to identify whether a gene 
was regulated or not, was a combination of statistical significance and fold induction 
(see materials and methods section 5.3.10.3).   
In the first comparison, using cDNA’s from early exponential phase cells grown 
with and without AroAAs, 898 ORFs gave signals that were either below background 
or rejected for technical reasons, 1645 ORFs gave variable signals with P-values 
(calculated from the replicate spots) above 10-3, and considered not significant, while 
529 ORFs gave statistically significant signals (P≤10-3). As seen in table #7, within 
the latter group, 36% were conserved hypothetical proteins (CHY) or hypothetical 
proteins (HY). 360 ORFs showed no change in the transcription level (fold change 
≤1.5), while a fold-change of 4.0 or higher was observed for 40 ORFs in synthetic 
medium without AroAAs relative to synthetic medium with AroAAs.  
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Table # 7
 
: Distribution of significantly regulated ORFs (P≤10 -3) in H. salinarum grown in 
synthetic medium without AroAAs, observed at OD600nm=0.2 and 0.58. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*-The AroAAs-related genes regulated at OD600nm=0.2 and 0.58, are shown in table #7 
 
 
6.2.1 Transcription of AroAAs-related genes 
The transcription of AroAAs-related genes of H. salinarum grown in synthetic 
medium without AroAAs relative to with AroAAs (OD600nm=0.2 and 0.58) is 
represented in table #8.  
In the chorismate pathway, high values of transcriptional regulation were 
observed only for aroK, aroA, and aroC (3.6-6 fold induction). aroE and aroD gave a 
low value (1.3, 1.6 fold induction, respectively), while no changes were detected in 
ORFs OE1472F and OE1475F. In the case of ORF OE1472F, the intensities obtained 
were below background, while for ORF OE1475F no significant regulation was found 
(fold induction=0.96, p=0.318). It was shown that OE1472F, OE1475F and OE1477R 
(aroD) are essential for AroAAs biosynthesis, so the transcription of these ORFs, was 
assessed as well by an independent method, RT-qPCR. As seen in table #8, the 
expression OE1472F was found to be strongly regulated (12.5±0.7 fold induction), as 
calculated from two biological repeats. On the other hand, fold induction of 1.5±1.2, 
and 2.3±1.7 was observed for OE1475F and OE1477R, respectively, indicating 
constitutive transcriptions of these genes.    
 OD600nm=0.2* OD600nm=0.58* 
Fold induction 
Assigned 
ORFs 
CHY HY 
Assigned 
ORFs 
CHY HY 
≥ 4.0 26 11 3 11 4 1 
1.5-4.0 64 49 16 70 33 12 
≤ 1.5 248 92 20 215 120 37 
Total 338 152 39 296 157 50 
Total   529 503 
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In the branch leading from chorismate to tryptophan, all the 7 ORFs were 
significantly induced at early exponential phase growth, while a decrease in the 
transcription was seen in the mid-exponential phase (OD600nm=0.58). The parallel 
changes in gene expression and their genomic position indicate that the 7 ORFs are 
organized into two separated operons, consisting of: trpCBA-OE1472F, and 
trpD1FE1G1 (see figure #81A and B).  
In the proposed de novo pathway for AroAAs biosynthesis, the first step is 
catalyzed by the OE1472F protein, which cleaves a six carbon substrate, DKFP, 
followed by condensation with ASA. According to the genomic data of H. salinarum 
(www.halolex.mpg.de), ASA can be synthesized either from homoserine (involving 
ORF OE4722R) or L-aspartate (involving ORFs OE4333R and OE3063F), but the 
microarray data in the current study showed no changes in the transcription of those 
ORFs. Moreover, no regulation was observed for ORF OE2500R, which was 
predicted to synthesize methyllglyoxal from GAP (the first is the precursor for 
DKFP), indicating constitutive induction of theses genes.   
6.2.1.1 Transport systems for AroAAs 
Five transport systems of AroAAs are known in E. coli (Ikeda, 2006): (1) mtr and 
tnaB which are responsible for the transport of tryptophan, (2) tyrP for the transport 
of tyrosine, (3) pheP for the transport of phenylalanine and (4) aroP for the transport 
of all aromatic amino acids. No strong homologues were found for mtr, tnaB, tyrP or 
pheP in H. salinarum.  
ORF OE2779F (homolog to aroP and pheP) was predicted to be an amino acid 
transport protein. This ORF was 3.5 fold up regulated in R1 cells grown without 
AroAAs and harvested at OD600nm=0.2. Similar up regulation (fold=3.3) was found 
for this ORF in cells harvested at OD600nm=0.58, indicating that the OE2779F protein 
could be responsible for the transport of AroAAs, and is regulated when no AroAAs 
are present in the medium. Unlike the other genes shown in the table #7, there was no 
change in the degree of regulation of this ORF at different growth phases, suggesting 
that AroAAs are still been taken up at mid-exponential phase growth. Moreover, ORF 
OE4384R (a weak homolog of tnaB) was 4 fold up regulated (p=2.4x10-4) in the 
deletion strain ∆OE1477R (synthetic medium with AroAAs+shikimate at 
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OD600nm=0.2). This ORF was also 2.6 fold up regulated in WT cells grown in 
synthetic medium supplemented with AroAAs. 
6.2.1.1.1 ABC transporters and Na+-dependent transporters 
Two categories of ABC transporters exist: ABC-transporters involved in the 
uptake of solutes from the medium, and transporters which export metabolites to the 
medium. Both types of transporters couple solute movement to ATP hydrolysis. In the 
annotation of microbial genome sequences, ORFs representing ABC transporters are 
usually reliably predicted, but the specific substrate of individual ABC transporters is 
much more difficult to predict by sequence homology, and additional evidence is 
needed to permit more accurate assignments. Keeping this in mind, it was found that 
seven ORFs predicted to be ABC transporters were strongly up regulated when 
AroAAs were omitted from the synthetic medium. These were annotated as 
oligopeptides/dipeptide transporters which would be consistent with the cells trying to 
scavenge AroAAs from the medium (table #8). Note that some of the ABC-transport 
genes are arranged in an operon, the dppA3B3C3D3F3 operon, seen in figure #42E. All 
the genes in this operon, except for ORF OE4317F (dppD3), were significantly 
regulated. This operon was not found to be regulated either in ∆OE1477R mutant or 
WT cells grown in synthetic medium supplemented with AroAAs and shikimate. 
In addition to the ABC-transporters, three ORFs annotated as Na+-dependent 
transporters were strongly regulated, when grown R1 in synthetic medium without 
AroAAs, as seen in table #8. Na+-dependent transporters may also be able to transport 
amino acids, using the Na+ gradient produced during phototrophic growth as a motive 
force ((Lanyi, 1977) and references within).   
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Table # 8
 
: Expression of AroAAs-related genes and transport-related genes in H. salinarum 
R1 cells grown in synthetic medium without AroAAs relative to synthetic medium with 
AroAAs. 
 
ORF Gene (1) Predicted function  (2) Fold induction at 
OD600nm 
0.2 0.58 
Precursors              DHQ 
OE1472F fba2 
2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate 
synthase 
 (3) 12.5±0.7 ---- 
OE1475F ------ 3-dehydroquinate synthase (EC 4.2.3.4) type II 
0.96, NS 
(3) 1.5±1.2 
---- 
DHQ             Chorismate 
OE1477R aroD 3-dehydroquinate dehydratase (EC 4.2.1.10) 
1.6 
(3) 2.3±1.7 
1.3 
OE1565F aroE shikimate 5-dehydrogenase (EC 1.1.1.25) 1.35 
NS 
2.56 
NS 
OE2785R aroK shikimate kinase (EC 2.7.1.71), archaeal-type 6.0 4.4 
OE2762R aroA 3-phosphoshikimate 1-carboxyvinyltransferase  
(EC 2.5.1.19) 
3.6  
(P=0.003) 
2.1 
OE2761R aroC chorismate synthase (EC 4.2.3.5) 6.3 4.4 
Chorismate                Prephenate 
OE2784R pheA1 chorismate mutase (EC 5.4.99.5) 2.0 3.8 
Prephenate                 Phenylpyruvate  
OE4117F pheA2 prephenate dehydratase (EC 4.2.1.51) 0.7 
1 
NS 
Prephenate                 4-hydroxyl Phenylpyruvate  
OE2770F tyrA prephenate dehydrogenase (EC 1.3.1.12) 6.5 2.7 
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Chorismate                Tryptophan    
OE3331R TrpG1 
anthranilate synthase (EC 4.1.3.27) component 
II 
2.1 1.4 
OE3332R TrpE1 
anthranilate synthase (EC 4.1.3.27) component 
I 
10 4.1 
OE3334R TrpD1 anthranilate phosphoribosyltransferase  
(EC 2.4.2.18) 
6.2 4.5 
OE3333R TrpF phosphoribosylanthranilate Isomerase 
 (EC 5.3.1.24) 
8.5 ND 
OE1469F TrpC indole-3-glycerol-phosphate synthase  
(EC 4.1.1.48) 
7.7  
OE1470F TrpB tryptophan synthase (EC 4.2.1.20) beta subunit 8.9 ND 
OE1471F TrpA tryptophan synthase (EC 4.2.1.20) α subunit 6.7 3.6 
Transport system of AroAAs 
OE2779F aroP amino acid transport protein  
(probable phenylalanine transport protein) 
3.5 3.3 
Sodium dependent transporters 
OE3173F  sodium-dependent transporter 3.2 13.2 
OE5143F  sodium-dependent transporter 12.5 ND 
OE3511F panF probable sodium/pantothenate symporter 4.5 ND 
ABC-transporters 
OE4311F dppA3 
ABC-type transport system periplasmic 
substrate-binding protein (probable substrate 
dipeptide/oligopeptide/nickel) 
5.6 ND 
OE4313F dppB3 
ABC-type transport system permease protein 
(probable substrate : dipeptide/ 
oligopeptide/nickel) 
4.2 ND 
OE4316F dppC3 ABC-type transport system permease protein 4.9 ND 
OE4317F dppD3 ABC-type transport system ATP-binding ND ND 
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protein (probable substrate : dipeptide/ 
oligopeptide/nickel) 
OE4318F dppF3 
ABC-type transport system ATP-binding 
protein (probable substrate :dipeptide/ 
oligopeptide/nickel) 
4.2 1.3 
OE4555F dppC2 
ABC-type transport system permease protein 
(probable substrate : dipeptide/ 
oligopeptide/nickel) 
3.2 1.6 
OE3631F potA 
ABC-type transport system ATP-binding 
protein (probable substrate:  spermidine/ 
putrescine) 
2.9 ND 
(1) ORF predictions are derived from the genome annotation at www.halolex.mpg.de. 
(2) The numerical data represent mean expression ratios in WT cells grown in medium 
without AroAAs vs cells grown in medium with AroAAs. These were determined at two 
different cell densities. All fold changes had p values of ≤10-3, except were indicated. 
(3) Values in bold were determined by RT-qPCR. For all calculation the average-Ct (cycle 
threshold) of 2 replicate reactions per primer pair was used. The standard deviation was 
calculated from two biological repeats.  
ND-not detected 
NS- not statistically significant (p>0.01) 
 
6.2.1.2 Conserved hypothetical proteins and hypothetical proteins  
Although the genome sequence of H. salinarum R1 has been determined and 
carefully annotated, there remains a considerable fraction of the ORFs that cannot be 
assigned to function due to the lack of sequence homologs of known function. These 
are annotated as hypothetical (HY) or conserved hypothetical (CHY) proteins. If these 
are real genes, then they should be transcribed (at least under some environmental 
conditions), and this can be detected using DNA microarrays which allow parallel 
investigation of all genes involved in controlling the physiological state of a culture.   
As shown in table #9, 7 ORFs annotated as CHY or HY were found to be 
significantly up regulated in the absence of AroAAs in the growth medium. These 
data not only show transcription of these hypothetical ORFs but also that they are 
likely to be important in the cell response to AroAAs limitation. It was also found that 
some members of this group are found in close proximity to each other, and are likely 
to be co-transcribed, i.e. form operons (figure #82A-D).  
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Table # 9
 
: Transcription of hypothetical (HY) and conserved hypothetical (CHY) proteins in 
H. salinarum cells grown in synthetic medium without AroAAs relative to synthetic medium 
with AroAAs. 
(1) ORF predictions are derived from the genome annotation at www.halolex.mpg.de. 
(2) The numerical data represent induction ratios in WT cells grown in medium without 
AroAAs vs. cells grown in medium with AroAAs. These were determined at cell density of 
0.2OD600nm. All fold changes had p values of ≤10-3. 
(3) ORFs organized in operons, see figure #42. 
ORF (1) Predicted function 
(2) Fold 
induction  
(3) Operon  
OE2776F probable transcription regulator (LrpA2) 14.9  
OE1775R CHY 11.1  
OE4414R CHY 3.8  
OE4412R threonine synthase (EC 4.2.3.1) 3.2  
OE2770F prephenate dehydrogenase (EC 1.3.1.12) (tyrA) 6.5 
A 
OE2772F CHY 17.9 
OE4418R HY 9.5 
B OE4419R argininosuccinate lyase (EC 4.3.2.1) (argH) 3.4 
OE4420R argininosuccinate synthase (EC 6.3.4.5) (argG) 12 
OE1772A1R CHY 4.2 
C 
OE1774R CHY 6.0 
OE1448R CHY 8.0 
D 
OE1447R 
probable metallo-beta-lactamase family 
hydrolase 
6.1 
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Figure # 42
 
: AroAAs regulated CHY and HY ORFs that are closely adjacent, and possibly 
organized in operons. The fold regulations are indicated below. * , **-represents a 10bp, and 
3bp overlapping regions, respectively. A-D see table #8. 
6.2.1.3 Growth of ∆OE1477R in synthetic medium with AroAAs plus 
shikimate 
When cDNA of WT H. salinarum was hybridized against cDNA of the deletion 
strain ∆OE1477R (page 76, figure #28), both grown in synthetic medium with 
AroAAs and shikimate, none of the AroAAs-related genes shown in table #8 were 
regulated in the mutant compared to the WT. This is in agreement with the uptake 
assay (table #3, and figure #31) showing similar uptake rates of Phe by both the WT 
and the mutant, which can support the growth without activating the AroAAs 
biosynthesis pathway, or by converting Shikimate to AroAAs. On the other hand, 
several CHY, HY, and transposase were significantly induced in the mutant (table 
#10). 
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Table # 10
 
: Expression of genes in ∆OE1477R mutant cells relative H. salinarum cells grown 
in synthetic medium with AroAAs and shikimate. 
ORF Gene (1) Predicted function  (2) Fold induction at OD600nm 
0.2 0.69 
OE2469F flgA1 flagellin A1 2.2 3.1 
OE4073R hcpB halocyanin hcpB 3.5 1.6 
OE4390F polA1 
DNA-directed DNA polymerase 
 (EC 2.7.7.7) type III subunit 1 
6 ND 
OE7033R gvpD1 regulatory protein gvpD 2.9 ND 
Transposase (ISH3) 
OE5027R  transposase (ISH3) 1.9 3.9 
OE5225R  transposase (ISH3) 2.2 3.2 
OE5383F  transposase (ISH3) ND 3.2 
OE7048F  transposase (ISH3) 1.8 4.3 
CHY 
OE1388R  conserved hypothetical protein ND 3.8 
OE1416F  conserved hypothetical protein 0.7 15.8 
OE4384R  conserved hypothetical protein 4.0 1.5 
OE5134F  conserved hypothetical protein 9.6 ND 
OE6130F  conserved hypothetical protein 2.9 4.2 
OE7003R  conserved hypothetical protein 3.2 ND 
HY 
OE4077F  hypothetical protein 3 ND 
OE6020R  hypothetical protein 3.8 ND 
(1) ORF predictions are derived from the genome annotation at www.halolex.mpg.de. 
(2) The numerical data represent mean expression ratios in ∆OE1477R cells grown in 
synthetic medium with AroAAs and shikimate vs WT cells grown in the same medium. These 
were determined at two different cell densities. All fold changes had p values of ≤10-3, except 
were indicated. 
ND-not detected 
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6.3 Expression and purification of proteins encoded 
by OE1472F, OE2019F & OE1477R   
Both OE1472F and OE2019F were annotated as fructose bisphosphate aldolase 
(EC 4.1.2.13, Figure#18), but only ORF OE1472F is believed to be involved in the 
AroAAs biosynthesis pathway (see introduction). ORF OE1477R, annotated as 3-
dehydroquinate dehydratase (EC 4.2.1.10, figure #19), is the 3rd ORF in the pathway. 
To study in detail the structural and functional properties of the proteins encoded 
by OE14772F, OE2019F and OE1477R, they needed to be purified. An 
overexpression system was essential because the natural level in the cells was 
probably low, and no assays were available that could be used to rapidly identify 
active fractions. It is known that heterologous overexpression may fail, or be 
inefficient for a number of reasons, such as the absence of cofactors, use of rare 
codons and consequent poor translation, differences in co- or post translation 
modification and processing, and improper protein folding due to different 
physiological conditions (such as presence of high salt). In consideration of those 
issues, an expression system in H. salinarum was tested first, using the vector pBPH-
M (Besir, 2001). Gene expression was controlled by the inducible bacteriorhodopsin 
(BR) promoter that is highly active when cells are grown under illumination (white 
light) and/or oxygen depletion. 
6.3.1 Expression of OE1472F in H. salinarum   
   A C-terminal His-tagged OE1472F was constructed by a one step PCR using the 
proofreading DNA polymerase LA-Taq. The 795bp gene, without the stop codon, was 
amplified by PCR, sequenced and subcloned into the E. coli-H. Salinarum shuttle 
vector, pBPH-M (figure #43A).  
The pBPH-M vector contains an inducible bop promoter, a 7xHis C-terminal 
purification tag, a MevR marker and part of OE3349F, to allow integration into the 
chromosome. The OE1472F-His C-7xhis/pBPH-M recombinant vector (pMG550) was 
transformed into H. salinarum and plated on media containing Mev. pMG550 can 
integrate into the chromosome using either OE1472F or OE3349F as a recombination 
site, but only recombination with OE3349F will allow OE1472F to be overexpressed 
and carry a His Tag.  To differentiate between the possible cross-over events, a PCR 
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was designed using primers which target both the bop promoter and OE3349F (red 
arrows, figure #43A). No amplification is expected for either a WT or an OE1472F 
recombinant, while a 972bp fragment is expected for an OE3349F recombinant. 
Total DNA was isolated from liquid cultures (Halo medium+10µg/ml Mev) of 5 
transformants and used for PCR with the primers shown in figure#43A. The gel 
analysis (figure #43B) shows that a 972bp fragment was amplified in four out of five 
transformants. PCR controls included chromosomal DNA from the WT, and DNA 
from plasmid pMG550.  
 
Figure # 43
 
: The desired integration of pMG550 into the chromosome of H. salinarum. A-
Schematic illustration of the integration. B- The expected genotype in the case of successful 
transformation. C- 1% agarose gel of PCR products using template DNA from WT (lane 2), 
pMG550 (lane 3) and transformants E1-E5 (lanes 4-8). MW markers are shown in lanes 1 (in 
bp). 
All four transformants with the correctly integrated plasmid (E1-2, E4-5) were 
tested for the overexpression of His-tagged OE1472F. They were grown to 
OD600nm=1.0 under oxygen depleted conditions to activate the bop promoter, cell 
lysates prepared, and proteins separated by SDS-PAGE (figure #44A). A similar gel 
was used for Western blotting and the His-tagged proteins were detected using an anti 
His-tag antibody (figure #44B). The calculated molecular weight of 7xHis tagged 
OE1472F is 29,055 Da, and as seen in figure #44B, E4 cells showed overexpression 
of proteins with molecular weight of ~30-40KDa. To identify this tagged protein, 
8.5ml of the cell-free extract in NPI10-KCl was loaded twice on a 1ml NiNTa affinity 
column equilibrated with the same binding buffer. The unbound protein was washed 
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away, while the bound protein eluted over 30min linear gradient between NPI10-KCl 
and NPI500-KCl. 
Figure # 44
 
: Overexpression of 7xHis tagged OE1472F in H. salinarum. A- 4-12% 
polyacrylamide SDS-PAGE  and B- Western blot of 1µg cell-free extract of E1, E2, E4 and 
E5 (lanes 2,4,7 and 9, respectively), and 10µg cell-free extract of E1, E2, E4 and E5 (lanes 
3,5,8 and 10, respectively). Lanes 1 and 11- prestained protein marker (in KDa), lane 6-His 
tagged marker. 
 
The tagged protein eluted in a single peak over an Imidazole concentration range 
of 60-143mM. A total of 0.132mg/ml protein was eluted, which was 6% of the total 
protein loaded on the column. 10µg of total protein from each elution fraction was 
separated on a 4-12% SDS-PAGE, and the gel stained by coomassie blue (figure 
#44A). The proteins were transferred to a PVDF membrane and probed with anti His 
antibody (figure #45A). As shown in figure #45A, the eluted protein was relatively 
pure.  
However, according to N terminal sequencing, the bands circled in red had an 
amino acid sequence (TDAASL), which corresponded to hydroxymethylglutaryl-CoA 
reductase (EC 1.1.1.34, OE3637R). This has a MW of 41067Da, and contains three 
histidine residues. Elution fractions 15 and 16 were subjected to mass spectrometry, 
revealing a main mass of 40286.9 Da, and 37559.7 Da, respectively. Neither of these 
values were the expected mass of the tagged OE1472F, i.e. 29055Da. 
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Figure # 45: Purification of OE3637R from cell-free extracts. A-4-12% polyacrylamide SDS-
PAGE, and B-Western blot of: lane 1: prestained protein marker (in KDa), lane2:1st load of 
NiNTa column, lane3: 2nd load of NiNTa column, lane4: wash fraction washed with NPI10-
KCL buffer, lane5: His marker (in KDa), lanes 6-12
 
: elution fractions 15-20, eluted in 30min 
linear gradient of NPI10-KCL-NPI500-KCL buffer. 
 
   To exclude the possibility that the His-tag in OE1472F was buried in the 3D 
structure of the expressed protein, and therefore was unable to bind to the NiNTA 
column, 1ml of the unbound cell-free extract from culture E4 after the second load 
(figure #45A, lane 3) was denatured with 8M urea and mixed with 1ml of NiNTa 
beads. The mixture was incubated overnight at 4°C, followed by batch separation. 
The beads were washed with NPI20+8M urea, and elution was done in a step gradient 
with NPI500+8M urea. Fractions collected from the purification were then analysed by 
SDS-PAGE, which was then stained with coomassie blue (figure #46A), and with a 
silver stain (figure #44C). To detect His-tagged proteins, the gel was also processed 
for Western blot analysis (figure #46B). Although the protein eluted in fractions 2-4 
appears to be His-tagged, the molecular weight of the main band according to the 
ESI-MS was found to be 27927.5Da, which was 1127Da shorter than expected for the 
tagged protein.  
Further attempts to over-express tagged OE1472F in cells grown under white light 
illumination (in order to induce the bop promoter), were unsuccessful in detecting 
His-tagged proteins on the western blot (results not shown, F189, F190). Given the 
difficulties found with this expression system, it was decided to try a more 
conventional expression system (see next section).  
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Figure # 46: Purification of over-expressed OE1472F after denaturation. A 4-12% 
polyacrylamide SDS-PAGE stained with A-Coomassie blue and C- with silver stain. B- 
Western blot. Lane1: pre-stained protein marker (in KDa), lane 2: crude cell extract, lane3: 
1st flow through fraction, lanes 4-6: wash fractions 1, 2 and 7, in NPI20-8M urea, lanes 8-11
 
: 
elution fractions 1-4, eluted in step gradient with NPI500-8M urea. 10µg (according to 
OD280nm) were loaded on the SDS-PAGE.  
 
6.3.2 Cell-free expression of OE1472F, OE2019F and OE1477R 
   Due to the difficulties in expressing OE1472F in H. salinarum, we tried next the 
E. coli as expression system, and as a first step, an in-vitro transcription-translation 
system was tested for its ability to express full-length haloarchaeal proteins. The 
EasyXpress System Kit (Qiagen) was selected for this purpose.   
   The genes of interest were amplified by PCR from R1 chromosomal DNA, and 
sequenced to check for errors. They were then cloned into TOPO vector, and 
subcloned into pET22b(+) (Novogen), using ElectroMax DHB10 cells. The 
transformants were checked for plasmids containing the correct insert, 6xHis-tag and 
the stop codon. These were then used for propagation and large scale isolation of 
plasmids OE1472F-His C-6xhis/ pET22b(+), OE1477R-His C-6xhis/ pET22b(+), and 
OE2019F-His C-6xhis/ pET22b(+). 
Expression of the three genes was tested by adding the purified plasmids to the 
transcription-translation reactions (EasyXpress protein Synthesis Kit, Qiagen), 
following the manufacturer’s recommendations. In-vitro expression was analysed by 
SDS-PAGE and Western blot (figure #47A and B, respectively). As shown in figure# 
47B, plasmids OE1472F-His C-6xhis/ pET22b(+), OE1477R-His C-6xhis/ pET22b(+), and 
OE2019F-His C-6xhis/ pET22b(+) directed the synthesis of correctly sized products, at 
readily detectable levels, and the expressed proteins were indeed His-tagged. A 
ladder-like pattern of faint bands was also seen in the western blot (figure #47B, lanes 
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8-12), including in the negative control (which contains no DNA template), and 
presumably represent E. coli proteins that react weakly with the anti His-tag antibody. 
The detected molecular weights of all the ORF’s were in the range of the 
calculated molecular weights of 28,298Da, 24,244Da, and 29,279Da (OE1472F, 
OE1477R and OE2019F, respectively). It is known that haloarchaea proteins migrate 
slower on SDS-PAGE due to their high content of acidic amino acids. While the three 
proteins being expressed were very acidic, the percentage of acidic residue varied 
(23.7%, 17.2%, and 16.7%, respectively). Together, the data indicate that OE1472F, 
OE1477R and OE2019F can be expressed in E. coli, as full-length His-tagged 
proteins.  
 
 
 
 
 
 
Figure # 47: Analysis of in-vitro synthesized products directed by OE1472F, OE1477R and 
OE2019F. A-SDS-PAGE (4-12%), B-western blot of lane 1: prestained protein marker 
(KDa), lanes 2-4: 1µl expression mixture of OE1472F, OE1477R, OE2019F, lanes 5-6: 
positive control, and negative control (no template), lane 7: His-tagged marker, lanes 8-10: 
5µl expression mixture of OE1472F, OE1477R, OE2019F, lanes 11-12
 
: positive control, and 
negative control (no template). 
6.3.2.1 Batch purification from cell-free extracts 
The expressed proteins generated in the cell-free reaction mixtures were purified 
via their His-tags using a batch protocol. The cell-free reaction mixtures (32µl) were 
diluted 1:3 with NP buffer and mixed with NiNTa beads (2hr RT), which were 
equilibrated with the same buffer. The unbound fraction was removed by 
centrifugation (1min, 5000g, RT), and the beads washed five times with NPI20. The 
bound protein was eluted using a two step gradient: first between 20-200mM 
Imidazole, and second between 200-500mM Imidazole. Proteins were analysed by 
SDS-PAGE and western blot. As shown in figure #48, His-tagged proteins were 
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detected in Western blots (figure #48D-F), and found to elute between Imidazole 
concentrations of 20-200mM. Some differences in the relative yields of the purified 
proteins were observed. A moderate yield was seen for OE1472F, while a high yield 
was obtained for OE1477R and a very low yield for OE2019F. None of the proteins 
were visible by coomassie blue staining, so the expression was poor in absolute terms, 
but expression was possible in this in vitro system, and it was expected that in vivo 
expression in E. coli would be more efficient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 48: Purification of in-vitro His-tag synthesized proteins OE1472F, OE1477R and 
OE2019F. A-C: SDS-PAGE after batch purification, D-F: Western blots. Lane 1: pre-stained 
protein marker in KDa, lane 2: sample before purification, lane 3: unbound fraction, lane 4: 
1st wash fraction using 20mM Imidazole, lane 5: 1st elution fraction using a step gradient of 
20-200mM Imidazole, lane 6: 4th elution fraction using a step gradient of 200-500mM 
Imidazole, lane 7
 
: His tagged marker. 
 
 
 
OE1472F                OE1477R              OE2019F 
 
                                                                                                                             Results 
 107 
6.3.3 In vivo expression of OE1472F, OE2019F and OE1477R 
in E. coli  
The previous section demonstrated that OE1472F, OE1477R and OE2019F, were 
all able to be expressed as a full-length His-tagged proteins in a cell-free system 
derived from E. coli. In vivo expression in E. coli was then tested using the same 
plasmids, and the DH3-Rosetta strain (Invitrogen) as the host. Unlike, the cell-free 
system, which was not optimized for expression of foreign genes, the Rosetta strain 
contains various combinations of rare tRNA to enhance the expression of genes 
isolated from organisms with AT or GC rich genomes. 
6.3.3.1 Transformation and expression in the DH3-Rosetta strain 
Plasmids OE1472F-His C-6xhis/ pET22b(+), OE1477R-His C-6xhis/ pET22b(+), and 
OE2019F-His C-6xhis/ pET22b(+), were introduced into E. coli DH3-Rosetta cells, and 
transformants were grown in 2ml of LB with antibiotics (overnight, 37°C, 250rpm). 
These pre-cultures were used to inoculate 10ml LB (+ antibiotics) in 100ml flasks, 
starting at a cell density of 0.1OD600nm. When the OD600nm reached ~ 0.6, gene 
expression was induced by the addition of 1mM IPTG and cultures incubated for 3h 
(37°C, 200rpm). 
Culture samples were collected before and after induction, and were analysed on 4-
12% SDS-PAGE gels (figure #49). Comparison of the coomassie stained proteins of 
non-induced cells and induced cells, shows that bands corresponding to the expected 
size of proteins OE1472F, OE1477R and OE2019F were expressed at high levels, as 
evidenced by the thick bands (indicated by the red boxes in figure #49). The 
calculated molecular weights of the 6xHis tagged OE1472F, OE1477R and OE2019F 
were 28,298.3Da, 24,244.7Da, and 29,279.2Da, respectively. All the above tagged 
proteins migrated slower on the SDS-PAGE compared to the calculated molecular 
weight.   
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Figure # 49
 
: Purification of in-vivo His-tag proteins OE1472F, OE1477R and OE2019F. The 
proteins are E. coli expressed OE1472F, OE1477R, and OE2019F-His C-6xhis/ pET22b(+) 
plasmids before and after induction. BI-before induction, I1-I3- cultures 1-3 after induction. 
MW markers were run in the left most lane. The expressed His tagged OE1472F, OE1477R 
and OE2019F are indicated by the red boxes. SDS-PAGE, 4-12%. 
6.3.3.2 Solubility of the E. coli expressed proteins 
To check whether the over-expressed proteins were soluble or expressed as 
inclusion bodies, transformants were grown in 50ml of LB medium (with antibiotics) 
until OD600nm=0.6, and then induced for 3h (37°C, 200rpm) with 1mM IPTG. The 
cells were broken by sonication, and centrifuged (4°C, 40000rpm, 40min) to separate 
the soluble cytoplasmic fraction from the cell precipitated cell debris. The pellet was 
resuspended in 8M urea to the same final volume as the supernatant. Figure #50 
shows the protein profiles of samples taken before induction, after induction, the 
supernatants after sonication, and the pellet after sonication. Comparison of the 
soluble and particulate fraction showed that all three proteins (OE1472F, OE1477R, 
and OE2019F) were over-expressed predominantly as soluble proteins. 
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Figure # 50
 
: Solubility of recombinant His tagged OE1472F, OE1477R and OE2019F 
proteins analyzed by SDS-PAGE on a 4-12% gel. I- induced samples, NI- Non-induced 
samples, S-supernatants after sonication, and P- pellets after sonication. Coomassie blue stain. 
The expressed His tagged OE1472F, OE1477R and OE2019F are indicated by the red boxes.  
 
6.3.4 Purification of His-tagged haloarchaeal proteins by 
affinity chromatography 
From the results of the preceding section, it was now possible to scale up the 
production of the three haloarchaeal proteins using in vivo expression in E. coli. Once 
purified, they could be used to examine enzyme activity, structure, and protein-protein 
interactions.   
6.3.4.1 Small scale purification of OE1472F, OE2019F and OE1477R 
proteins 
Initial purification attempts were performed using 50ml cultures over-expressing 
OE1472F, OE1477R and OE2019F. Cells were collected by centrifugation, sonicated 
to release soluble proteins, and the supernatants loaded on 1ml NiNTa columns, 
equilibrated with PBS. The flow through was washed with NPI20, and the bound 
protein eluted with NPI250. As shown in figure #51, proteins OE1472F, OE1477R, and 
OE2019F elute with high purity in the third elution fraction of Imidazole a step 
gradient (20-250mM). Some contaminating E. coli proteins were seen in SDS-PAGE 
gels, running above and below the proteins of interest.   
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Figure # 51: Purification of OE1472F (A), OE1477R (B) and OE2019F (C) on NiNTa 
columns. Lane 1: Pre-stained protein marker in KDa, lane 2: cell supernatant, lane 3: 
unbound proteins, lane 4: 1st wash fraction in NPI20, lanes 5-8
 
: elution fractions 1-4 eluted in 
step gradient using NPI20-NPI250. 4-12% acrylamide SDS-PAGE gels, coomassie blue stain.  
Table # 11
 
: Molecular masses and N-terminal sequences of His-tagged OE1472F, OE1477R 
and OE2019F, as measured by ESI-MS, and the sequence of the first N terminal amino acid 
determined by N-terminal sequence (1). 
Expressed protein Calculated mass Observed mass 
(ESI-MS)  
# of  
Methionine 
sequence of 
first 6 amino 
acids (1)  
OE1472F-6XHis 28,298.31 Da 28,298.80 Da +2  MM
OE1477R-6XHis 
TDAG 
24,244.72 Da 
24,241.47 Da +2  MM
24,110.93 Da 
EFQD 
+1 MEFQD 
OE2019F-6XHis 29,279.25 Da 29,279.30 Da +2  
MM
MRPFE 
RPFE 
 
The N-terminal sequences of each of the purified proteins, and their molecular 
masses were determined by ESI-MS. These are presented in table #11. There was a 
close correspondence between the calculated and experimentally determined masses.  
All proteins had two methionines, one intrinsic methionine and a second 
methionine, which was introduced during the in-frame cloning with the restriction site 
NdeI. Post translation modification was not expected, due to the cloning strategy 
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applied. While cloning the genes of interest into pET22b(+), the signal peptide 
sequence for periplasmic localization, was removed, so expressed proteins would not 
be exported and post translation modification will not occur. But, proteins OE1472F, 
and OE2019F, showed some processing of the first methionine to give N-termini with 
just one methionine.  
The N terminal sequences results were in agreement with the ESI-MS findings 
(table#11), except for OE2019F, where an additional species was found containing 
only one methionine. Both, ESI-MS, and N-terminal sequencing, confirmed that the 
proteins were His-tagged and full length. 
6.3.4.2 Separation under native conditions using 1M KCl  
To investigate whether His-tagged OE1472F could be recovered in high purity 
using native, high salt conditions, it was purified from E. coli cells in the presence of 
1M KCl and separated on NiNTa using Imidazole which contained 1M KCl (see 
materials and methods section 5.1.3.2). 
Before sonication, the cell pellet was resuspended in NPI20-KCl. After sonication, the 
cell lysate loaded on a 1ml NiNTa column equilibrated with NPI20-KCl. Unbound 
protein was washed through, and two step elution gradients were performed; the first 
from NPI20-103-KCl, and the second from NPI103-250-KCl. As shown in figure#52, the 
protein eluted in both of the step gradients. No significant improvement in the purity 
was seen when comparing the protein eluted in high salt, to the protein eluted in low 
salt (figure #52, lane 7, 11, and 12).   
 
Figure # 52: Purification of His-tagged 
OE1472F under native conditions with 
high salt buffers. Lane 1: prestained 
protein marker in KDa, lane 2: cell 
lysate from the induced culture, lane 3: 
sample before separation in NPI20-KCl, 
lane 4: unbound fraction in NPI20-KCl, 
lane 5:1st wash fraction in NPI20-KCl, 
lane 6-8: 14th, 15th and 16th wash 
fractions in NPI20-103-KCl, lanes 9-11: 
Elution fractions 1-3 in NPI103-250-KCl, 
lane 12: control, 3rd elution fraction in 
NPI20-250 purified in low salt. 
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6.3.4.3 Large scale purification of OE1472F and OE1477R 
Given the previous results showing good expression and purification from small 
volume cultures, the next step was to scale up in order to produce sufficient quantities 
of protein for detailed study.  
OE1472F-His C-6xhis and OE1477R-His C-6xhis were produced from 1 liter and 2 liter 
induced culture, respectively, as follows. The cells were collected by centrifugation, 
resuspended in NP buffer with DNAase and 20mM PMSF, and broken open using a 
French press. After centrifugation, the supernatant was loaded on a 1ml column of 
NiNTa. Unbound protein was washed through with NPI20, and bound protein was 
eluted using a step gradient of NPI20-250. Fractions from the column were separated on 
a 4-12% SDS-PAGE gel, and stained with coommassie blue. As shown in figure 
#53A-B, while some of the expressed protein eluted in low Imidazole concentrations 
(20mM Imidazole), the majority eluted in NPI20-250 (figure #53A, lanes8-12 and figure 
#53B, lanes 7-9).  
 
Figure # 53: Purification of His-tagged OE1472F (A) and OE1477R (B). Bout proteins were 
purified under native conditions. Gel A- lane 1: prestained protein marker in KDa, lane 2: 
cell lysate from the non- induced culture, lane 3: cell lysate from the induced culture, lane 4: 
sample before separation on NiNTa in NP buffer, lane 5: unbound fraction in NP buffer, lane 
6:1st wash fraction in NPI20, lane 7: 10th was fraction in NPI20, lanes 8-12: eluted fractions 1-5 
in NPI20-250. Gel B- lane 1: prestained protein marker in KDa, lane 2: sample before 
separation on NiNTa in NP buffer, lanes 3-5: wash fractions #2, 10 and 18 in NPI20 buffer, 
lanes 6-11
 
: elution fractions #20, 21, 22, 24, 26 and 28 in NPI20-250 
Now that purification protocols were established for OE1472F, OE2019F and 
OE1477R the next step was to measured the activities of the purified proteins. Note 
that the activity of OE1472F and OE2019F was measured after purification from 
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50ml and 2liter culture (figures #51,53), while the activity of protein OE1477R was 
measured after purification from 2liter culture, pooling elution fractions 20-24 (Figure 
#53, lanes 6-9), and dialysis against 3M KCl+50mM Tris HCl pH 7.2.   
According to BCA assay 13mg/ml tagged OE1472F and 9.9mg/ml tagged 
OE1477R were produced from 2liter culture, while ~2.1mg/ml tagged OE2019F was 
purified from 50ml culture. 
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6.4 Enzyme activity and specificity 
Having purified the proteins of ORFs OE1477R, OE1472F and OE2019F, this 
section summarizes the development and validation of assays to measure their 
expected enzyme activities.  
ORF OE1477R was annotated as 3-dehydroquinate dehydratase (EC 4.2.1.10) and 
expected to catalyze the formation of DHS (3-dehydroshikimate). ORF OE1472F was 
suggested to catalyze the first step in the biosynthesis of AroAAs in H. salinarum, 
using ASA and DKFP as precursors. This step can be carried out by a transaldolase. 
ORF OE2019F was annotated as F-1,6-P aldolase (EC 4.1.2.13). 
6.4.1 Aldolase Assay 
ORF OE2019F, was expected to cleave F-1,6-P. As an aldolase it would split F-
1,6-P into two triosephosphates: glyceraldehyde phosphate (GAP) and 
dihydroxyacetone phosphate (DHAP). Aldolase activity can be measured by the 
colorimetric method of Sibley and Lehninger (Pinto, 1969; Sibley, 1949), which has 
been shown to efficiently measure aldolase activity in cell-free extracts of haloarchaea 
(Altekar W., 1987; D'souza S.E., 1998; D'Souza, 1982; Dhar and Altekar, 1986). In 
this assay, the products (DHAP and GAP), are trapped by reaction with hydrazine, 
and then converted to their colored dinitrophenylhydrazones. Using 2,4 
dinitropheneylhydrazine (DNPH), the hydrazone generated can be detected at 540nm. 
As shown in figure #54, aldehydes and ketones react with hydrazine to form 
hydrazone.  
 
 
 
Figure # 54
 
:  Derivatization reaction of aldehydes and ketones with hydrazine.  
6.4.1.1 Testing the assay using aldolase from rabbit muscle (Sigma)   
The ability to detect the formation of DHAP and GAP by the colorimetric assay 
was checked first with a commercial aldolase (from rabbit muscle, Sigma), using the 
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coupled assay suggested by the manufacturer. The activity of the commercial 
alodolase was measured by continuous monitoring of NADH at 340nm. Since NADH 
is consumed in the reaction, there should be a continuous decrease in the absorbance 
at 340nm. One unit of enzyme reduces one µmole NADH per minute at 25°C in 
86.7mM Tris HCl pH=7.4. A decrease in the absorbance of NADH occurred only 
when the substrate, F-1,6-P, was added to the reaction mixture (figure #55, black 
arrow). From the corresponding slopes, the activity of the commercial aldolase was 
calculated to be 0.42±0.03U/ml or 12.1± 0.9U/mg protein (n=5, figure #55, blue 
curve). As expected, the reaction rate was halved when TIM (Trioesphosphate 
Isomerase, EC 5.3.1.1) was not added to the reaction mixture (figure #55, red curve). 
 
 
 
 
 
 
 
 
 
 
Figure # 55
 
: Activity of commercial aldolase measured with the coupled enzyme assay using 
1.92mM F-1,6-P, 16.7U/ml TIM, 1.67U/ml GDH, and 0.15mM NADH. The arrow indicates 
addition of aldolase to the reaction mixture. Blue curve: aldolase activity was measured in the 
presence of TIM and GDH. Red curve: aldolase activity was measured in the presence of 
GDH only.    
 
For comparison, the same aldolase used in the coupled assay (12.6±1.2 U/mg) was 
used in the colorimetric assay. As shown in table#12 below, both assays gave very 
similar values for specific enzyme activity.  
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Table # 12
 
: Comparison of the colorimetric assay and coupled assay using a rabbit muscle 
aldolase and TIM. 
 
 
 
6.4.1.2 E. coli-expressed OE1472F and OE2019F show aldolase activity 
The ORF OE2019F (fab1) was annotated as fructose-bisphosphate aldolase (EC 
4.1.2.13) and, by definition, the gene product should be able to cleave F-1,6-P into 
GAP and DHAP. ORF OE1472F, which is part of the trp operon, was reannotated as 
2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate synthase, in accordance with the 
functional evidence of MJ0400 in M. jannaschii (White, 2004). As such, the gene 
product is expected to cleave DKFP, which is assumed to be one of the precursors in 
the proposed AroAAs biosynthesis pathway, and therefore is not expected to display 
aldolase activity.  
OE2019F and OE1472F were both expressed in E.coli and purified on a NiNTa 
column under low salt conditions using buffers containing 300mM NaCl. The activity 
of the proteins was measured using the colorimetric assay (low salt, Figure #56A and 
C). The activity of the freshly eluted protein (fraction E-3 eluted after step gradient 
NPI20-250, low salt) was measured directly in elution buffer (“before”) and again after 
exchanging the buffer to one with high salt (“after”). As shown in figure #56A, both 
proteins possess readily detectable aldolase activity, and are able to cleave F-1,6-P. 
Their specific activities were very similar, and were increased when the buffer of the 
enzyme was exchanged to 1M KCl, prior to the assay.   
Since the gene product of OE1472F derives from an extreme halophile, it would be 
expected to function optimally at high salt conditions, similar to the conditions 
present in the cytoplasm. It is also likely to retain higher activity if purified under high 
salt condition. For this reason, the specific enzyme activity was measured after 
purification in 1M KCl. The specific activity of protein eluted in 15th fraction (W15- 
wash with NPI20-103-KCl buffer, separation shown in figure #53, lane 7) was 
compared to the activity of the 3rd elution fraction (E-3 eluted with NPI103-250-KCl 
buffer, separation shown in figure #53, lane 7).  
 U/mg 
Colorimetric assay 14.6±2.5 
Coupled assay 12.6±1.2 
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As shown in figure #56B, no significant difference in the specific activity was seen 
before and after buffer exchange when the enzyme was purified in 1M KCl, as 
opposed to low salt purification, where the specific activity was 7 fold higher after 
buffer exchange (figure # 56A). Note that a significant difference was seen in the 
specific activity of fraction W-15, compared to fraction E-3. Fraction E-3 was 3-fold 
more active compared to fraction W-15 (32mU/mg protein and 11mU/mg protein, 
respectively).  
Figure # 56
The proteins were 
purified from 50ml of 
culture, separated on 
NiNTa column, and 
eluted in NPI20-250 buffer 
with 300mM NaCl (low 
salt) or in NiNTa buffer 
with 1M KCl buffer (high 
salt). Fraction W-15 
eluted in NPI20-103-KCl 
buffer, while fraction E-3 
eluted in NPI103-250-KCl 
buffer. Aldolase activity 
is expressed as µmoles 
DHAP formed/mg 
protein/30min at 37°C. 
The colorimetric assay 
was performed in 2M 
KCl in 78.7mM Tris HCl 
(pH=7.2), and 5.9mM 
NaCl.  
: Specific 
aldolase activity of 
E.coli-expressed 
OE1472F and OE2019F 
purified A-at low salt 
buffers (300mM NaCl) 
B- E.coli-expressed 
OE1472F purified at high 
salt buffers (1M KCl).  
Before- activity measured 
in elution buffer,  
After- activity measured 
after buffer exchange. 
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As seen in figure #57, there is no need to purify the enzyme under high salt 
concentrations (1M KCl). Similar specific activities were obtained when the protein 
was purified under standard conditions (300mM NaCl) and the buffer was exchanged, 
compared to purification in high salt (1M KCl), (70mU/mg protein and 43mU/mg 
protein, respectively. Note that the specific activity of the commercial rabbit muscle 
aldolase (table #12, 14.6±2.5 U/mg protein) was significantly higher that of OE1472F 
(figure #56A, 70mU/mg protein). The aldolase from sigma was 206-fold more active 
compared to OE1472F.  
 
 
 
 
 
 
 
 
 
Figure # 57
 
: Specific activity of recombinant OE1472F purified on a NiNTa column using 
low salt buffers (300mM NaCl) or high salt buffers (1M KCl). The activity was measured 
before and after buffer exchange using the colorimetric assay. The concentration of the 
protein was measured by BCA assay. Aldolase activity is expressed as µmoles DHAP 
formed/mg protein/30min at 37°C. before- activity measured in elution buffer, after- activity 
measured after buffer exchange. The proteins used for the measurement are seen in figure #51 
for low salt purification, and figure #52 lane 12, for high salt purification lanes 7 and 11. 
 
6.4.1.2.1 Confirming the basis of the colorimetric assay  
Sibley and Lehninger (Sibley, 1949) showed that hydrazine traps the 
triosephosphates GAP and DHAP as soon as they are formed after cleavage of F-1,6-
P by aldolase. Hydrazine reacts with the carbonyl group in the triosephosphates to 
form the corresponding hydrazones. The products of splitting DKFP were expected as 
well to be trapped by hydrazine and if so be detectable by the colorimetric assay 
(figure #58).  
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This assumption was checked by measuring the absorbance of the corresponding 
hydrazones when 1.2mM DHAP, GAP and HA were mixed with 3mM hydrazine in 
2.475M KCl. Since hydrazine does not absorb at 240nm, changes in the absorbance at 
this wavelength can only occur if the corresponding hydrazones are formed. A plot of 
the increase in A240nm would then allow the rates of the reaction to be determined from 
the slope (a=OD240nm/min).  
 
 
 
 
 
 
 
 
 
Figure # 58
 
: The structures of F-1,6-P (blue) and DKFP (orange). DHAP- dihydroxyacetone 
phosphate, GAP- glyceraldehyde 3-phosphate, HA- hydroxyacetone (2 keto 1-propanol), 
HPAP- hydroxpyruvaldehyde phosphate. 
 
As seen in figure #59, the rate of formation of the corresponding hydrazones of 
DHAP and GAP was not the same as seen from the initial slopes, but the similar final 
OD240nm was achieved after 10min of incubation, indicating that similar 
concentrations of the corresponding hydrazones were formed. No change was 
observed when HA was mixed with hydrazine, meaning that HA-hydrazone was not 
formed, and thus the colorimetric assay cannot be used to detect cleavage of DKFP by 
ORF OE1472F.   
The formation of the corresponding hydrazones of DKFP and F-1,6-P were 
measured as well. No hydrazone was detected when F-1,6-P was added to hydrazine, 
while DKFP formed the corresponding hydrazone (1.47±0.03 OD240nm/min, 
respectively). 
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Figure # 59
 
: Detection of the corresponding hydrazones of 1.2mM F-1,6-P, 1.2mM HA, 
1.2mM DHAP, 1.2mM GAP, and 1.2mM DKFP. All reactions were carried out at RT, in total 
volume of 1ml. The reactions contained as well 3mM hydrazine and 2.475M KCl in Tris HCl 
pH =7.2. The initial slope after adding the substrate was subtracted from the slope obtained in 
the first 2min (a=0.0054±0.0002OD/min, reaction mixture contained buffer and hydrazine 
only). A constant increase in the absorbance over time was seen only when substrates were 
added to the reaction mixtures (after 2 min).    
6.4.2 Transaldolase activity 
The first step in the proposed pathway is a transaldolase reaction, which catalyzes 
the transfer a HA moiety from DKFP while releasing hydroxypyruvaldehyde 
phosphate (figure #60).  
Transaldolase activity of the purified recombinant proteins was tested, in the 
presence of the precursors, ASA and DKFP, using two different assays, LC-MS and 
GC-MS. LC-MS and GC-MS allow the detection and identification of the derivatized 
intermediates. Compounds are first separated by HPLC or by GC. In the second 
dimension (MS), the masses of derivatized compounds can be accurately measured. 
The advantage of the second dimension is the possibility of detecting a wide range of 
intermediates by their mass.  
 
DKFP: 1.5±0.03 
GAP:    0.113 
DHAP: 0.23±0.01 
 
HA:        0.013±0.0 
F-1,6-P: 0.002±0.0 
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Figure # 60
 
: The transaldolase reaction catalyzed by ORF OE1472F using ASA and DKFP as 
precursors. Aldole-like condensation between HA moiety and ASA releases HPAP 
(hydroxpyruvaldehyde phosphate).  
6.4.2.1 Validating the LC-MS assay for determining aldolase activity   
As a first step the LC-MS method was validated. Pure preparations of ASA, 
DKFP, F-1,6-P, DHAP, GAP, and DHQ were derivatized according to the protocol 
described in materials and methods, and the derivatized masses were identified by 
LC-MS. Their retention times are given in appendix table #15.  
Next, the purified tagged OE1472F was incubated with different substrates for 
30min at 37°C, followed by derivatization and analysis by LC-MS. None of the 
expected products or intermediates were detected when the recombinant protein 
OE1472F was incubated with ASA and DKFP. Moreover, OE1472F showed no 
aldolase activity with the substrates F-1,6-P. The latter result was unexpected, as the 
colorimetric assay indicated that OE1472F could cleave F-1,6-P (figure #56A). This 
discrepancy can be explained either by a difference in sensitivity of the two assays, or 
the efficiency of derivatization. Both of those aspects were then examined in more 
detail.  
As seen in figure # 61A and B, ≤12.5 nmole DHAP (in 500µl) can be detected by 
the colorimetric assay while ≤1 nmole DHAP can be detected by the LC-MS, 
meaning that the LC-MS method is 12 fold more sensitive compared to the 
colorimetric assay. The derivatization efficiency can not be measured by the 
colorimetric assay, but in the LC-MS method it is clear that the efficiency of the 
derivatization was high, as no excess of NBHA (O-(4-nitrobenzyl) hydroxylamine 
hydrochloride) was seen after the derivatization when using 2-3mM substrate and 
2mM NBHA. Thus, neither the sensitivity nor the derivatization efficiency was the 
reason for the inconsistency between the assays. 
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Figure # 61
 
: Calibration curves of derivatized DHAP in A-colorimetric assay and B-LC-MS. 
To further examine the source of the discrepancy, the activity of commercial rabbit 
muscle aldolase was measured both by the coupled enzyme assay (stock 6.3±0.4U/mg 
protein, n=5) and LC-MS. The enzyme solution was mixed with 1.92mM F-1,6-P and 
16.7U/ml TIM, incubated for 30min at 37°C, then the products derivatized and 
separated on a  C-18 column. The area of the peaks detected at 254nm was calculated 
and found to be 62.1±2.1 mAu. Using the calibration curve shown in figure #61B 
(WO salt), the area was found to correspond to 4.0±0.1U/mg protein, which is 63±2% 
of the total activity determined by coupled enzyme assay.  
Nevertheless, the aldolase activity of the commercial enzyme was readily 
detectable. The fact that protein OE1472F showed no detectable aldolase or 
transaldolase activity is, most likely due to the low specific activity of this enzyme, 
combined with the small volumes that can be loaded on the column (up to 9µl). The 
specific activity of OE1472F determined by the colorimetric assay was 70mU/mg 
protein, meaning 35.6nmole of DHAP would be formed after 30min at 37°C. 
Following the derivatization protocol for LC-MS, this amount of DHAP will be 
further diluted (1/2.5), and since the maximum load volume is 9µl, this would 
introduce only 0.85nmole DHAP for MS analysis. This is below the limit of detection 
of the LC-MS. Overnight incubation of reaction mixtures at 37°C did not improve the 
sensitivity, as no products or intermediates were detected (data not shown). Although 
it is known that halophilic proteins are often thermostable, it might be that this 
enzyme is not. 
                                                                                                                             Results 
 123 
From the above results, it was not possible to determine the aldolase/transaldolase 
activity of the purified OE1472F using the LC-MS method described here. 
Improvements that could be tested include: higher protein concentration, and removal 
of salt from the reaction products before derivatization. Optimizing the enzyme 
reaction conditions would also be useful to explore.    
 
 
 
 
 
 
 
Figure # 62
 
: Derivatized DHAP obtained after cleavage of F-1,6-P with commercial aldolase 
and TIM. Black curve, the TIC; red curve, absorbance detected at 254nm.  
6.4.2.2 Validating the GC-MS assay for determining transaldolase 
activity   
GC-MS analysis requires one or more appropriate derivatization procedures to 
block active protons and labile keto groups. The combination of methoximation with 
subsequent silylation is conveniently used. The first step is methoximation of the 
carbonyl group to form the corresponding oximes (figure #63A). The second step is 
using silylating agent (TMS or TBS) which replaces the labile hydrogens with a -
Si(CH3)3 or -Si(CH3)2-C(CH3)3 group, respectively (figure #63B). Theses 
derivatization steps are used to prepare volatile and thermally stable derivatives for 
GC-MS.  
In order check whether methoximation was necessary in addition to TMS or TBS 
derivatization, glucose was used as model molecule in this assay. As seen in figure 
#64, without methoximation the derivatization of glucose with TMS yielded several 
products (peak#3 was the desired product), while when using methoximation along 
with TMS derivatization, only the two stereiosomers of the desired product were 
detected.  
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Figure # 63
 
: Two steps derivatization for GC-MS. A- Methoximation with O-
methylhydroxyl-hydrochloride. B- silylation with TBS [N-methyl-N-(tert-
butyldiamethylsilyl) trifluroacetamide]. 
 
Next, a two-step derivatization with either TMS or TBS was tested on the 
following compounds: ASA, DKFP, F-1,6-P, GAP, DHAP, DHA, DHQ and 
shikimate. The correct masses of the derivatized substrates were identified by GC-
MS, along with the indicated retention times, as shown in the appendix tables #17-18. 
Methoximation plus TBS derivatization was the preferred method due to the ability to 
detect all the substrates listed above. This was not possible when the second 
derivatization was TMS. Moreover the derivatization method used in this method 
allowed detection of shikimate, which was not possible in the derivatization used in 
the LC-MS method.  
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Figure # 64
 
: Derivatization of glucose with and without methoximation followed by a 2nd 
derivatization with TMS. Peaks 1-2: β-DL-arabinopyranose, 3-D-glucose, 4-1,6-anhydro-β-
D-glucose, 5-Glucopyranose, 6-7: D-glucose. 
6.4.3 The OE1477R gene product shows dehydroquinase 
activity 
ORF OE1477R was annotated as 3-dehydroquinate dehydratase (EC 4.2.1.10), an 
enzyme that removes a water molecule from DHQ to form DHS (figure#65). The 
formation of DHS from DHQ was measured using LC-MS and spectrophotometer. 
 
 
 
 
Figure # 65
 
: Schematic representation of the reaction that OE1477R protein might catalyze. 
3-dehydroqinase dehydratase activity of the purified protein was assayed first by 
monitoring the formation of 3-dehydroshikimate (DHS) at 234nm at RT. The standard 
assay mixture contained 2.57M KCl, 43.75mM Tris HCl (pH=7.2) and 10mM 3-
dehydroquinate (DHQ). The specific activity was found to be 55±6mU/mg protein 
(n=2). 3-dehydroqinase dehydratase activity was also detected using the LC-MS 
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method (appendix, table #16), where a product corresponding to the mass of the 
derivatized DHS was detected after incubating DHQ with purified OE1477R.  
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6.5 Transformation of N. pharaonis strain 2160 
6.5.1 Background and objectives 
The well-studied archaeon H. salinarum is an important model organism for the 
study of haloarchaea. Its genome has been sequenced and annotated ((Falb et al., 
2005),www.halolex.mpg.de), and extensive investigations have been preformed on its 
flagellar biosynthesis, motility, signal transduction, energy metabolism, retinal 
proteins and so on. Many of those studies were possible because of the availability of 
the PEG-mediated transformation method introduced by Cline and Doolittle (Cline et 
al., 1989). In 1982, a novel member of the Halobacteriaceae was isolated from the 
highly saline soda lakes of Egypt, and named N. pharaonis (Soliman, 1982). This 
aerobic haloalkaliphilic archaeon (phylum euryarchaeota), grows under extreme 
alkaline and hypersaline conditions (pH 9-11, 4M NaCl). The genome sequence has 
been determined (www.halolex.mpg.de, (Falb et al., 2005)) but, to date, the study of 
N. pharaonis has been restricted to comparative genomics and structural studies of 
purified proteins. The lack of genetic tools for N. pharaonis prevents essential genetic 
studies and molecular engineering of this organism. 
Developing genetic tools in N. pharaonis is of substantial importance for the 
following reasons. Firstly, the biological basis of its adaptation to high pH and high 
salinity is of fundamental biological interest and would provide a model system for 
haloarchaea that live in this doubly extreme environment. Secondly, genetic 
manipulations would allow the extension of previous studies on the chloride pump 
halorhodopsin (Lanyi et al., 1990), sensory rhodopsin II ((Hein et al., 2003); (Schmies 
et al., 2000)) and its transducer HtrII (Klare et al., 2004). Thirdly, there are many 
intriguing questions arising from close examination of the N. pharaonis genome 
(www.halolex.mpg.de). On the one hand there are many genes with unknown 
functions, whereas other genes, that would be expected to be present as part of a 
known biological pathway, are absent. Surprisingly, 42% of theses ORFs are of 
unknown function or not similar to anything previously known. 24% of the ORFs are 
conserved hypothetical proteins (CHY) and, 18% are hypothetical proteins (HY). 
Without methods for analysing the functions of these unknown genes, a full 
understanding of this organism will not be possible. One example of particular 
interest revealed by the genome sequence of N. pharaonis (Falb et al., 2005), is that it 
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contains an unknown analogue of complex III, in a functional respiratory chain. The 
organism also appears to have a unique nitrogen metabolism. 
Only one study has described the construction of a potential shuttle vector for 
haloalkaliphilic archaea (Zhou et al., 2004b). These authors based their vector on a 
plasmid from Natronobacterium sp. Strain AS7091, and while this vector could be 
introduced into non-haloalkaliphilic hosts, such as H. salinarum, the authors were 
unable to show that it would function in Natronobacterium or any other alkaliphilic 
haloarchaea. No conclusions were given regarding the failure to transform 
haloalkaliphilic strains with this plasmid but one might speculate that the two most 
likely reasons are the inability to form competent cells (by EDTA/PEG treatment for 
uptake of DNA), or that gene for drug resistance did not provide adequate selection.   
6.5.2 Mevinolin is a suitable antibiotic for drug selection N. 
pharaonis 
The two commonly used antibiotics for drug selection in haloarchaea are 
Mevinolin (Mev) and Novobiocin (Nov) (Allers, 2005). To test whether these 
antibiotics can be used for selection of transformants, and to determine the optimum 
concentration, the growth of N. pharaonis was monitored in the presence of different 
concentrations of these antibiotics (figure #66).  
As seen in figure #66, increasing concentrations of both drugs caused reduction in 
the growth rates. Mevinolin was profoundly effective at 1µg/ml (=2.47µM), 
extending the Gn time from 12.48h to 28.5h, while 10µg/ml completely blocked the 
growth. These concentrations (2-4µg/ml) are similar to those used for selection of 
transformants in other haloarchaea (Dyall-Smith). Novobiocin was less effective, as 
even at relatively high concentrations (10µg/ml, 15.7µM) cell growth was diminished 
but not prevented.   
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Figure # 66
 
: Growth of N. pharaonis in medium M205 (pH=8.9) supplemented with different 
concentrations of Novobiocin (Nov, left panel) and Mevinolin (Mev, right panel).  
6.5.3 Construction of shuttle vectors for N. pharaonis 
pNB101 was the first plasmid isolated from the haloalkaliphilic archaeon 
Natronobacterium sp. Strain AS7091(Zhou et al., 2004b). This 2.5Kbp rolling-circle 
replicating plasmid contains three major open reading frames (ORF1 ,ORF2, and 
ORF3), as well as three sequence motifs (Motifs I-III) which are common to Rep 
proteins of RC plasmid family (Zhou et al., 2004b). pNB101 was used to construct the 
shuttle plasmid pNB102 (Zhou et al., 2004b) which could be used to transform both 
E. coli and H. salinarum (strain SNOB).  
pNB102, a gift from Dr. Hua Xiang (Institute of Microbiology, Beijing) was used 
in the current study for constructing plasmids pMG100 and pMG200 (figure#53B, 
and 53C, respectively). The cleaved Ori of N. pharaonis (pNB101, (Zhou et al., 
2004a)) was ligated to either pUS-Mev ((Pfeiffer et al., 1999; Schweiger, 1996) or 
pMKK100 (Koch and Oesterhelt, 2005), as outlined in figure #67 below, and then 
introduced into competent E. coli cells. Transformed colonies, which contained the 
ligated plasmids, were chosen after mini prep analysis, as seen in figure #68. 
Transformed E. coli colonies were screened for plasmid DNA containing the correct 
insert by restriction with BamHI and HindIII for pMG100, or  HindIII for pMG200 
(figure #67A, and B, respectively).   
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Figure # 67
 
: Construction of shuttle vectors pMG100 (B) and pMG200 (C) using the 
HindIII-fragment from pNB102 (A). pUS-Mev was constructed in-house by Uli Schweiger 
(Pfeiffer et al., 1999; Schweiger, 1996), and pMKK100 was constructed by Koch and 
Oesterhelt (Koch and Oesterhelt, 2005). 
 
 
 
Figure # 68: Mini prep plasmid DNA from separate transformants. The 1% agarose gel 
showing A-BamHI-HindIII-digested plasmid DNA from different transformed colonies after 
introduction of pMG100. B- HindIII-digested plasmids from 9 colonies after ligation and 
transformation of pMG200. The loading scheme was the same for both gels. Lane #1: MW 
size ladder (in bp), lanes 2-11: mini prep plasmid DNA from separate transformants. 
                                                                                                                             Results 
 131 
6.5.4 Evaluation of transformation methods for N. pharaonis 
6.5.4.1 EDTA treatment to remove the S-layer 
The transformation procedure using the PEG method for halophilic Archaea can be 
briefly outlined as followed: washing and resuspending cells in spheroplasting 
solution, adding EDTA to chelate the Mg2+ and thereby remove the S-layer (forming 
spheroplasts), adding DNA, adding PEG600 solution (PEG makes the membrane 
permeable for DNA), washing the spheroplasts (to remove the PEG), and plating. 
Although this method has been used successfully with several euryarchaeota that 
form spheroplasts readily by treating the cells with EDTA (for review see (Allers, 
2005)), the conventional method failed to generate spheroplasts of N. pharaonis 
(∆O.D600nm=0.614, EDTA for 10min at RT, 30 min at RT, and 30min at 370C). This 
could indicate that the S-layer of N. pharaonis is different to other haloarchaea in its 
composition (Falb et al., 2005) or in its subunit interactions. Spheroplast formation 
and the direct access of DNA to the cell membrane is believed to be an important step 
of the PEG transformation method, so other techniques to remove the S-layer were 
investigated. 
6.5.4.1.1 Bacitracin forms spheroplast in N. pharaonis  
Bacitracin is one of the antibiotics known to interfere with the cell wall formation 
in Bacteria and Archaea (Pollock et al., 1994; Siewert and Strominger, 1967; Stone 
and Strominger, 1971; Storm and Strominger, 1973). It forms a complex with a 
functional phospholipid, which is a carrier that transports sugars from the cytoplasm 
to the cell membrane (figure #69). By forming this complex, Bacitracin prevents the 
enzymatic dephosphorylation of the carrier lipid, which is an important step in the 
biosynthesis of the cell wall. By inhibiting cell wall synthesis, the cells are unable to 
maintain their normal shape (Upreti et al., 2003). Mescher and Strominger (Mescher 
and Strominger, 1976) studied the effect of Bacitracin on the morphology of H. 
salinarum and concluded that the cell surface glycoproteins are responsible for 
maintenance of normal cell morphology.  
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Figure # 69
     
: Peptidoglycan synthesis and the mode of action of Bacitracin. Bacitracin is 
forming a complex with the lipid carrier and inhibit its dephosphorylation. A lipid (DOI-P) or 
nucleotide (GDP, UDP) molecule serves as sugar carrier. GT-glycosyl transferase, UDP-
uridine diphosphate, GDP-guanidine diphosphate, Xxx- any amino acid. From (Upreti et al., 
2003). 
                                    
The effect of Bacitracin on the growth rate and morphology of the cells was tested 
by growing N. pharaonis in the presence of different concentrations of Bacitracin 
ranging from 5-100µg/ml. As shown in figure #70A, up to 50µg/ml Bacitracin had 
little effect on the growth of N. pharaonis. However, 100µg/ml Bacitracin completely 
inhibits growth (figure#57A, red curve).  
Figure # 70: A-Growth of N. pharaonis in different concentrations of Bacitracin. B-% of 
spheroplasts vs. different concentrations of Bacitracin at different time points. 
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The effect of Bacitracin on the morphology of N. pharaonis was examined in 
cultures supplemented with different concentrations of this antibiotic. Cell 
morphology was followed using phase-contrast microscopy (x100 with oil), and the 
percentage of spheroplasts seen at different time points is summarized in the appendix 
table #24. As seen in figure#70B, a peak of 44% spheroplasts was observed after 48hr 
when the medium was supplemented with 10µg/ml Bacitracin. The morphology of the 
cells at this concentration is shown in figure #71. Bacitracin greatly increased the 
population of cells that had lost their normal rod shape and become rounded up. 
Given the known mode of action of Bacitracin (Upreti et al., 2003) the results are 
consistent with the disturbance of S-layer formation leading to a weakened or absent 
cell wall, so forming spheroplasts.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 71: Cell morphology of N. pharaonis at different times during cultivation in medium 
containing 10µg/ml Bacitracin. Samples taken at different times after inoculation of N. 
pharaonis into M205 medium with 10µg/ml Bacitracin. Time points are shown in the top right 
hand of each photograph. left  Spheroplast (blue circle), rod shape (red circle). Control- N. 
pharaonis after 48h growth in M205 medium. Phase-contrast microscopy photos taken at  
x100. 
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A closer look at the relationship between the growing curve and the % of 
spheroplasts (figure #72B), reveals that the highest % of spheroplasts occurred at the 
end of the exponential phase and just before the beginning of the stationary phase. 
The decrease in the % of spheroplasts in the stationary phase may indicate either lysis 
of spheroplasts or their conversation back to rod shape cells.   
To summarize these experiments, Bacitracin appeared to be effective in converting 
a significant proportion of N. pharaonis cells to spheroplasts (20-40%), and is 
potentially a useful treatment for introducing DNA into the cells.   
Figure # 72
 
: Correlation between cell density and % of spheroplasts when growing N. 
pharaonis in A-medium without Bacitracin, B-medium containing 10µg/ml Bacitracin.  
 
 
6.5.4.1.2 Protease treatment produces spheroplasts in N. pharaonis 
Another way of removing the S-layer proteins from haloarchaea is treatment with 
proteolytic enzymes, such as the protease from Streptomyces griseus (Mescher and 
Strominger, 1976). This protease retains activity at high salt concentrations and has 
been shown to form spheroplasts of H. salinarum. In that study, the effect of protease 
on cell morphology and glycoprotein content of H. salinarum was observed both by 
electron microscopy and gel electrophoresis. In this way, Mescher and Strominger 
(Mescher and Strominger, 1976) demonstrated the shape-maintaining role of surface 
glycoproteins.  
In the current study, a soluble protease from Streptomyces griseus was selected 
because it was active at high salt concentration and over a pH range between pH 5-9. 
                                                                                                                             Results 
 135 
As seen in figure #73A, increasing concentrations of protease slowed the apparent 
growth rate, causing a 2 fold increase in the Gn times (Gn (WO protease)=12.9h, Gn (with 
0.9mg/ml)=30.9h). However, this treatment was very effective at generating spheroplasts 
(appendix table #25).  Spheroplast proportions of 69% and 66% were seen after 97h 
and 72.9h, respectively (figure #73B), when N. pharaonis was growing in medium 
with 0.3mg/ml Protease. Although at first glance, 0.6mg/ml and 0.9mg/ml protease 
appeared to be useful concentrations due to the high % of spheroplasts (90-100% at 3-
5 days), the lower growth at those concentrations made 0.3mg/ml protease the more 
suitable choice, as it is produced ~70% spheroplasts at 3-4 days. 
Figure # 73
 
: A-Growth of N. pharaonis in different concentrations of Protease. B-% of 
spheroplasts vs. different concentrations of Protease at different time points. 
 
 
 
As seen in figure#74B, in contrast to Bacitracin, the % of spheroplasts increased 
with the O.D of the culture till the end of the stationary phase (96h, 
∆O.D600nm=0.58, 69% spheroplast). The morphology of the cells at different time 
points during growth in 0.3mg/ml Protease is shown in figure #75. 
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Figure # 74
 
: Correlation between growth density and % of spheroplasts when growing N. 
pharaonis in A-standard M205 (40°C, 100rpm), B-medium with 0.3mg/ml Protease.  
 
Figure # 75
 
: Cell morphology of N. pharaonis at different times during cultivation in medium 
containing 0.3µg/ml Protease. Spheroplasts (blue circle), rod shape cells (red circle). Control- 
N. pharaonis after 97.1h in M205 medium. Phase-contrast microscopy, photos taken at x100. 
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The spheroplasts formed by N. pharaonis in M205 medium supplemented with 
0.3mg/ml protease (62%) remained viable and grew again when inoculated into M205 
medium without protease (figure# 76, left panel). Most cells regained their rod shape, 
with only ~20% spheroplasts, which is in the range of the background level seen in 
untreated cells (figure #76 left panel). When protease-treated cells were subcultured 
into M205 medium supplemented with 0.3mg/ml protease (figure #76, right panel), 
there was 48h lag phase in which the % of spheroplasts did not change.  In the 
stationary phase the % of spheroplast was increased again to 62%.  
Figure # 76
 
: Protease-treated N. pharaonis cells inoculated into M205 medium without 
Protease   (-P, left panel), and into M205 medium with 0.3mg/ml Protease (+P, right panel). 
6.5.4.1.3 Optimizing the composition of spheroplasting buffer (SPH) 
Now that spheroplasts of N. pharaonis could be formed, other conditions used in 
the standard PEG method to introduce foreign DNA into N. pharaonis, were 
examined. Sucrose is a component of SPH buffer (2MNaCl, 25mM KCl and 15% 
(w/v) Sucrose) used to suspended cells before the addition of DNA and PEG600.  
While sucrose is known to provide an improvement in cell recovery it was thought 
that betaine, a naturally occurring compatible solute, may be superior. This was tested 
as follows. Viable N. pharaonis cells (8.3x108 cells/ml) were incubated in the 
presence of different concentrations of Basal salt pH-8.8 with or without osmolytes 
(Sucrose or Betaine), for 28h at RT. The cells were diluted the next day and plated on 
M205 plates (three different dilutions for each condition), and the viable count used to 
determine the % of cells which survived the treatment. 
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As seen in figure #77 (left most bar), the highest % of survival was obtained when 
N. pharaonis was incubated in 2M Basal salts supplemented with 2.3M Betaine (blue 
bar). No significant difference was seen when the medium included either basal salts 
or basal salts + sucrose (orange and green bars, respectively). Nevertheless, Betaine 
was about 3-fold better than 15% sucrose, giving ~28% recovery of viable cells. A 
high % of survival (24%) was obtained as well when the basal salts concentration was 
reduced to 0.5M in the presence of 3.8M Betaine. Furthermore, 0.74% of cells 
survived (6.1x106 cell/ml) when the basal salts concentration was reduced down to 
0.1M supplemented with 4.2M Betaine. While the cell survival was low, the latter 
combination of buffers could be suitable for DNA uptake by electroporation.  
The effect of lowering the basal salts concentration was also examined. N. 
pharaonis was able to survive at salt concentrations of 1M basal salt, but unable to 
survive at a salt concentration below 1M NaCl without Betaine (marked with black 
arrow in figure #77). 
Figure # 77
 
: % of N. pharaonis which survived 28h incubation in medium containing 
different concentrations of basal salt (orange bars) with and without Sucrose (green bars) or 
Betaine (blue bars). 100%=8.275x108 cells/ml. The conventional SPH buffer is indicated with 
red arrow 
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6.5.4.1.4 Combination of Bacitracin, protease and the PEG method 
At this stage, collaboration with the group of Dr Angela Witte from the university 
of Vienna (Dep. Microbiology and Immunology), was established. Her laboratory had 
independently developed a method to transform haloalkaliphilic Archaea and had also 
used Bacitracin/protease treatment to form spheroplasts. The plasmids pMG100 and 
pMG200 were sent to her laboratory and were used to transform N. pharaonis. 
Potential transformants were screened for plasmid pMG100 as follows. Plasmid 
extracts from 3 different transformants colonies were used as template in PCRs with 
plasmid-specific primers. A 2393bp fragment was expected if the plasmid was 
present, while no amplification was expected if the cells did not contain plasmid. As 
seen in figure # 78, the expected fragment was visible only in pMG100 transformants 
(lanes 4-6). The PCR also generated some smaller products. No amplification was 
seen in the negative control (lane 3), while the plasmid control (positive control, lane 
2) gave the expected band plus many shorter products. Regardless of the smaller PCR 
products, the PCR results gave convincing evidence that the transformants colonies 
harbored the pMG100 plasmid, showing that not only did the transformation method 
work for N. pharaonis, but also that the plasmid replication and MevR marker 
functioned as anticipated.   
 
 
 
 
 
 
 
 
Figure # 78
 
: PCR to detect pMG100 in N. pharaonis transformants. Lane 1: Lamda BstEII 
(in bp), Lane 2: positive control, isolated pMG100 plasmid, Lane 3-negative control, DNA 
from N. pharaonis, Lanes 4-6: plasmids from 3 transformed colonies after introduction of 
pMG100 (method of A. Witte).The expected fragment is indicated by an arrow. 
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6.5.4.2 Is electroporation possible in haloarchaea? 
Electroporation is a common method for the introduction of foreign DNA into host 
cells using high-voltage electric pulses. The electric field induces transient pores in 
the cell wall and thereby increases the permeability of the host cells to 
macromolecules, such as DNA (Gehl, 2003; Mir, 2008; Neumann et al., 1982).  
For known reasons, electroporation is not applicable in haloarchaea, as the method 
requires a high voltage (so a very low salt concentrations) and haloarchaea can not 
tolerate salt concentrations less than 1M NaCl ((Allers, 2005) and figure #77 
indicated by black arrow). It is clear that in order to perform electroporation the salt 
concentration needs to be decreased to ≤100mM NaCl, while at the same time cell 
lysis needs to be prevented. The experiments summarized in figure #77 indicated that 
this could be achieved, as the external salt can be replaced by Betaine.   
Betaine is highly soluble in water (≤ 5M) and is a zwitterionic organic osmolyte, so 
by definition at natural pH it contains both negatively and positively charged 
moieties. This natural behavior of zwitterionic osmolytes makes them suitable 
candidates for use in electroporation solutions, as they have no net charge but can 
maintain the osmotic balance necessary for cell survival.  
To test the possibility of replacing salts in the medium with Betaine, viable cells 
corresponding to 5.34x108 cell/ml, were centrifuged, resuspended in M205 medium 
without or with different concentrations of Betaine, incubated 1h at RT, and than 
plated on M205 plates. As seen in figure #79A, 50.1%±1.7% (n=2) survived in M205 
medium with 4.3M NaCl, whereas, 2.2%±1.7% (n=2) survived 1h incubation in 4.3M 
Betaine alone. Even though the % of survival is low, 2.2% cells is equal to 1.8x107 
cells/ml. Reducing betaine concentrations to 3M and 2M lowered the % of survival by 
2 orders of magnitude, and 3 orders of magnitude, respectively (figure #79B).   
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Figure # 79
 
: % of N. pharaonis cells surviving after 1h incubation in M205 (Blue), and at 
different concentrations of Betaine. 100%=5.34x108 cells/ml. 
6.5.4.2.1 Developing a protocol for electroporation of N. pharaonis 
The results of the preceding experiments were used to develop a method that 
would allow electroporation of N. pharaonis. Cells grown in M205 medium (OD600nm 
0.5-0.7), were centrifuged (2min, 10000g, RT) and the supernatant was discarded. 
The cells were centrifuged again to remove residual medium and the pellet was 
resuspended with 4.3M Betaine in 50mM Tris HCl pH 8.7. Plasmid DNA was added 
to the cell suspensions and the tubes were incubated in RT for 10min. The mixture 
was electroporated and cells recovered then plated as described in section below.  
6.5.4.2.1.1 Settings and conditions 
Optimum electroporation conditions can differ not only between type and species 
but also for strains within species. Therefore, it is important to determine the best 
parameters of electroporation, such as the time constant and the field strength applied 
to the sample (Lurquin, 1997). The time constant is dependent on the total resistance 
of the sample and the capacitance selected on the electroporation device. The field 
strength is dependent on the initial voltage delivered by the electroporator and the 
distance between the electrodes of the cuvette (Lurquin, 1997).  
 The time constant was varied by using different resistence values while the 
capacitance and the voltage been constant (25µF, 1.5kV, see appendix table #20). 
Additionally, from 1-3 pulses were tried in order to compensate for the low observed 
time constants, and the different incubation buffers which contained either sucrose or 
Betaine. Controls included both N. pharaonis and H. salinarum but without the 
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addition of plasmid DNA. These were plated on non-selective media, and colonies 
counted after 14 days (C-71). Although, cells survived the electroporation, no 
successful transformation of the plasmids were obtained either with N. pharaonis or 
with H. salinarum. A small number of colonies of N. pharaonis and H. salinarum 
were obtained after electroporation (3 pulses of ∞ resistance with 1sec break in 
between) on selective plates (10µg/ml Mev) after 6 weeks incubation at 37°C (C-
169), but there was no time available to determine if they contained plasmids. 
6.5.4.3 Biolistic-particle delivery system (Gun particle)  
Biolistic transformation is considered to be a useful tool for transformation of 
plants and animal cells (Daniell et al., 1990; Sanford, 1988, 1990; Williams et al., 
1991; Yang et al., 1990). In 1990, this method was first used to transform the 
prokaryote Bacillus megaterium, which was chosen due to its large cell size 
(1.5x5.0µm) and the difficulty to transform this gram-positive by other methods 
(Shark K.B., 1990). Two years later, the same lab succeeded in transforming five 
bacterial species including E. coli, Agrobacterium tumefaciens, Erwinia amylovora, 
Erwinia stewartii and Pseudomonas syringae pv. syringae. They reported 
transformation rates of 104 transformants per 0.8µg DNA for E. coli, and lower 
transformation rates for the other species (>102 transformants per 0.8µg DNA).  
The Biolistic®PDS-100/He device seen in figure #80 (Kikkert, 1993), is marketed 
by Bio-Rad laboratories, and is based on the PDS-1000 model, which was designed 
by Sanford at el. (Sanford J. C., 1987). Briefly, helium pressure and vacuum circuits 
are used to accelerate microcarriers, coated with DNA, into the target cells. Activating 
the Fire switch allows helium to flow into the gas acceleration tube. The gas is held 
until a rupture disk is burst. This burst generates a helium shock wave, which hits the 
microcarriers and launches them toward the target cells.  
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Figure # 80
 
: A-The Biolistic®PDS-1000/He device. B-Components of the Biolistic®PDS-
1000/He device: acceleration mechanism and main chamber. 
6.5.4.3.1.1 Settings and conditions 
After the bombardment, 1.5-3x108 cells/ml of E. coli, N. pharaonis and H. 
salinarum were plated and then incubated at 37°C (14 days for haloarchaea and o.n 
for E. coli).  
500µg of microcarriers and 0.625µg DNA were used per bombardment, based on 
the method of Sanford et al., (Sanford et al., 1993). In this study, either M5 Tungsten 
particles or gold particles were used. M5 tungsten particles are characterized by a 
mean diameter of 0.71µm, a median of 0.362µm, and a mode in the range of 0.1-
0.2µm (figure#2 in (Smith et al., 1992). The gold particles are characterized by a tight 
bimodoal distribution of particles, with peaks of 1.0 and 0.2µm (figure#2 in (Smith et 
al., 1992). Despite the disadvantages of M5 tungsten particles (more heterogeneous in 
size and shape compared to gold, and its ability to catalytically degrade DNA over 
time), it has been reported that M5 tungsten particles give significantly more 
transformants than cells bombarded with gold (transformants per plate- M5 tungsten 
particles: 3488, gold: 142, (Smith et al., 1992)).  
Colonies were visible on selective plates (10µg/ml Mev) after 8 weeks, but time 
constraint prevented further analysis. 
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6.5.4.4 Lipofection in N. pharaonis 
Metcalf et al., (Metcalf et al., 1997) successfully adapted the liposome-mediated 
transformation method for use with species of Methanosarcina. This method allowed 
transformation of 9 of the 11 strains tested, as well as E. coli. In 2005, Ehlers et al., 
was successful in using this method to transform M. mazei by improving the plating 
efficiency and optimizing the liposome-mediated transformation protocol (Ehlers et 
al., 2005). Even electrocompetent E. coli cells were successfully transformed using 
the liposome-mediated lipofection method, without the use of electroporation 
(transformation efficiency 2x104-1x105 transformants/µg DNA) (Kawata et al., 2003).    
In the current study, N. pharaonis cells were sonicated to disturb their cell walls 
followed by lipofection. Early exponential phase cells (OD600nm=0.362), were 
sonicated (duty cycle-50%, output control-5) for 30sec, 70sec and 190sec, 
corresponding to 16.5%, 20.35% and 52% broken cells, respectively.  As seen in table 
#13, sonication lowered the viable count from 184 to 24.5x106 cell/ml, after 190sec of 
sonication. No significant difference in viable count was seen between 30 and 70sec 
of sonication. Colonies were visible after 12 days. 
Next, the influence of sonication and lipofection with DOTPA (Roche) was tested. 
After transformation with the plasmids, treated cells were incubated in M205 medium 
with 15% sucrose o.n at 37°C, 250rpm. The cells were plated the next day and 
colonies were visible after 3-4 weeks.  As seen in table #14, no significant difference 
was seen in the viable cell count whether DOTPA was added or not. There was no 
possibility to pursue these experiments further due to time constraint (G149, H-105). 
 
Table # 13
 
: The effect of sonication on viable cells of N. pharaonis. Cells were plated after 
dilution of 1/106, in duplicates on M205 plates. 
Tube no  Sonication 
(sec) 
Colonies 
9 (control, no sonication ) - 184.5x106 cells/ml 
18 30 126.5x106 cells/ml 
19 70 116.5x108 cells/ml 
20 190 24.5x107 cells/ml 
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Table # 14
 
: The effect of sonication and lipofaction with DOTPA on viable cells of N. 
pharaonis. 
Sonication (sec) DOTPA # of colonies on 
selective plates (1) 
pMG200(2) pMG300(2) 
0 (control, WO sonication) - full (c) 80 
30 - 32 187 
70 - >200 5 
190 - 32 ND 
0 (control, WO sonication) + full (c) full (c) 
30 + 12 165 
70 + 0 0 
190 + 0 0 
 
(1) treated cells were plated on M205+10µg/ml Mev+X gal, except for the controls, which 
     were plated on unselective M205 plate. 
 
(2) 3.7µg of pMG200 and pMG300 were used for transformation 
 
(3) the plates contained too many colonies to be possible to count. 
 
6.5.5 Future plans 
To allow fundamental genetic studies and molecular engineering of N. pharaonis, 
genetic tools are essential i.e. shuttle vectors and a transformation method. The data 
presented in this chapter demonstrated that the plasmids constructed for N. pharaonis 
are indeed able to function as shuttle vectors (figure #67 and 78). These plasmids 
were used in different transformation methods, including the PEG method combined 
with bacitracin and protease, electroporation, gun particle delivery and lipofection. To 
date, it seems that the most promising transformation method was the PEG method 
combined with bacitracin and protease (figure #78). The other methods tested may 
still be useful especially because they are less time consuming procedures. All the 
methods presented need to be examined father to determine the optimum efficiency of 
transformation, but the basic obstacles to genetic manipulation of this host are now 
overcame. 
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7 Discussion 
7.1 Microarray analysis of AroAAs-related genes 
Of the 17 enzymes involved in shikimate pathway in E. coli, 13 homologues were 
found in H. salinarum (figure #8). These encompass the steps necessary to convert 
DHQ to AroAAs, indicating that down stream of DHQ, the canonical pathway for 
biosynthesis of AroAAs is used by H. salinarum. In the current study, a number of 
strategies were employed to assign function to individual genes of this pathway, 
ranging from targeted mutation of specific genes to a global examination of AroAAs 
regulated genes using a genome-wide microarray for H. salinarum (Twellmeyer et al., 
2007). As seen in figure #81, the DNA microarray data provided solid evidence to 
support the function of the 13 genes downstream of DHQ, as these were differentially 
expressed (p≤0.001, fold induction ≥3.0) when AroAAs were omitted from the 
growing media of R1. Additional insights retrieved from the microarray experiments 
concerning regulation, transport systems and transcription factors are described in 
more detail in the following sections.  
7.1.1 Regulation of gene expression, uptake and metabolic 
flow 
Microorganisms require mechanisms that allow fast and efficient adjustments to 
rapid changes in external conditions. These are necessary for survival, and to conserve 
both energy and resources. Most microorganisms dedicate an appreciable fraction of 
their genetic material to regulatory functions, and by doing so, they ensure that they 
will have the flexibility to respond appropriately to changes in pH, temperature, 
available substrates, etc. Common regulatory checkpoints occur at various stages of 
gene expression (transcription, translation), and at the level of enzyme activity 
(feedback inhibition, enzyme activation). The intracellular levels of metabolites can 
also be utilized to activate or inhibit metabolic pathways. The interplay of multiple 
regulatory systems acting on specific enzymes and pathways can be extremely 
complex (Adhya, 1999). At an organizational level, the clustering of genes with 
related functions into single transcription units (operons) allows simultaneous 
regulation, and is an efficient means of producing the correct proteins ratios, such as 
the enzymes required for a specific biosynthetic pathway.  
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Figure # 81
 
: Transcription of the differentially expressed AroAAs-related genes. All of the 
ORFs showed significant changes (p≤0.001, fold induction ≥3.0), except for OE1565F (aroE, 
p=0.017), and OE2762R (aroA, p=0.003). Green represents the ORFs in the chorismate 
pathway starting from DHQ, pink- the ORFs of the tryptophan branch, blue- the ORFs in the 
phenylalanine branch, and red- the ORFs in the tyrosine branch. ORFs organized in operons 
are marked with brown arrows. The operons are discussed with more details in the following 
sections. 
7.1.1.1 Trp, tyrA and aroK-pheA1 operons 
Based on the genetic context, two trp gene clusters were identified which contain 
the enzymes on the branch leading from chorismate to tryptophan. As seen in figure 
#82A, the first trp cluster consists of the overlapping ORFs OE1469F, OE1470F and 
OE1471F, followed by a 25bp sequence which connects ORF OE1472F to the cluster. 
The second trp cluster seen in figure #82B, trpD1FE1G1, consists of four overlapping 
ORFs. Transcription of both clusters was strongly induced by the absence of AroAAs 
in the growth medium (figure #82).  
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Each of the trp clusters can be described as operons, as each possesses a common 
promoter region. In the first cluster (figure #82A), a putative TATA box promoter 
element was identified at position -33 from the starting codon of ORF OE1469F, 
while the 25bp sequence between ORF OE1471F and OE1472F, does not contain any 
TATA box sequence. The second trp cluster (figure #82B), contained a putative 
TATA box promoter element sequence at position -49. Both TATA box motifs were 
consistent with the conserved 8 bp promoter sequence element (TTTAWATR, with 
W=A or T, R=A or G) found in most Archaea (Gregor and Pfeifer, 2005). In a study 
by Koide et al., (Koide et al., 2009; Price et al., 2005), both of the trp clusters were 
identified as operons in H. salinarum sp. NCR-1, based on genomic-specific distance 
models and transcription start and end points of annotated operons by Koide et al,.  
 
Figure # 82
 
: AroAAs biosynthesis genes that display operon-like organization in H. 
salinarum. A and B: the two trp operons, C: the tyrA operon, D-aroK-pheA1 operon. The 
fold regulations as found in the DNA microarray experiment are indicated below the ORFs. a-
fold regulation was calculated from RT-qPCR experiment using two biological repeats. *-
represents a 4bp overlapping region, **-represents a 10bp overlapping region, ***-represents 
a 66bp overlapping region. The putative TATA box promoter motifs are indicted. CHY- 
conserved hypothetical protein. 
In H. salinarum, H. salinarum sp NCR-1, H. marismortui, H. walsbyi and N. 
pharaonis, the genes specifying the seven enzymatic reactions leading to the 
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formation of tryptophan from chorismate are organized in a similar arrangement, 
meaning split into two separated operons (figure #83). This is different to the 
arrangement of E. coli and methanococcus. For example, Methanobacterium 
thermoautotrophicum, possesses all seven trp genes adjacent to each other in the 
order trpEGCFBAD (Gast et al., 1994; Meile et al., 1991), as do some other Archaea 
(figure #5, (Xie et al., 2003)). Surprisingly, the trp operon in M. maripaludis is 
organized in the same way as in E. coli, trpEDCBA but, in contrast to E. coli, it does 
not contain a 14 amino acid leader peptide immediately preceding trpE (figure #85). 
Although it is believed that essential metabolic pathways have been likely transferred 
horizontally between Archaea and Bacteria, the histidine operon in E. coli, 
hisGDCNBHAFI, is another example were genes clustered in operon, were either 
scattered thorough the halobacterials genome (i.e. H. salinarum, N. pharaonis, and H. 
walsbyi), or partially clustered (i.e. P. furiosus) (Fondi et al., 2009).   
 
 
 
 
 
Figure # 83
WWW.Synteview.u-psud.fr
: trp operons in different archaea. trpG1E1FD1 (left panel) and trpCBA-X (right 
panel) in different archaea. Halsp- Halobacterium sp. NRC-1, Halma-Haloarcula 
marismortui ATCC 43049, Halwa- Haloquadratum walsbyi DSM 16790, Natph- 
Natronomonas pharaonis DSM2160, Metja- Methanocaldococcus jannascii DSM 2661. 
Modified from  (Lemoine et al., 2008). 
 
Based on the microarray results, the overlapping gene pairs, tyrA-CHY, and aroK-
pheA1 are also likely to form operons, as depicted in figure #82C, D, respectively. 
Both clusters were identified as operons in H. salinarum sp NCR-1 based on 
transcription start and end points (Koide et al., 2009; Price et al., 2005). The tyrA-
CHY operon is composed of ORF OE2770F (tyrA) and a conserved hypothetical 
protein (CHY, ORF OE2772F). Both ORFs are regulated according to the DNA 
microarray results obtained from synthetic medium lacking AroAAs, indicating that 
the CHY is a utilized ORF and potentially significant for biosynthesis or regulation of 
AroAAs. One the basis of its position, it is possible that this CHY could catalyse the 
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formation of tyrosine from 4-hydroxyphenylpyruvate, which is catalyzed by tyrB in 
E. coli (EC 2.6.1.57 or EC 2.6.1.5, aromatic-amino-acid transaminase, and tyrosine 
transaminase, respectively). No candidates for tyrB have been identified in 
haloarchaea by sequence similarity to the E. coli gene, suggesting that ORF OE2772F 
might be either a new member of transaminase family (although no conserved motifs 
were found), or has some other, as yet unknown, role in the AroAAs pathway. In E. 
coli, tyrA clusters with aroF which catalyses the first step in aromatic amino acid 
biosynthesis from the precursors PEP and E-4-P.  
As seen in figure #82D, transcription of the gene cluster aroK-pheA1, was 
regulated by AroAAs and was found to be conserved in haloarchaea but not in M. 
maripaludis, M. jannaschii or E. coli (figure #84).   
 
 
 
 
 
Figure # 84
WWW.Synteview.u-psud.fr
: tyrA and aroK-pheA1 operons in different archaea. Halsp- Halobacterium sp. 
NRC-1, Halma-Haloarcula marismortui ATCC 43049, Halwa- Haloquadratum walsbyi 
DSM 16790, Natph- Natronomonas pharaonis DSM2160, Metja- Methanocaldococcus 
jannaschii DSM 2661, Esc05-E.coli K12. Modified from  
(Lemoine et al., 2008). 
 
As seen in figure #83 and 84, the trpG1E1FD1, trpCBA-OE1472F, tyrA-CHY and 
aroK-pheA1 operons are conserved in Halobacterium sp. NRC-1, H. salinarum, 
Haloarcula marismortui, Haloquadratum walsbyi, and Natronomonas pharaonis. 
Differences are seen in M. jannaschii, in which the operons are missing or partly 
missing. 
An arrangement of genes in operons confers both advantages and disadvantages. 
The most obvious advantage is that genes with similar function are transcribed 
together. The greatest disadvantage is that, unless some further level of regulation 
exist (differences in the amount of mRNA or its stability, the strength of ribosomal 
binding sites, and so on), the amount of polypeptides from those genes will be the 
same even though resultant enzymes may have different catalytic rates (Glansdorff, 
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1999). The enzymes with slower rates will be the limiting factor in the pathway. As a 
result, when genes are transcribed together, an excess of some enzymes is likely to 
occur. However, the amount of the mRNA and polypeptide synthesis is only one 
aspect of the control of the tryptophan pathway. In E. coli, besides these, there are two 
other levels of control that affect the amount of tryptophan synthesis within the cell. 
The first is feed-back inhibition which influence the activity of the first reaction 
(figure #86), and thereby the amount of metabolites flowing through the pathway. The 
second is the formation of multi-enzyme complexes that greatly increases the catalytic 
efficiency of the various reactions. In complexes, the product of one reaction can be 
used directly by the next enzyme because the concentration of the substrate in the 
vicinity of the second enzyme is much higher than would occur were the two enzymes 
separate. Examples of such complexes are trpE-trpG(D) and trpA-trpB (Ikeda, 2006).  
The transcription of trp operon and pheA in E.coli are regulated by attenuation, in 
response to changing intracellular concentrations of trp and phe, in the cell (Yanofsky, 
1981). A leader peptide contains “control codons” that specify the amino acid end 
product of the enzymes encoded in the operon. When the supply of amino acid and 
thus of cognate aminoacyl-tRNA is deficient, the ribosome stalls at the control 
codons, the leader RNA forms a preemptor 2:3 hairpin, and transcription starts (figure 
#85C). If the aminoacyl-tRNA is abundant, the ribosome stops at the end of the leader 
peptide, thereby forming the prohibiting 3:4 hairpin, and transcription of the 
remainder of the operon does not occur (attenuation, figure #85B). In E. coli, the 
leader peptide of the trp operon contains 2 trp codons, while 7 phe codons precede the 
Phe ORF (Gollnick and Babitzke, 2002). It seems that transcriptions of the trp 
operons in H. salinarum are not regulated by attenuation, as no leader peptide was 
identified, and moreover, no trp codons were identified upstream to the first ORF in 
the operons. 
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Figure # 85
 
: Regulation by transcription attenuation in E. coli. a-5′-end of trp mRNA 
containing the leader region is shown. Open bar, leader peptide; red bar-control codons. The 
arrows indicate the regions (1-4) that form various potential RNA hairpin structures. b- if 
ribosomes (shaded) complete the translation of leader peptide (i.e., there is sufficient charged 
tRNAtrp), they allow 3:4 terminator hairpin. c-if the ribosome stalls at the control codons 
because of the lack of charged tRNAtrp, they permit 2:3 hairpin formation, which precludes 
attenuation. (Adhya, 1999). 
7.1.1.2 AroAAs Transport systems 
In E. coli, at least five different systems are known for the aromatic amino acid 
transport (figure #86). These include the specific transport systems for L-tyrosine (the 
tyrP gene product), L-phenylalanine (the pheP gene product), and L-tryptophan (the 
mtr and tnaB gene products), as well as a general transport system (the aroP gene 
product) (Ikeda, 2006; Whipp and Pittard, 1977).  
A search of the H. salinarum genome sequence using the E. coli aroP and pheP 
protein sequences (by BLASTP) revealed three potential candidate for AroAAs 
transporters: OE2779F, annotated as an amino acid transport protein (probable 
phenylalanine transport protein); OE5101R and OE1288F, both annotated as 
probable cationic amino acid transport protein (with overall 22-24% amino acid 
identity). BLASTP searches for homologs of E. coli tyrP, mtr and tnaB proteins, 
retrieved additional ORFs: OE1476R, OE2891F, and OE4384R, respectively, all 
annotated as conserved hypothetical proteins.  
If these genes are AroAAs transporters then it might be expected that their 
expression would be regulated by the external levels of one or more of the amino 
acids they transport. As shown by the microarray results, this was true for at least 
some of the predicted ORFs. ORF OE2779F (homolog to aroP and pheP) was 3.5 fold 
up regulated in R1 cells grown without AroAAs. Moreover, ORF OE4384R 
(conserved hypothetical) was 4 fold up regulated in the deletion strain ∆OE1477R 
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grown in synthetic medium supplemented with AroAAs and shikimate. It might be 
that in spite of the low similarity, this conserved hypothetical ORF has an unknown 
function associated with AroAAs biosynthesis, and one can speculate that ORF 
OE4384R could be a candidate for a second low-affinity transport system of 
tryptophan, while aroP (OE2779F) is the high affinity transport system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 86
 
: Biosynthetic pathways, regulation and transport systems of aromatic amino 
acids in E. coli, modified from (Ikeda, 2006)). The dotted lines and the dashed lines indicate 
feedback inhibition and repression, respectively. Symbols for genes follow mostly the E. coli 
K-12 linkage map.  
 
 
 
7.1.1.3 Cellular control mechanisms of AroAAs biosynthesis 
The regulation mechanisms of AroAAs biosynthesis of E. coli and M. maripaludis 
would be discussed in some details while comparing to H. salinarum with the aim to 
recognize similar regulation patterns i.e. regolons.    
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7.1.1.3.1 Regulation of AroAAs biosynthesis in E. coli 
In E. coli, the control of metabolic flow in AroAAs biosynthesis occurs mainly by 
end-product inhibition of bifunctional enzymes, such as chorismate mutase-
prephenate dehydratase (specified by pheA and tyrA), and anthranilate synthase 
(specified by trpE, trpG(D)). This is illustrated in figure #86.  
The first step in the pathway is carried out by three DAHPS isoenzymes (DAHPS-
3-deoxy-D-arabion-heptulosonate-7-phosphate synthase, aroF, aroG and aroH, EC 
2.4.1.54 (Davies and Davidson, 1982; Shultz et al., 1984; Zurawski et al., 1981)), 
each feedback-regulated by one of the aromatic amino acids Tyr (aroF), Phe (aroG), 
and Trp (aroH), respectively (Byng et al., 1983). The Phe-inhibited aroG (79%) and 
the Tyr-inhibited aroF (20%) deliver nearly all of the DAHPS activity for the cell. 
The Trp-inhibited aroH contributes only 1% of the cellular enzyme activity (Tribe et 
al., 1976). Inhibition of aroG (Phe-inhibited) and aroF (Tyr-inhibited) is highly 
effective and abolishes >95% of their specific enzyme activity (McCandliss et al., 
1978; Schoner and Herrmann, 1976), whereas the Trp inhibition of aroH is only 
≈60%, thereby resulting in a 40% constitutive aroH activity (Pittard, 1996). 
In addition to feedback control, the expression of genes relevant to aromatic amino 
acid biosynthesis and transport are regulated at a global level, by regulons. By 
definition, regulons control multiple operons by one common, but specific regulator. 
The purpose of this type of regulation is to extend the same coordinated control to 
more than one operon that encodes a similar function. In E.coli, two AroAAs regulons 
have been identified: TyrR and TrpR. The genes regulated by TyrR comprise at least 
eight transcription units, each of which is regulated in a distinctive manner by the 
TyrR proteins. The nature of regulation of each promoter (repression or activation) is 
determined by the binding site of the RNA polymerase and the different forms of the 
TyrR protein (Pittard et al., 2005). Genes regulated by TyrR include aroF, aroL, tyrP, 
mtr, aroP, tyrB and aroG. While the TyrR gene product can act both as a repressor 
and as an activator of transcription, TrpR mediates only repression. The genes 
regulated by TrpR include aroH, the trp operon, aroL, and mtr (Ikeda, 2006). Once 
the transcription of E. coli trp operon initiated (regulated by TrpR), the elongating 
transcription complex is subjected to control by transcription attenuation (see section 
7.1.1.1). The combined actions of repression (80-fold) and transcription attenuation 
(8-fold) allow approximately 600-fold regulation in response to changing 
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concentrations of intracellular tryptophan (Gollnick and Babitzke, 2002). No 
orthologs of TyrR and TrpR have been identified in haloarchaea. 
7.1.1.3.2 Regulation of AroAAs biosynthesis in M. maripaludis 
Porat at el., (Porat et al., 2004) tested the specific activities of three enzymes of 
AroAAs biosynthesis in M. maripaludis; CM (chorismate mutase), PDT (prephenate 
dehydratase), and PDH (prephenate dehydrogenase). Measurements were made in cell 
extracts of M. maripaludis after growth in synthetic medium supplemented with 
AroAAs (table #3 in (Porat et al., 2004)). These data were used to elucidate the 
regulatory features of AroAAs biosynthesis, and are been summarized in figure #87. 
The presence of tyrosine was not found to affect the activity of CM, but inhibited the 
activity of PHD (4 fold), while activating PDT (2.2 fold). Supplementing the medium 
with phenylalanine had no influence on the specific activity of CM or PDH, but 
inhibited strongly the activity of PDT (3.4 fold). 
Additionally, it was found that aryl acids are substrates of a second pathway for the 
biosynthesis of AroAAs in M. maripaludis (figure #87). This was proven by growth 
experiments where three aryl acids fulfilled the requirement for AroAAs by the 
auxotrophic mutant. The three aryl acids, indoleactate, p-hydroxyphenylacetate, and 
phenylacetate are activated to their CoA derivatives, and then reductively 
carboxylated by the enzyme indolepyruvate oxidreductase (IOR, EC 1.2.7.8) to 
indolepyruvate, p-hydroxyphenylpyruvate, and phenylpyruvate, respectively. These 
substrates are then converted to tryptophan, tyrosine and phenylalanine, respectively, 
by aromatic aminotransferases (AroAT). It was shown experimentally by Porat at el., 
(Porat et al., 2004), that addition of p-hydroxyphenylacetate to the synthetic medium 
did not effect the activity of either CM or PDT but inhibited the activity of PDH (2.3 
fold), while addition p-hydroxyphenylpyruvate inhibited the activity of PDH as well 
(2.3 fold). Furthermore, addition of aryl acids to the growth medium reduced the 
activity of DHQ dehydratase by one-third. Porat et al., (Porat et al., 2006), suggested 
that the expression of fructose-1,6-phosphate (ORF MJ1585) was regulated by aryl 
acids, due to the nearly complete absence of labeled shikimate and dehydroshikimate 
in cells following growth with aryl acids (Porat et al., 2006).  
In halophilic archaea on the other hand, the occurrence of AroAAs synthesis via 
indolepyruvate oxidoreductase is unlikely, since only two ferredoxin- dependent 
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oxidoreductase complexes, pyruvate- and 2-oxoglutarate-ferredoxin oxidoreductase, 
have been identified within their genomes (OE2623R, OE2622R, and OE1711R, 
OE1710R, respectively). No homologs of indolepyruvate- ferredoxin oxidoreductase 
(iroA2, EC 1.2.7.8, MMP0713, and MMP0714, the α and the β subunits, 
respectively) have been found in H. salinarum. If aryl acids can be utilized by H. 
salinarum for AroAAs biosynthesis then the enzymes are unrelated to those of M. 
maripaludis. Alternatively, another still unknown additional pathway for synthesis of 
AroAAs may be present. 
From the regulation of AroAAs biosynthesis in both E. coli and M. maripaludis, 
one can conclude that neither of them can provide a model for the regulation of 
AroAAs in H. salinarum.    
 
 
 
 
 
 
 
 
Figure # 87
 
: Pathways for the biosynthesis of AroAAs in M. maripaludis as presented in 
(Porat et al., 2004). The aryl acid pathway starts from phenylacetate, p-hydroxyphenylacetate, 
and indoleacetate (marked with blue boxes), precursors for phenylalanine, tyrosine, and 
tryptophan, respectively. The enzymes shown are DHQ (3-dehydroquinate dehydratase), CM 
(chorismate mutase), PDT (prephenate dehydratase), PDH (prephenate dehydrogenase), 
AroAT (aromatic aminotransferase), and IOR (indolepyruvate oxidreductase). Possible 
transcriptional regulation of DHQ is indicated by double dashed lines. Inhibition (–) or 
activation (+) of the PDT and PDH enzyme activities are indicated by single dashed lines. 
(Porat et al., 2004). 
7.1.1.4 Transcription factors: TBP, TFB and TrmB 
Transcription in archaea is catalyzed by a eukaryotic type RNA polymerase, that 
requires only two transcription factors, TATA-binding protein (TBP) and 
transcription factor B (TFB). However, multiple transcription factor homologues have 
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been identified in H. salinarum R1 (6 TBPs, and 7 TFBs) (Baliga et al., 2000; 
Facciotti et al., 2007). A systematic knock out of each of the TBPs and TFBs has 
revealed that two TFBs (-f and -g) and three TBPs (-b, -e, and -f) appear to be 
essential for growth under standard laboratory conditions (Facciotti et al., 2007). It 
was also observed that TBPe interacts with numerous TFBs (TFBb, -c, -d, -e, and -g), 
suggesting a dominant role among TBPs for TBPe. This hypothesis was supported as 
well in the current study, where DNA microarray results of R1 revealed that only 
TBPe (ORF OE4146F) was regulated (3.2 fold) by addition of AroAAs to the growth 
medium, while transcription of the TFBs remained unchanged (1.0 fold regulation).  
A TrmB-like global transcriptional regulator (VNG1451C) was identified in H. 
salinarum NRC-1, and was predicted to act on 113 different promoters involved in 
diverse metabolic pathways, such as glycolysis, TCA cycle, amino acid biosynthesis 
pathways and the biosynthesis of their cognate cofactors {Schmid, 2009 #236} 
Interestingly, some of the ORF involved in AroAAs biosynthesis were noted by 
Facciotti et al., to be directly controlled by trmB. These include: OE1475F (3-
dehydroquinate synthase in H. salinarum, EC 4.6.6.3), OE2761R (aroC), OE1565F 
(aroE, trmB acts as repressor), and OE2563R (menD, one of the ORFs involved in 
menaquinone biosynthesis), while ORFs OE1472F (1st gene involved in the de novo 
pathway), and OE2019F (an F-1,6-P aldolase, trmB acts as activator), were regulated 
by TrmB but not directly controlled by it (supplementary material table #6 {Schmid, 
2009 #236}. In the current study, the archaeal TrmB ortholog OE3018F in H. 
salinarum R1 was found to be weakly induced (1.9 fold regulation) when AroAAs 
were added to the growing medium of H. salinarum. 
7.1.1.5 Lrp-like proteins  
The trh (or LrpA/AsnC) family of transcription regulators was first discovered in 
E. coli (Willins et al., 1991) and controls the expression of large number of operons, 
directly or indirectly. They can act as both repressors and activators. A recently 
published DNA microarray analysis revealed that Lrp affects transcription of at least 
10% of all E. coli genes, including most of the genes that are expressed upon entrance 
into stationary phase (Tani et al., 2002). The E. coli Lrp regulon conntrols genes that 
are involved in amino acid metabolism. H. salinarum possesses 7 Lrp-like 
transcriptional regulators (trh1 to trh7), which have homologues that are widely 
                                                                                                                      Discussion 
 158
distributed across bacterial and archaeal species (Bateman et al., 2004). Their specific 
role in the regulation of H. salinarum strain NRC-1 was unknown until a study by 
Bonneau et al.,(Bonneau et al., 2006) which predicted that 4 trh proteins (trh3, trh4, 
trh5 and trh7) plays a significant role in coordinating the expression of diverse 
cellular processes with competing transport processes. By showing the subnetwork 
surrounding trh3, trh4, trh5 and trh7, they found that each trh protein regulates a 
unique set of bioclusters. For example, they predicted that trh3 is a repressor of 
phosphate and amino acid uptake systems and that it is co-regulated with diverse 
metabolic processes involving phosphate consumption. Moreover, Schwaiger et al., 
(Schwaiger, 2010) showed that Lrp (trh4, OE3923F) is responsible for activating the 
expression of glutamine synthetase gene glnA, for regulating the peptide-and 
phosphate transport, and for activating the expression of the transcription regulator 
sirR. While LrpA1 (trh7, OE2621R) repressed the expression of the aspartate 
transaminase gene aspB3.  
The DNA microarray results obtained in the current study showed that ORF 
OE2776F (trh1=LrpA2) was strongly regulated (14.9 fold) when R1 was grown in 
synthetic medium without AroAAs, indicating that LrpA2 is a regulator of AroAAs 
biosynthesis. Furthermore, in cells grown in synthetic medium supplemented with 
AroAAs and shikimate, ORF OE2621R (trh7=LrpA1) was also strongly regulated (15 
fold) in the WT strain compared to the deletion mutant ∆OE1477R. ORF MJ0723 
(Prt2) of M. jannaschii (homolog of OE2621R with 32% amino acid identity), was 
shown in vitro to positively regulate the archaeal transcription apparatus by 
recruitment of the TATA-binding protein (Ouhammouch et al., 2003). 
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7.2 The first three genes in the pathway 
The genome of H. salinarum possesses homologs for five out of seven genes of the 
de novo pathway of AroAAs biosynthesis up to chorismate. ORFs OE1472F and 
OE1475F were assigned according to M. jannaschii’s ORFs MJ40400 and MJ1249, 
respectively, which have been shown to play a role in the alternative pathway of DHQ 
biosynthesis (Porat et al., 2006; White, 2004), while ORF OE1477R is homologous to 
aroD, which encodes the third enzyme in the pathway.  
While the presence, sequence similarities and gene organization are reasonable 
evidence for assigning putative function for these genes, solid proof must come from 
experimental data. In this study, a number of strategies were employed to determine 
the role of these genes, ranging from targeted mutation of specific genes, nutritional 
requirements, phenotype, and uptake assays to specific activity of the purified gene 
product. In the following paragraphs the results of these studies will be discussed 
separately for each ORF.  
 
Figure # 88
 
: ORFs catalyzing the first three steps of the proposed de novo pathway for the 
biosynthesis of AroAs in H. salinarum. The fold induction of these ORFs, as calculated from 
RT-qPCR experiments, is indicated below the arrows. The numbers above the arrows 
downstream to DHS indicates the numbers of enzymatic steps required to synthesis the 
intermediates.  
7.2.1 ORF OE1472F - the first ORF in the AroAAs pathway  
ORF OE1472F was annotated in the H. salinarum genome as fructose bis-
phosphate aldolase II (EC 4.1.2.13), an enzyme that cleaves F-1,6-P to the 
corresponding triose phosphates. The sequence of OE1472F is 43% identical with that 
of MJ0400 from M. jannaschii (Porat et al., 2006; White, 2004), which has been 
demonstrated to be member of the superfamily an aldolase/transaldolase {Morar, 
2007 #224}, catalyzing ASA and DKFP via an elimination of hydroxypyruvaldehyde 
phosphate (HPAP) to yield 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid 
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(ADH). In the current study, the role of the gene product OE1472F in H. salinarum 
was assessed experimentally and the results discussed below. 
7.2.1.1 Classification of OE1472F as an archaeal type aldolase class IA  
The presence of two class IA aldolase paralogues in M. jannaschii, A. fulgidus, H. 
salinarum NRC-1 and H. salinarum R1 (Siebers et al., 2001) raises the question why 
there is a need for two aldolases? Galperin et al., (Galperin et al., 2000), predicted that 
although both of the orthologs are aldolases, one member will be an aldolase whereas 
the other will be a deoxyribose phosphate aldolase or a transaldolase. Like 
transaldolase, aldolase would cleave F-1,6-P into GAP and DHAP. Whereas an 
aldolase releases both of these molecules as products, a transaldolase releases only 
GAP and transfers the DHAP group to an aldose acceptor. Thus, aldolases do not 
require an aldose acceptor substrate for turnover to occur, whereas a transaldolase 
does.  
The two paralogues genes in H. salinarum, OE2019F and OE1472F (table #1), 
were annotated as fructose bis-phosphate aldolase I, and II, respectively. Although 
both ORFs showed similar aldolase activity (figure #56A), ORF OE2019F is expected 
to be an aldolase, while ORF OE1472F is likely to be a transaldolase that initiates the 
AroAAs biosynthesis pathway. The latter assiginment is based on the gemonic 
position of this ORF is part of the multicistronic trpCBA-OE1472F operon.  
Recent work by White (White, 2004) on M. jannaschii showed that the gene 
product MJ0400, annotated as 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid 
(ADH) synthase, catalyses a transaldolase reaction between DKFP and ASA to yield 
ADH. A crystal structure of ADH synthase (2.6Å) from M. jannaschii in a complex 
with F-1,6-P and with DHAP was solved by Morar et al (Morar et al., 2007), who also 
compared the crystal structure of the M. jannaschii ADH synthase to the enzyme from 
Thermoproteus tenax (T. tenax). Both of the enzymes were homodecamers containing 
the active site at the top of the barrel (on strand β6), with approximately 60% 
conserved residues in the active site (Morar et al., 2007). The M. jannaschii enzyme 
was confirmed to be a member of the class the 1A aldolase/ transaldolase family 
based on the fold of the enzyme, the utilization of a Schiff base intermediate, and the 
presence and localization of the catalytic Lys-Tyr residues.  
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The sequence alignment of OE1472F to MJ0400 from M. jannaschii is presented 
in figure #89, and shows the following: (1) 43% of the amino acids are completely 
conserved while 61% of the residues are similar. (2) all the active site residues 
described by Morar et al for M. jannaschii (Morar et al., 2007) can be identified in 
OE1472F from H. salinarum and are all completely conserved. (3) the conserved 
sequence motifs in archaea described by Siebers et al (Siebers et al., 2001) were all 
identified. (4) when superposition of the MJ0400-F1,6-P complex (figure #89, lower 
panel, in blue) with the OE1472F sequence (figure #89, lower panel, in red), one can 
see almost no differences except in the unstructured loop regions. On the basis of 
sequence alignment, presence of active site residues, conserved motifs and that the 
purified protein can form octamers (appendix section 8.8), H. salinarum ORF 
OE1472F is likely a member of the class 1A aldolase/ transaldolase family (figure 
#89). 
Figure # 89
http://us.expasy.org
: Sequence alignment of OE1472F from H. salinarum and MJ0400 from M. 
jannaschii. Conserved sequence motifs in archaea described by Siebers et al (Siebers et al., 
2001) are marked with black boxes. Active site residues described by Morar et al for M. 
jannaschii (Morar et al., 2007) are marked in boldface letters and *. The catalytic lysine 
residue (Lys237) determined for the E. coli class IA aldolase (DhnA type aldolase), is marked 
with a black asterisk (Thomson et al., 1998). Completely conserved residues are colored in 
yellow (43%); similar residues are colored in orange (61%). The alignment was done using 
ClustalW multiple sequence alignment program ( ). The secondary 
structure elements according to MJ0400 (Morar et al., 2007) are shown at the top of the 
alignment. Lower panel
http://us.expasy.org
-Superposition of MJ0400-F1,6-P complex with OE1472F. Blue-
MJ0400, red-OE1472F, green-F-1,6-P. The PDB file of OE1472F was generated by Phyre 
( ) and 3D structure was viewed by Pymol. 
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7.2.1.2 Enzyme activity of the OE1472F and OE2019F proteins 
To determine the biological function of ORFs OE1472F and OE2019F, the gene 
products were expressed in E. coli and purified. Assuming that the proposed de novo 
pathway of M. jannaschii (White, 2004) takes place also in H. salinarum, OE1472F 
(homolog to MJ0400) was predicted to catalyze a transaldolase reaction between 
DKFP and ASA, while OE2019F was predicted to be an aldolase. These predictions 
were tested using E. coli-expressed and purified proteins. 
Unexpectedly, both OE1472F and OE2019F purified proteins displayed similar F-
1,6-P aldolase activity as measured by the colorimetric assay (table #15, H. 
salinarum). From the comparison to M. jannaschii, OE1472F (homolog of MJ0400) 
showed 70-fold higher specific activity compared to MJ0400, while the specific 
activity of OE2019F (homolog of MJ1585) was 6.9-fold, 2.9-fold and 7.4-fold lower 
compared to aldolases from M. jannaschii, T. tenax and P. furiosus, respectively. 
Although one can clearly identify MJ1585 from M. jannaschii as an aldolase, this 
conclusion can not be made for OE1472F of H. salinarum, because of its similar 
specific activity towards F-1,6-P.   
 
Table # 15
 
: Aldolase and transaldolase activity detected in different archaea. 
Organism Assay 
Specific activity 
 (mU/mg Protein) Reference 
ORF activity 
M. 
jannaschii 
coupled assay,  
recombinant proteins 
(1) MJ0400 
(2) MJ1585 
<0.1 
540 
(Porat et 
al., 2006) 
M. 
maripaludis 
coupled assay,  
cell extract 
WT,  
(1) ∆MMP0686  
6.6-7.2 
6.6-7.2 
(Porat et 
al., 2006) 
M.   
jannaschii (4) 
GC-MS,   
purified enzymes 
(1) MJ0400+ (2) MJ1249 
MJ0400+MJ1249+NADP 
MJ0400+MJ1249+NAD 
4.8 
103.1 
226.8 
(White, 
2004) 
H.  
salinarum 
colorimetric assay,  
purified proteins 
(1) OE1472F 
(2) OE2019F 
71 
78 
This study 
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T. 
tenax(5) 
coupled assay,  
recombinant proteins 
AJ310483(7) 230 (Siebers et al., 2001) 
P.  
furiosus(6) 
coupled assay,  
recombinant proteins 
AF368259(7) 580 (Siebers et al., 2001) 
 
(1)MJ0400 from M. jannaschii is homologous to OE1472F from H. salinarum and MMP0686 
from M. maripaludis. It is believed to be an transaldolase that catalyzes the first reaction in 
the AroAAs biosynthesis in these organisms.  
 
(2)MJ1585 from M. jannaschii is homologous to OE2019F from H. salinarum and MMP0293 
from M. maripaludis. It is an aldolase. 
 
(3)MJ1249 is homologous to OE1475F from H. salinarum and MMP0006 from M. 
maripaludis. It is believed to catalyze the second reaction in the AroAAs biosynthesis, 
synthesizing DHQ.  
 
(4) The formation of DHQ was measured using 1.6mM ASA and 2.2mM DKFP as substrate 
(White, 2004), while in all others the substrate was F-1,6-P. 
 
(5) Thermoproteus tenax, crenarchaeon 
 
(6) Pyrococcus furiosus, euryarchaeon 
(7) GenBank accession number 
 
The fact that OE1472F displayed aldolase activity towards F-1,6-P may indicate 
that F-1,6-P is playing a role in the biosynthesis of AroAAs. Moreover, as 
demonstrated by Morar et al ((Morar et al., 2007) and figure #89), both transaldolases 
(OE1472F and MJ0400) can bind F-1,6-P in the active site. While MJ0400 showed no 
detectable aldolase activity, OE1472F displayed aldolase activity towards F-1,6-P 
(table #15).  
Together, the data may indicate either (1) ASA and F-1,6-P are the precursors in 
the AroAAs biosynthesis pathway in H. salinarum, or (2) ORF OE1472F has an 
additional role in the AroAAs biosynthesis pathway, such as the formation of DKFP. 
If the former is true, an aldole-like condensation between DHAP moiety of F-1,6-P 
and ASA is expected. GAP will be released, and compound I will be formed. 
However, oxidative deamination and phosphorylation by ORF OE1475F will not lead 
to the formation of DHQ (figure #90A). This will only be possible from ASA and F-
1,6-P if HPAP (hydroxpyruvaldehyde phosphate) is released after the aldole-like 
condensation (figure #90B). But this is not likely as OE1472F is classified as an 
aldolase/transaldolase, and is expected to cleave F-1,6-P to GAP and DHAP. 
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Figure # 90
http://www.chem.qmul.ac.uk/iubmb/enzyme
: The expected products and intermediates after cleavage of F-1,6-P and 
condensation with ASA.  A- Aldoe-like condensation of DHAP moiety from F-1,6-P to ASA 
dose not result in DHQ. B- Formation of DHQ is possible only when compound II’ is formed 
after releasing HPAP and oxidative deamination of compound I’. Compound II’ is identical to 
the first intermediate formed in the canonical pathway when PEP and E-4-P are condensed 
(IUBMB Enzyme Nomenclature website, , EC 
2.5.1.54). ASA-L-aspartate semialdehyde, F-1,6-P- fructose 1,6-bisphosphate, GAP- 
glyceraldehyde 3-phosphate, HPAP- hydroxpyruvaldehyde phosphate, DHQ-3 
dehydroquinate, PEP- phosphoenolpyruvate, E-4-P- erythrose-4-phosphate.  
 
The second explanation for an aldolase activity of ORF OE1472F is the possibility 
that this ORF is involved as well in the formation of DKFP. White and Xu (White and 
Xu, 2006) demonstrated that the recombinant MJ1585 gene product from M. 
jannaschii catalyzes the condensation of methylglyoxal with a DHAP fragment 
(derived from F-1-P and/or F-1,6-P), to generating DKFP (table #2, experiment 5 and 
6 in (White and Xu, 2006)). This observation was consist with the MJ1585 gene 
product also functioning as a F-1,6-P aldolase ((Porat et al., 2006) and table #15).  
Thus, White and  Xu (White and Xu, 2006) concluded that the glycolytic enzyme 
MJ1585 is a multifunctional enzyme, responsible for both cleavage of F-1,6-P (figure 
#91 reaction #1) and the formation of DKFP from methylglyoxal and the DHAP 
moiety derived from F-16-P and/or F-1-P  (figure #91, reaction #3). On the other 
hand, a transaldolase reaction between ASA and DKFP (precursors of the AroAAs 
biosynthesis) is mediated by the product of the MJ0400 gene (White, 2004), which 
showed no detectable aldolase activity ((Porat et al., 2006). In contrast to M. 
jannaschii, both of the homologs in H. salinarum: OE2019F (homolog to MJ1585) 
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and OE1472F (homolog to MJ0400), demonstrated similar aldolase activities (table 
#15). Thus one can speculate that the two aldolase reactions depicted in figure #91 
might be catalyzed either by OE2019F (reaction #1) and OE1472F (reaction #3) or 
only by OE1472F (reaction #1 and #3). Some indirect evidence to support the 
possibility that ORF OE1472F can catalyze reaction #3 was given in the paper 
published by Morar et al (Morar et al., 2007), where MJ0400 (homolog to OE1472F) 
was crystallized with DHAP, resulting from soaking the crystal with F-1-P. The 
structure contained a clear DHAP electron density linked to Lys184 (figure #89, 
located on strand β6, shown to be one of the active site residues).  
The methylglyoxal used for the production of DKFP can derived from specific 
enzymatic reactions. One source might be methylglyoxal synthase (EC 4.2.3.3), 
which converts DHAP to pyruvate via methylglyoxal and D-lactate during glycolysis 
in E. coli (Cooper and Anderson, 1970; Kalapos, 1999). The probability of this to be 
the source of methylglyoxal in haloarchaea is low due to the absence of 
methylglyoxal synthase in the genomes of haloarchaea. On the other hand, 
methylglyoxal may arise enzymatically from GAP via elimination of phosphate 
catalyzed by triose phosphate isomerase, using OE2500R (EC 5.3.1.1) (figure #91 
reaction #2 and (Richard, 1991).  
 
 
 
 
 
 
 
 
 
Figure # 91: Proposed pathways for the formation of Methylglyoxal and DKFP. Reactions 
#1 & 2: were suggested to be catalyzed by the multifunctional glycolytic enzyme, MJ1585 in 
M. jannaschii. Reaction #2: was suggested to be catalyzed by triose phosphate Isomerase EC 
5.3.1.1 in M. jannaschii and H. salinarum by ORFs MJ1528 and OE2500R, respectively. 
Modified from White and Xu (White and Xu, 2006). 
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Although OE1472F showed aldolase activity, in order to initiate the AroAAs 
biosynthesis pathway in H. salinarum, this enzyme should demonstrate a 
transaldolase activity with ASA and DKFP as substrates. Since the standard 
transaldolase coupled assay could not be used, an LC-MS assay was established in 
which substrates and or intermediate could be derivatized, detected and identified in 
high salt. Although the method was validated, OE1472F showed no detectable 
aldolase/ transaldolase activity. This was most likely due to its low specific activity, 
which was shown to be below the limit of detection of this assay. Although no 
transaldolase activity was demonstrated for ORF OE1472F, it is most likely 
transaldolase, as predicted from the sequence similarity of ORF OE1472F to MJ0400 
(figure #89). Nevertheless, improvements to the LC-MS methods need to be tested in 
order to determine experimentally whether or not the gene product of OE1472F is a 
transaldolase. From the data presented in table #15 for M. jannaschii, White (White, 
2004) was able to demonstrate that the combination of MJ0400 and MJ1249 
(homologs of OE1472F and OE1475F, respectively), could stimulate the production 
of DHQ, thus the gene products of MJ0400 and MJ1249 are the first steps needed for 
formation of DHQ in M. jannaschii. This approach need to be tested as well in H. 
salinarum, where OE1472F and OE1475F, will be expected to generate DHQ, using 
ASA and DKFP as precursors (figure #88).  
7.2.1.3 Phenotype of the OE1471F::pMG501 mutant  
Even though transaldolase activity was not demonstrated for the OE1472F protein, 
its role in the AroAAs biosynthesis pathway was determined in mutants where the 
corresponding gene was disturbed by insertion (figure #35). Assuming that no 
additional pathways exist for synthesizing AroAAs in H. salinarum, a mutant 
defective in one of the genes in the AroAAs biosynthesis pathway would be expected 
to be auxotrophic for one or more AroAAs. 
The mutant, OE1471F::pMG501, showed reduced ability to grow without 
AroAAs, while addition of AroAAs allowed growth at the same level as WT, thereby 
confirming the role of this ORF in the AroAAs pathway. Furthermore, RT-qPCR 
results showed that ORF OE1472F was 12-fold induced when AroAAs were omitted 
from the growing medium. Mutant OE1471F::pMG501 grows to some extent without 
AroAAs due to either incomplete blocking of OE1472F transcription or by limited 
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compensation by some other gene product. In the later case, this could be by 
OE2019F, as it is one of the paralogous genes to class the 1A aldolase family, which 
was shown in this study to cleave F-1,6-P (figure #56A). 
Supplementing the synthetic medium with AroAAs plus either shikimate or DHQ, 
was sufficient for the mutant to grow as well as WT, indicating that the OE1472F 
enzyme acts on a substrate upstream of DHQ and shikimate.  
The ability of the mutant to take up Phe from the medium supplemented only by 
AroAAs, suggests that while ORF OE1475F and OE1477R can regulate the specific 
transporters of AroAAs, the gene product of OE1472F has little or no regulatory 
effect on the Phe transport, allowing cells to take up Phe from the medium.  
7.2.2 ORF OE1475F- the second ORF in the AroAAs pathway   
ORF OE1475F was annotated in H. salinarum genome as a conserved hypothetical 
protein. It was found to be homologous to MJ1294 from M. jannaschii, with which it 
shares 41% amino acid identity. MJ1294 was annotated as 3-dehydroquinate synthase 
(EC 4.6.1.3) and shown to catalyze the NAD dependent oxidative deamination and 
the cyclization reaction of 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid (NDH) 
to form 3-dehydroquinate (figure #3 in (White, 2004)). The role of the gene product 
of OE1475F in H. salinarum was determined experimentally. 
7.2.2.1 Phenotype of the OE1475F::pMG601 mutant 
The role of ORF OE1475F in the AroAAs biosynthesis pathway was determined in 
mutants where the target gene was disturbed by insertion (figure #39). The mutant 
OE1475F::pMG501 showed reduced ability to grow without AroAAs, but when 
AroAAs were added to the synthetic medium, cells grew as well as the WT. These 
results confirmed the role of this ORF in the AroAAs pathway.  
The mutant was capable of growing on synthetic medium supplemented with all 
three AroAAs, and although the uptake of Phe was poor, as observed from uptake 
assays (table #6), it was sufficient to support the growth of the mutant. As shown by 
Gonzales et al., (Gonzalez et al., 2009) for WT H. salinarum, for most of the supplied 
amino acids, the uptake rates exceeds the rate at which they are directly incorporated. 
More specifically, it was proven experimentally that only 0.2mM Phe were 
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incorporated into biomass, allowing cell growth to an optical density of 1.8OD600nm.  
This represents a consumption of 0.11mM Phe OD-1 cell biomass. In the case of 
mutant OE1475F::pMG601, 0.094mM Phe OD-1 was consumed by the cells when 
grown in synthetic medium supplemented only by AroAAs (table#6). This level of 
Phe consumption is sufficient to support growth, as shown by Gonzalez et al., (figure 
#4 in (Gonzalez et al., 2009)). Interestingly, the consumption rate of Phe by the 
mutant was elevated in the presence of AroAAs plus either DHQ or shikimate (table 
#6), suggesting that the intracellular concentration of DHQ and shikimate induces the 
uptake of Phe by the mutant.  
The ability of the mutant to grow in the presence of AroAAs plus either shikimate 
or DHQ, indicated that the gene product of OE1475F acts on substrate upstream (i.e. 
before) of DHQ or shikimate. 
In contrast to OE1475F and MJ1249 (H. salinarum and M. jannaschii, 
respectively), the homolog from M. maripaludis (ORF MMP0006) was demonstrated 
not to be involved in AroAAs biosynthesis. Deletion of this gene did not result in a 
growth requirement for AroAAs, the mutant grew as well as the WT strain (figure 
#5B in (Porat et al., 2006)). In addition, labeling experiments showed that shikimate 
and dihydroshikimate (DHS) pools were labeled to nearly the same extent as in the 
WT. Therefore, Porat et al (Porat et al., 2006) concluded that the gene MMP0006 was 
not required for AroAAs biosynthesis in M. maripaludis.  
7.2.2.2 Enzyme activity and structure 
The enzyme responsible for the formation of DHQ, 3-dehydroquinate synthase (EC 
4.6.1.3), is of a great interest because it catalyses five individual reactions in a single 
active site involving alcohol oxidation, phosphate elimination, carbonyl reduction, 
ring opening and intermolecular aldol condensation (Srinivasan et al., 1963; 
Widlanski et al., 1989). To date, 3D structures for this enzyme are available from 
Aspergillus nidulans (PDB accession code 1SG6), Emericella nidulans (PDB codes: 
1NVB, 1NVD, 1NVE), Thermus thermophilus (PDB code 1UJN), and 
Staphylococcus aureus (PDB codes: 1XAG, 1XAH, 1XAI, 1XAJ). No crystal 
structure is available for the archaeal-type 3-dehydroquinate synthase. Submitting the 
sequence of OE1475F to 3D-JIGSAW (server which builds three-dimensional models 
for proteins based on homologues of known structure, 
                                                                                                                      Discussion 
 169 
http://bmm.cancerresearchuk.org/~3djigsaw/) retrieved no homologous sequences in 
PFAM, PDB or SCOP.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 92
www.halolex.mpg.de
: Sequence comparison of 3-dehydroquinate synthases from eukaryotic, 
prokaryotic and archaeal origins. Aspergillus nidulans (UniProt accession P07547), 
Saccharomyces cerevisiae (UniProt accession PO85566), E. coli (GenBank accession 
P07639), Bacillus subtilis (P31102), OE1475F (H. salinarum, ), and 
MJ1249 (from M. jannaschii). *- identical amino acid in all six sequences, :-similar amino 
acids in all six sequence. Identical amino acid in fungal, prokaryotes and archaea are marked 
in blue, violet and orange, respectively. The catalytic residues identified in A. nidulans are 
marked with black boxes (Nichols et al., 2003). The fungi sequences are the N-terminal 
subunit of the representative multi-enzyme complexes. Catalytic residues: Asn162, Asn268, 
His275, Arg264, Arg130, Lys152, Lys356, Lys250 and Glu260. The alignment was done 
using ClustalW multiple sequence alignment program (http://us.expasy.org). 
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As seen in figure #92, OE1472F showed low overall identity with homologs of A. 
nidulans and S. ceervisiae (11%), and with E. coli and B. subtilis (12%), while 41% 
sequence identity was found with MJ0400 from M. jannaschii. But ORF OE1475F 
shows 75-65% sequence identity to homologs found in other haloarchaea such as N. 
pharaonis, Haloarcula marismortui and Haloquadratum walsbyi 
(www.halolex.mpg.de). Nevertheless, some regions are highly conserved among all 
sequences. Downstream to the first conserved region there is an insertion in the 
sequences of E. coli , B. subtilis , H. salinarum and M. jannaschii of different length. 
This insertion is followed by another conserved region.  
9 catalytic residues are responsible for the reactions leading to the formation of 
DHQ, these were identified in the crystal structure of 3-dehydroquinate synthase from 
A. nidulans (Carpenter et al., 1998; Nichols et al., 2003). As seen in figure #92 (in 
black boxes), all the catalytic residues are completely conserved among the fungi and 
prokaryotic sequence, but not in the archaeal sequences (figure #92), which is not 
surprising due to the high number of Lys residues involved. Out of 9 residues 3 are 
Lys (Lys152, Lys356 and Lys250), which are involved in more then one reaction: 
Lys152 is involved in reactions 2, 4 and 5, Lys250 is involved in reactions 4 and 5, 
while Lys356 is involved in the second reaction. As shown earlier (Madern et al., 
2000; Madern et al., 1995), the primary sequence of halophilic proteins is 
characterized by an increased level of acidic residues along with a drastic reduction of 
lysine residues, compared to their mesophilic contraparts.     
7.2.3 ORF OE1477R- the third ORF in the AroAAs pathway 
ORF OE1477R (aroD) was annotated as 3-dehydroquinate dehydratase (EC 
4.2.1.10), and by definition was expected to remove a water molecule from 3-
dehydroquinate (DHQ) to form 3-dehydroshikimate (DHS), as shown in figure #88. It 
was predicted to catalyse the 3rd step in the de novo biosynthesis pathway of AroAAs 
in H. salinarum, so a deletion of this ORF should result in AroAAs auxotrophy. It is 
also possible that expression of this gene might be regulated by the exogenous levels 
of AroAAs.  
From the RT-qPCR results shown in figure #88, no significant regulation was 
observed for ORF OE1477R, whether AroAAs were present or not in the synthetic 
medium, suggesting that this gene might be constitutively expressed, as opposed to a 
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genetic switch, which assures that the expression of a specific gene is turned on when 
a signal, (e.g., a nutrient), is present and turned off when the signal is absent. 
7.2.3.1 Phenotype of the deletion mutant ∆OE1477R 
In-frame deletion of ORF OE1477R was achieved by recombination, and the 
mutant was recovered by aerobic growth in the dark in synthetic medium 
supplemented with 1.1mM AroAAs and 1.1mM DHQ. The genotype of ∆OE1477R 
was confirmed by PCR and Southern blot analysis.  
The phenotype of ∆OE1477R was studied by cultivation in synthetic medium with 
and without AroAAs. The inability of the mutant to grow without AroAAs confirmed 
the role of OE1477R in the biosynthesis of AroAAs.  
The deletion strain was capable of growing slowly on synthetic medium 
supplemented with AroAAs, by utilizing only low concentrations of Phe sufficient for 
supporting this low growth (figure #31 and table #3). Nevertheless, when the mutant 
grew on synthetic medium supplemented with AroAAs plus either DHQ or shikimate 
the mutant was capable of utilizing all the Phe supplied in the medium. This 
observation can be interpreted as evidence that the internal levels of DHQ and 
shikimate regulates the uptake of Phe from the medium. This allows the incorporation 
of AroAAs into proteins or as free metabolites, as well as serving as carbon skeleton 
donors.  
7.2.3.2 Enzyme activity of OE1477R 
As expected, the purified gene product of ORF OE1477R was shown to possess 
dehydroquinate dehydratase activity, i.e. formation of DHS from DHQ. The specific 
activity of the purified gene product of OE1477R from H. salinarum was 
55±6mU/mg protein. In comparison, the specific activity of dehydroquinate 
dehydratase found in cell extracts of M. maripaludis was 6.0±0.2mU/mg protein 
(Porat et al., 2004). No detectable activity was found when aroD was deleted 
(<0.5mU/mg protein) (Porat et al., 2004). A purified enzyme from E. coli displayed a 
similar specific activity (89mu/mg protein) compared to OE1477R from H. salinarum 
(Mitsuhashi and Davis, 1954). 
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Figure # 93: Multiple alignment of archaeal and bacterial dehydroquinase sequences, 
modified from (Smith and Gallagher, 2008). Five archaeal sequences are at the top, followed 
by four bacterial sequences. The organism names are abbreviated as follows: Fulg- 
Archaeoglobus fulgidus, Halo- Halobacterium sp. NRC-1, Pyro- Pyrococcus furiosus, Meth- 
Methanocaldococcus jannaschii, Solf- Sulfolobus solfataricus, Aqui- Aquifex aeolicus, Coli-
Escherichia coli, Salm- Salmonella typhimurium, and Staf- Staphylococcus aureus. The three 
known structures are Fulg (at the top), Salm and Staf (the last two). Residue numbers along 
the top are for the A. fulgidus sequence. Residues that are completely conserved among the 
nine sequences are shown in bold and marked both with an asterisk and with a blue box, 
while those that are conserved with one or two exceptions are marked both with a plus sign 
and red box. The secondary structure below the alignment, giving numbers for the eight 
strands and helices of the barrel, corresponds to the Salmonella enzyme and corresponds 
approximately with the others. For the three known structures (Fulg, Salm and Staf), the 
alignment was structure-based, while for the other sequences it was calculated by ClustalW 
based on sequence homology. The active site residues are marked in green boxes, 
corresponding to Glu23, Arg45, His98, Lys122, and Arg159 in A. fulgidus. Non-conserved 
active site residues are marked in black box (Ser22, and Ser232 in S. typhimurium).  
                                                                                                                      Discussion 
 173 
7.2.3.3 OE1477R- a dehydroquinate dehydratase type I enzyme 
Additional confrmation that ORF OE1477R is indeed dehydroquinate dehydratase 
is given in figure #93. The alignment of type I 3-dehydroquinate dehydratase from the 
thermophilic archaeon Archaeoglobus fulgidus with multiple bacterial homologs, 
demonstrates that the active site is generally similar in its key residues and their 
geometry. Out of the seven residues within the product-complex structure of the S. 
typhimurium enzyme, five are well conserved in the alignment, and are expected to 
play a similar role in the H. salinarum enzyme, (figure #93, marked with green 
boxes). The greatest difference is seen in two of the active site residues in S. 
typhimurium (Ser21, and Ser232), which are nonconserved, (figure #93 marked with 
black boxes) (Smith and Gallagher, 2008). Additionally, one can see that  many of the 
helical regions, especially helices 2 and 4, appear to be absent or significantly shorter 
in the archaeal protein (figure #93 and (Smith and Gallagher, 2008)).  
7.2.4 A non- canonical pathway for AroAAs biosynthesis in H. 
salinarum 
The putative functions of ORFs OE1472F, OE1475F and OE1477R were 
confirmed experimentally, both in vivo and in vitro. All three ORFs were found to be 
part of a non-canonical pathway for AroAAs biosynthesis in H. salinarum, and to act 
on substrates upstream to DHS, as demonstrated from the phenotype of mutant strains 
defective in these ORFs. The set of reactions leading to the formation of DHQ is 
represented in figure #94. 
In summary, ORF OE1472F was classified as a member of the archaeal 
aldolase/transaldolase family based on the known 3D structure of transaldolase from 
M. jannaschii, and that it displays an aldolase activity towards F-1,6-P as substrate. 
Although, transaldolase activity was not shown experimentally, it is predicted from 
the data presented that ORF OE1472F is the first gene in the de novo pathway in H. 
salinarum. Moreover, the unexpected aldolase activity of this enzyme may indicate 
involvement in the formation of DKFP.   
In addition, ORF OE1475F was found to play a role in the biosynthesis of AroAAs 
in H. salinarum as the mutant required both AroAAs plus either shikimate or DHQ 
for growth. This conserved protein is believed to be a 3-dehydroquinate synthase, and 
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as such, responsible for the oxidative deamination and the cyclization reactions, to 
form DHQ. Up to date, no crystal structure of the archaeal-type enzyme is available. 
Finally, evidence was provided to show that the gene product of OE1477R 
catalyses the third step in the de novo pathway of AroAAs biosynthesis in H. 
salinarum. The enzyme was classified as 3-dehydroquinate dehydratase, and the 
purified gene product was capable of forming DHS from DHQ.  
Based on the microarray analysis and RT-qPCR results, it was shown that several 
regulatory mechanisms are used when H. salinarum utilize AroAAs via a non- 
canonical biosynthesis pathway. In summary; (1) all 13 homologous genes 
downstream to DHQ were strongly regulated when AroAAs were omitted from 
growth medium of R1; (2) upstream to DHQ, while ORF OE1472F was strongly 
regulated in the absence of AroAAs, ORFs OE1475F and OE1477R were expressed 
constitutively; (3) the involvement of specific and unspecific transporters were 
shown, including aroP, various Na-dependent transporters and ABC transporters, 
which would be consistent with the cells trying to scavenge AroAAs from the 
medium; (4) global regulators such as TrmB and Lrp-like proteins were found to be 
regulate. While TrmB was weakly induced when AroAAs were added to the growing 
medium of R1, LrpA2 was strongly induced when AroAAs were absent in the 
growing medium, and LrpA1 was strongly up regulated when R1 was grown in 
synthetic medium supplemented with AroAAs and shikimate.   
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Figure # 94
 
: A non-canonical pathway for AroAAs biosynthesis in H. salinarum. The ORF 
catalyzing the specific steps are indicated below the arrows. The canonical pathway takes 
place downstream to DHQ. 
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8 Appendix 
8.1 Derivatized masses identified by LC-MS 
The derivatized masses of the pure substrates identified by GC-MS with the 
indicated retention times. DHS was the only compound in the table which was not 
injected as a pure substance. DHS was detected (with the indicated mass and retention 
time), in reaction with protein OE1477R and DHQ. 
 
Table # 16
 
 : The mass detected by LC-MS after derivatization with NBHA 
 Formula 
Exact 
Mass 
 
(g/mole) 
Exact Mass 
after 
derivatization (1)  
(g/mole) 
Mass detected 
by LC-MS (2) 
(g/mole) 
RT  
 
(min) 
ASA C4H7O3N 117.10 267.24 268.09 12.5 
DKFP C6H11O8P 242.12 542.39 543.11 (3) 28.2 
F-1,6-P C6H14O12P2 340.11 490.25 491.04 3.7 
DHAP, GAP C3H7O6P 170.05 320.19 321.05 
14.5, 
15.2 
DHQ C7H10O6 190.15 340.29 341.09 14.8 
DHS (5) C7H8O5 172.13 322.27 323.08 (4) 20.1 
NBHA C7H8N2O3 168.15 -------- 169.06 5.6 
(1)-Calculated exact mass.  
(2)-Calculated exact mass after derivatization and release of water molecules.  
(3)-The exact mass as detected by LC-MS.  
(4)- DKFP was derivatized twice and released of two molecules of water. 
(5)- DHS was not used as a standard, but was identified by mass after the cleavage of DHQ by 
OE1477R.   
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8.2 Derivatized masses identified by GC-MS  
The pure substrates ASA, DKFP, F-1,6-P, GAP, DHAP, DHA, DHQ and 
Shikimate were derivatized by methoximation followed by TMS (table#6) or TBS 
(table #7). The derivatized masses, and the retention times are listed in the tables 
below.   
 
Table # 17
 
: The mass detected by GC-MS after derivatization with methoximation and TMS.  
 Formula 
Exact Mass 
 
(g/mole) 
Exact Mass 
after derivatization 
(1)  
(g/mole) 
Mass detected 
by GC-MS (2) 
(g/mole) 
RT  
 
(min) 
ASA C4H7O3N 117.042 290.148 nd  
DKFP C6H9O8P 240.003 588.230 nd  
F-1,6-P C6H10O12P2 335.964 873.299 nd  
GAP C3H5O6P 167.982 415.143 415.1431 
12.46, 
12.54 
DHAP C3H5O6P 167.982 415.143 nd  
DHA C3H6O3 90.031 263.137  8.67 
DHQ C7H9O6 189.039 507.232 507 13.71 
DHS C7H7O5 171.1306 417.1823 ------- ------ 
Shikimate C7H9O5 173.045 462.210 462 13.17 
(1)-Calculated exact mass after derivatization by methoximation and TMS.  
(2)-The exact mass as detected by GC-MS.  
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Table # 18
 
 : The mass detected by GC-MS after derivatization by methoximation and TBS.  
 Formula 
Exact 
Mass 
(g/mole) 
Exact Mass 
after 
derivatization (1) 
(g/mole) 
Mass detected 
by GC-MS (2) 
(g/mole) 
RT 
(min) 
ASA C4H7O3N 117.042 374.242 
317.242, 
289.242(3) 
24.86 
DKFP C6H9O8P 240.003 756.418 699.418 43.38 
F-1,6-P C6H10O12P2 335.964 1167.627 
nd 
mass to high 
 
GAP C3H5O6P 167.982 541.284 456.284 30.48 
DHAP C3H5O6P 167.982 541.284 484.284 30.72, 30.95 
DHA C3H6O3 90.031 374.231 290.231 20.87 
DHQ C7H9O6 189.039 675.420 
675.420, 
618.420(3) 
36.90-36.94 
DHS C7H7O5 171.1306 543.323 
486.323, 
458.323 
36.91 
Shikimate C7H9O5 173.045 630.398 
630.399, 
573.399(3) 
34.52 
(1)-Calculated exact mass after derivatization by methoximation and TBS 
(2)-The exact mass as detected by GC-MS.  
(3) Variation from the calculated mass are due to cleavage of 57Da [C(CH3)3], or 85Da  
    [C(CH3)3CO].  
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8.3 Oligonucleotides 
 
Table # 19
 
 : List of oligonucleotides used in this study 
Primer name Sequence Tm 
P1a of pMG550.for  
GGCCGG_ AGCTTATGACTGACGCCGGGAAAACC 
GCACGACTC (HindIII) 
85.0 
P2a of pMG550.rev 
CCGGCC_GGATCC_C_GGCGTCGACGACGAGACC 
GGCCCGG (BamHI) 
91.0 
P1a of pMG650.for 
GGCCGG_ AAGCTT ATGACACGGTCCGTTTGGCTG 
AAAGCTGACG (HindIII) 
84.0 
P2a of pMG650.rev 
CCGGCC_GGATCC_C_CTGCTCGATGATGCGCTCG 
TCGATGGCCTCC (BamHI) 
89.0 
P1a of pMG750.for  
GGCCGG_ AAGCTTATGGAGTTCCAGGATTTTCTGC 
TCGCCGCG  (HindIII) 
84.0 
P2a of pMG750.rev  
CCGGCC_GGATCC_C _CTGTAGGTCGGCGATCAGC 
GCCTGTAGC (BamHI) 
88.0 
pMG560   
pET-OE1472F.For 
GGCCGG_CATATGATGACTGA CGCCGGGAAAACC 
GCACGAC TC (NdeI) 
85.0 
pET-OE1472F.rev 
CCGGCC_CTCGAGGGCGTCGACGACGAGACCGGC 
CCGG (XhoI) 
90.0 
pMG660   
pET-OE1475F.For 
GGCCGG_CATATGATGACACG GTCCGTTTGG CTG
AAAGCTG ACG (NdeI) 
84.0 
pET-OE1475F.rev 
CCGGCC_CTCGAGCTGCTCGATGATGCGCTCGTCG
ATGGCCTCC (XhoI) 
88.0 
pMG760   
pET-OE1477R.For 
GGCCGG_CATATGATGGAGTTCCAGGATTTTCTGC
TCGCCG CG (NdeI) 
84.0 
pET-OE1477R.rev 
CCGGCC_CTCGAGCTGTAGGTCGGCGATCAGCGC 
CTGTAGC (XhoI) 
87.0 
pMG860   
pET-OE2019F.For 
GGCCGG_CATATGATGCGACCCTTCGAGGACTCAC 
CGATCT CCCGC (NdeI) 
87.0 
pET-OE2019F.rev 
CCGGCC_CTCGAGGATGCGTCCGAGCGCCTCGTCG 
ACGCTGG (XhoI) 
90.0 
pMG500   
P1 of OE1472F.For GGCCGG _ GGATCCCGGGCGTCTCCGGGTTCGTGG  81.9 
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(BamHI) 
P2 of OE1472F.rev 
CCGGCC _ 
CTGCAGTGGTACTGGCTAGCAAACGTTGGG  
(PstI) 
77.4 
P3 of OE1472F.For 
GGCCGG _ TGCAGCGCTCGGCGTCAGTCACCTGCC  
(PstI) 
81.5 
P4 of OE1472F.rev 
CCGGCC _ AAGCTTCAGTCGACGCCGGCCTCCAGG  
(HindIII) 
79.4 
pMG600   
P1 of OE1475F.For 
GGCCGG _ GGATCCCCCGGCGCGATGACCGCCGCC  
(BamHI) 
84.4 
P2 of OE1475F.rev 
CCGGCC _ TGCAGTGCCGGATGGAGGCGGCACGCG  
(PstI) 
82.7 
P3 of OE1475F.For 
GGCCGG _ TGCAGCCGCGG TCAGTCCAGCTCCCCG  
(PstI) 
82.7 
P4 of OE1475F.rev 
CCGGCC _ AGCTTGGCGGCGCTACAGGCGCTGATC  
(HindIII) 
79.1 
pMG700   
P1 of OE1477R.For 
GGCCGG_GGATCCTCGAGGGCGT CGCCACGTCC T
G (BamHI) 
81.5 
P2 of OE1477R.rev 
CCGGCC_CTGCAGACCCGGCTCACACGCGGCCAG  
(PstI) 
81.9 
P3 of OE1477R.For 
GGCCGG 
_CTGCAGGTGGCCGCG TTCGGTGGGT TTAC (PstI) 
80.0 
P4 of OE1477R.rev 
CCGGCC_AAGCTTCGCCACTTCGGGGAGGCCATCG  
(HindIII) 
79.1 
pMG501   
Terminator (XbaI). for    
ctagaCCGCGCGGTATTTTCTCCGAATCGGGGTTTTTT
TCGTGTGTAGCTGGCActgca 
 
 
Terminator (PstI). rev  
gTGCCAGCTACACACGAAAAAAACCCCGATTCGGA
GAAAATACCGCGCggt 
 
 
P1of trpA.For 
GGCCGG_GGATCCCGGCGTTCGTCTCCGCGGCGGC
CGAGGCGGGC (BamHI) 95.0 
P2of trpA.rev 
CCGGCC_TCTAGACTATTTGTGTTCCGGTTCCGGC
ACGC (XbaI) 82.0 
pMG601   
P7 of mid OE1475F.For 
GGCCGG_GGATCCGACGGCGAAGGCGACGGCACC
G(BamHI) 87.0 
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P8 of mid OE1475F.rev 
CCGGCC_GCATGCCGACTGGGCGGTTTCGGCGTGC 
(SphI) 86.0 
Primers for RT-PCR   
RT- L10ER.for GTACCGGAAGATCGACAAGC 60.0 
RT- L10ER.rev GGAACAAGGCTGATCTGTACG 61.0 
RT- OE1472F.for ATCAGCACCGACGACAGAC 59.0 
RT- OE1472F.rev CGTTGAGGTGGACGATGTAG 60.0 
RT- OE1475F.for GAGGAAACCACGCTCGTC 58.0 
RT- OE1475F.rev CTCCTCGATGGTGGTGATG 59.0 
RT- OE1477R.for ACGACTACGACGGAGTGTTG 60.0 
RT- OE1477R.rev GTTGTGGTGTCTGTCGAACG 60.0 
 
 
8.4 Volcano plot 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure # 95
 
: Volcano plot generated by TIGR MEV. The data used for the plot was cDNA 
from cells grown in medium with AroAAs (at OD600nm=0.2) compared to the cDNA 
prepared from cells grown in medium without AroAAs. The plot can be divided into non-
statistically significant genes (p≥0.001), and statistically significant genes (p≤0.001), below 
and above the blue line, respectively. The statistically significant genes can be divided into 
three groups:  A-genes with gene mean ≤-1.02 (equals ≤0.49 fold regulation), B- genes with 
gene mean between -1.02 to 1.02 (fold regulation of 0.49-2.03), and C-genes with gene mean 
≥1.02 (fold regulation ≥2.03). 
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8.5 Time constants 
Table # 20
 
: Time constants when electroporating N. pharaonis and H. salinarum (R1) using: 
25µF, 1.5Kv, 0.2cm cuvette and different resistance values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.6 Growth of OE1471F::pMG501 & OE1475F::pMG601 
mutants on plates 
The phenotypes of OE1471F::pMG501 and OE1475F::pMG601 mutants were 
compared to a WT and R1 transformed with pST1-pReport plasmid (constructed by 
Katarina Furtwangler) as controls for WT cells transformed with plasmids containing 
the MevR cassette. 
The mutants were grown in synthetic medium with 1.1mM AroAAs, 1.1mM 
shikimate and 10µg/ml Mev. R1 was grown on the same medium without Mev. All 
cells were then plated on synthetic medium with or without AroAAs. As seen in 
figure #91, R1 did not grow on either of the plates due to the presence of Mev. Both 
of the mutants were able to grow on all media, although growth was slower on 
synthetic medium without AroAAs. The control, R1 transformed with pST1-pReport 
plasmid grow better on synthetic medium without AroAAs compared to the mutants. 
Resistance 
(Ω) 
Calculated  
time  
constant  
(ms) 
 
Displayed 
time constant (ms) 
N. 
pharaonis 
H. 
salinarum 
(TOM) 
100 2.5 1.7 1.9 
200 5 2.5 3.2 
400 10 3 4.3 
600 15 3.4 4 
800 20 3.5 4.3 
1000 25 3.6 5.2 
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As a control for the viability of the cells and to demonstrate the cells can grow on 
those plates, cells grown in liquid synthetic medium supplemented with AroAAs and 
shikimate were plated as well.  
 
 
 
 
 
 
 
 
Figure # 96
 
: Phenotype of OE1471F::pMG501 and OE1475F::pMG601 compared to R1 
transformed with plasmid pPST1-pReport (plasmid containing MevR) and WT strain R1. 
Cells were grown in liquid synthetic medium supplemented with 1.1mM AroAAs and 1.1mM 
shikimate (40°C, 100rpm). Cells were washed with basal salt before diluting 1/10-2 with basal 
salt and spotting 3µl from each dilution. 
8.7 Generation times and the uptake rates of Phe in 
WT and different mutants. 
8.7.1 Growth of the WT and ∆OE1477R 
Table # 21
 
: Generation times (Gn) and the uptake rates (Y) of Phe in cultures of H. salinarum 
and ∆OE1477R mutant. 
Synthetic medium 
supplemented with 
Gn  
(h) 
Phe uptake rates  
(µMxOD-1xh-1) 
R1 ∆OE1477R R1 ∆OE1477R 
AroAAs 9.53±1.7  17.38±6.7 9.2 0 
 Without AroAAs 23.39±7.3 ------   
AroAAs+Shikimate 11.17±2.4 9.09±0.7  8.7 8.47 
AroAAs+DHQ 11.35±3.7 9.42±2.6 12.5 8.19 
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8.7.2 Growth of the WT and OE1471F::pMG501 mutant 
Table # 22
 
: Generation times (Gn) and the uptake rates (Y) of Phe in cultures of H. salinarum 
and OE1471F::pMG501 mutant. 
Synthetic medium 
supplemented with 
Gn  
(h) 
Phe uptake rates 
 (µMxOD-1xh-1) 
R1 OE1471F::pMG501 R1 OE1471F::pMG501 
AroAAs 10.4±2.6 10.6±1.6 10.8 7.5 
Without AroAAs 31.5±3.5  60.13±4.8    
AroAAs+Shikimate 11.5±0.5 12.18±2.5 9.6 5.2 
AroAAs+DHQ 11.3±2.3 11.14±1.2 13.8 11.8 
 
8.7.3 Growth of the WT and OE1475F::pMG601 mutant 
Table # 23
 
: Generation times (Gn) and the uptake rates (Y) of Phe in cultures of H. salinarum 
and OE1475F::pMG601 mutant. 
Synthetic medium 
supplemented with 
Gn  
(h) 
Phe uptake rates 
 (µMxOD-1xh-1) 
R1 OE1475F::pMG601 R1 OE1475F::pMG601 
AroAAs 10.5±1.9 15.6±2.8 10.8 1.3 
Without AroAAs 30.6±4.7  63.3±10    
AroAAs+Shikimate 11.1±1.8 11.6±1.9 9.1 12.2 
AroAAs+DHQ 11.3±2.3 11.7±0.7 11.9 16.5 
 
8.8 Size exclusion chromatography of purified 
OE1472F  
The enzyme was purified from 1 liter culture and loaded on NiNTa column. The 
bound protein eluted after a step gradient between 20-250mM Imidazole. The protein 
elution buffer (50mM NaH2PO4 + 300mM NaCl+250mM Imidazole pH=8.0) was 
                                                                                                                         Appendix 
 185 
exchange to 1M KCl+100mM Tris HCl (pH 7.2)+5mM MgCl2 by dialysis o.n at 4°C.  
100µl was loaded on S-200. The protein was eluted using the same buffer.  
 
 
 
 
 
 
 
 
 
 
 
~4mg/ml protein was unfolded with 8M Urea using dialysis and folding in 2M 
KCl+20mM Tris-HCl (pH 7.2)+5mM MgCl2. 100µl was loaded on S-200. The 
protein was eluted using the same buffer, forming 14% of octamers. 
 
 
 
 
 
 
 
 
 
 
 
 
Elution Volume (ml) % 
# of 
monomers 
1.43ml 43% x 4 
1.64ml 30% x 2 
1.80ml 27% x 0.5 
Elution 
Volume 
 (ml) 
% 
# of 
monomers 
1.26ml 14% x 8 
1.55ml 18% x 2 
1.71ml 55% x 1 
2.05 ml 13% 
x 0.5 or 
smaller 
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.0
0.1
0.2
0.3
0.4
0.5
 
In
te
ns
ity
 (O
D
 2
80
)
Volume (ml)
0.93ml 
1.43ml 
1.64ml 
1.80 ml 
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.00
0.05
0.10
0.15
0.20
0.25
0.30
 
in
te
ns
ity
 (m
AU
)
volume (ml)
1.26ml 
1.55ml 
1.71ml 
2.05ml 
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8.9 Percentage of spheroplasts after treatments to 
remove the S-layer 
8.9.1 Bacitracin treatment 
Table # 24:
 
  % of spheroplasts in different concentration of Bacitracin, after 48h growth. 
Sum: total of cell count, Sphero:spheroplast, SD: standard deviation.   
 
 
OD600nm=0.37 
0µg/ml Bacitracin 
Flask #1:     rod Sphero 
Sum (n=4) 241 26 
total 267 
% Sphero of total  10 
SD 11 2 
 
 
OD600nm=0.38 
5µg/ml Bacitracin 
Flask #2:     rod Sphero 
Sum (n=12) 213 86 
total 299 
% Sphero of total  29 
SD 5 2 
 
 
OD600nm=0.34 
10µg/ml Bacitracin 
Flask #3:     rod Sphero 
Sum (n=11) 71 56 
total 127 
% Sphero of total  44 
SD 3 2 
 
 
OD600nm=0.31 
25µg/ml Bacitracin 
Flask #4:   rod Sphero 
Sum (n=13) 243 86 
total 329 
% Sphero of total  26 
SD 5 2 
 
 
OD600nm=0.25 
50µg/ml Bacitracin 
Flask #5:     rod Sphero 
Sum (n=13) 239 37 
total 276 
% Sphero of total  13 
SD 7 2 
 
 
OD600nm=0.09 
100µg/ml Bacitracin 
Flask #6:     rod Sphero 
Sum (n=7) 23 3 
total 26 
% Sphero of total  12 
SD 2 1 
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8.9.2 Protease treatment 
Table # 25
 
: % of spheroplast in different concentration of Protease, after 97.1h growth. 
Samples #1 and #2 were diluted ¼ before counting the cells. Sum: total cell count, Sphero: 
spheroflast, SD: standard deviation.   
 
OD600nm=1.064 
0mg/ml Protease 
Flask #1:     rod Sphero 
Sum (n=5) 149 22 
Sumx4 596 88 
total 684 
% Sphero of total  13 
SD 8 2 
 
 
OD600nm=0.58 
0.3mg/ml Protease 
Flask #3:     rod Sphero 
Sum (n=11) 552 117 
total 169 
% Sphero of total  69 
SD 3 4 
 
 
OD600nm=0.138 
0.9µg/ml Protease 
Flask #5:     rod Sphero 
Sum (n=10) 1 42 
total 43 
% Sphero of total  98 
SD 0 2 
 
 
OD600nm=0.92 
0.1mg/ml Protease 
Flask #2:     rod Sphero 
Sum (n=6) 125 8 
Sumx4 500 32 
total 532 
% Sphero of total  6 
SD 11 2 
 
 
OD600nm=0.29 
0.6µg/ml Protease 
Flask #4:     rod Sphero 
Sum (n=14) 1 57 
total 58 
% Sphero of total  98 
SD 0 2 
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8.10 Activity of GPDH in cell-free extracts 
8.10.1.1 Activity of GPDH measured in basal salt 
The activity of glycerol-1-phosphate dehydrogenase (GPDH) in cell-free extracts 
was recorded by measuring the decrease in the absorbance of NADPH at 340nm, 
using basal salt as buffer, as seen in figure #97. 0.15mM NADPH was added to 800µl 
Basal salt solution and 25mM Tris-HCl (pH 7.2), at RT. The absorbance at 340mM 
was measured continuously for 3min (a1). Then 20µl of cell-free extract (=1 mg) was 
added to the reaction mixture, and the absorbance was measured again continuously 
for ~2.5min (a2). The reaction was initiated by adding 1.2mM DHAP (a3).  
The activity after each addition was calculated (a1, a2 and a3, respectively), as seen 
in table #26, and the specific activity of GPDH in the cell-free extract was calculated 
by subtracting the unspecific activities (after adding NADPH, after adding cell-free 
extract, respectively) from the activity calculated after adding the substrate. The 
activity of GPDH in cell-free extract was found to be 88 mU/ml. Approximately 50% of 
the detected activity (177 mU/ml) is unspecific, and caused by oxidization of NADPH 
in the cell-free extract. 
 
 
 
 
 
 
 
 
Figure # 97
 
: The rates of NADH reduction after each addition (a1, a2 and a3) are given in 
table #19 
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Table # 26
 
: Activity of cell-free extract in basal salt 
8.10.1.2 What is the cofactor for GPDH?  
To check the preferred cofactor for GPDH, the activity of GPDH was monitored 
continuously at 340nm using either NADH or NADPH, as cofactors. The activity 
(mU/ml) after each addition was calculated, and the specific activity was calculated 
by subtracting the unspecific activities from the activity measured after the precursor 
was added. As seen in figure #98 addition of cofactor to the cell-free extract resulted 
in activity, most probably because of metabolites in the cell-free extract, which can 
use NADH/NADPH as reducing agents. But only when NADPH was used as cofactor 
did the addition of DHAP result in an additional decrease in absorbance.   
 
 
Table # 27
 
: The activity of GPDH in cell-free extract using NADH or NADPH as cofactors. 
Activity was measure in basal salt, at RT. 
 
 
 
 
 
 
 
 
 
Unspecific activity (mU/ml) when adding Specific activity 
(mU/ml) 
 
a3-a2-a1 
NADPH 
(0.15mM) 
a1 
Cell extract 
(20µl) 
a2 
Precursor 
(1.2mM DHAP) 
a3 
In NaCl (#90) 16 mU/ml 73 mu/ml 177 mU/ml 88 mU/ml 
 
Unspecific activity (mU/ml) when adding 
Specific activity 
(mU/ml) 
Cofactor 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(1.2mM DHAP) 
With NADH (# 88) 39  129  153  0  
With NADPH (#85) 16 73 177 88 
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Figure # 98
 
: Activity of GPDH in cell-free extract using NADH or NADPH as cofactors. The 
decrease in the absorbance at 340nm was measured at RT in Basal salt. Arrows indicates were 
additions were made. 
8.10.1.3 Activity of GPDH measured in 2.8M KCl 
As GPDH is an intracellular enzyme, it might be possible to increase the detected 
specific activity of GPDH in the cell-free extracts by changing the buffer to one 
containing KCl. This hypothesis was confirmed when the activity of GPDH was 
measured in the presence of 2.8M KCl.  
0.15mM NADPH  in 2.8M KCl and 25mM Tris-HCl (pH 7.2) were added to 20µl 
of cell-free extract (=1mg). The reaction was initiated by adding 1.2mM DHAP to the 
reaction mixture. The absorbance was measured continuously over 10min, at 340nm 
RT. A specific activity of 247±18 mU/ml (n=3) was detected (table #21, figure #84), 
26% of the total activity detected, was unspecific, due to the cell-free extract, and 5% 
of the total activity detected was due to oxidation of the NADPH.  
 
 
  
 
 
 
 
Figure # 99: Activity of GPDH in cell-free extracts using NADPH as cofactors. The decrease 
in the absorbance at 340nm was measured at RT in 2.8M KCl.  
DHAP Cell-extract 
NADH/NADPH 
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Table # 28
 
: The specific activity of GPDH in 2.8M KCl buffer. 
 
Unspecific activity (mU/ml) when adding Specific 
activity 
(mU/ml) 
NADPH 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(1.2mM DHAP) 
# 140  8  81  347  258  
#145  0.8 81 339 257 
#169  48 121 395 226 
Average 19±25 94±23 360±30 247±18 
 
The specific activity of GPDH detected in cell-free extracts was compared to the 
unspecific activity detected in mixtures without added precursor, or without cell-free 
extract, or without added cofactor. The absorbance at 340nm of those samples was 
recorded, as seen in figure #99.  
 
 
 
 
 
 
 
 
Figure # 100
 
: Activity of GPDH in cell-free extract using NADPH as cofactors. The decrease 
in the absorbance at 340nm was measured at RT in 2.8M KCl. Activity of GPDH without 
DHAP, without cell-free extract, and without NADPH. 
The maximum unspecific activity of the cell-free extract without DHAP was 
1mU/ml (figure #100, green curve, table #29), whereas, unspecific activity of 8mU/ml 
was detected when NADPH was added to DHAP. By far, the higher contribution to 
the unspecific activity was seen when cell-free extract was added to NADPH. This 
activity was 36% of the specific activity detected when DAHP was added as well to 
the reaction mixture. A slight decrease in the absorbance was seen when there was 
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only NADPH or DHAP in the reaction mixture, suggesting the NADPH was not 
oxidized during the 10min reaction, and only the combination of NADPH + DHAP + 
cell free extract resulted in specific activity. 
 
Table # 29
 
: The unspecific activity of GPDH due to addition cell-extract, NADPH and 
DHAP. 
 
 
 
 
The activity of GPDH was measured both in basal salts and in 2.8M KCl. As seen 
in table # 30, slight differences are seen in the unspecific activities when the activity 
of GPDH was measured either in basal salts, or in KCl.  But, the steeper slope seen 
when DHAP was added to the reaction mixture containing KCl, resulted in ~3-fold 
higher specific activity (258mU/ml vs 88mU/ml, respectively). 
 
Table # 30
 
: Effect of NaCl and KCl on the activity of GPDH 
 
 
 
 
 
 
 
 
 
(a)- The activity after each addition was calculated: after adding NADPH, cell-free extract, and 
     precursor, in the concentrations indicated in the table. 
 
(b)-The specific activity of GPDH in the cell-free extracts was calculated by subtracting the 
unspecific activities (after adding NADPH, after adding cell-free extract, respectively) from 
the activity calculated after adding the precursor. 
 
 
 
 
Unspecific activity (mU/ml) when adding Specific  
activity 
(mU/ml) 
NADPH 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(1.2mM DHAP) 
# 170 (WO DHAP) 16  121  105   
#171 (WO cell extract) 8 0 0 8 
#172 (WO NADPH) 1 2 0 1 
 
(a)Unspecific activity (mU/ml) when adding 
(b)Specific 
activity 
(mU/ml) 
NADPH 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(1.2mM 
DHAP) 
In NaCl (#90) 16 73 177 88 
In KCl (# 140) (n=3)  19±25 94±23 360±30 247±18 
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8.10.1.4 Optimizing the conditions for GPDH 
8.10.1.4.1 Effect of increasing the volume of cell-extract  
The influence of different volumes of cell-free extract (stock 50mg/ml) was 
measured, in order to find the optimal volume of the cell-free extract for assessing 
GPDH activity. 0.15mM NADPH was added to the reaction mixture which contained 
2.8M KCl+ 25mM TrisHCl (pH 7.2), then, different volumes of cell-free extract were 
added (between 10µl-150µl), followed by addition of 1.2mM DHAP. The absorbance 
at 340nm was recorded, as seen in figure #101.  
 
 
 
 
 
 
 
 
Figure # 101
 
: The effect of different volumes of cell extract on the activity of Glycerol-1-
phosphate dehydrogenase (GPDH). Extract additions were color coded: 10µl, 20µl, 40µl, 
60µl, 150µl, respectively. 
 
As seen from table #31, 10µl or 20µl cell-free extract (equals to 0.5, and 1mg/ml 
total protein according to BCA assay) were the optimal choices for the concentration 
of protein used in the assay, as seen from the linear increase of the ∆A/min, which 
corresponded to the increase in the volume. Higher cell-free extract volumes did not 
follow the expected correlation. The lowest unspecific activity (~120mU/ml) was 
obtained when using 10-40µl cell extract (=0.5-2mg/ml total protein).  
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Table # 31
 
: The correlation between the volume of the cell extracts and the slopes obtained 
after adding DHAP.  
Sample  
# 
Vol. of cell 
 extract (µl) 
Slope when adding  
DHAP (∆A/min) 
Unspecific Activity 
(mu/ml) 
Activity* 
(mU/ml) 
146 10µl -0.021 113 340 
145 20µl -0.042 81 340 
147 40µl -0.062 117 250 
148 60µl -0.1 145 270 
144 150µl -0.089 186 96 
* The unspecific activity was not subtracted  
 
8.10.1.4.2 Effect of increasing the concentration of substrate 
The influence of different substrate concentration on the specific activity of 
glycerol 1-P dehydrogenase, was tested 20µl (=1mg/ml total protein) of cell-free 
extract, as seen in figure #102. As seen in table #32, the specific activity correlated to 
the increase in the concentration of DHAP, when using concentrations between 6-
12mM DHAP.  
 
 
 
 
 
 
 
 
 
Figure # 102
 
: The effect of different concentration of DHAP (1.2mM, 6mM, 12mM, 
respectively) on the activity of Glycerol-1-phosphate dehydrogenase (GPDH). 
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 Table # 32
 
: The specific activity of GPDH calculated after addition of different 
concentration of DHAP. 
 
 
 
 
 
 
 
 
 
 
 
 
8.10.1.5 GPDH from cells grown in complex medium vs. synthetic   
medium WO AroAAs 
According to MS results of A. Tebbe, the regulation factor of the GPDH gene 
OE1620F (EC 1.1.1.261) is +2.17 (synthetic medium/complex medium). This fact 
might indicate that cell-free extracts prepared from synthetic medium will contain 
more enzyme compared to cells from complex medium. As seen in figure #103 and 
table #33, the enzyme activity was ~1.6 higher in cell extracts derived from cells 
growing in complex medium. 
 
 
 
 
 
 
 
 
 
 
 
Figure # 103
 
: The activity of Glycerol-1-phosphate dehydrogenase (OE1620F) in cell-free 
extract from complex medium vs. synthetic medium WO AroAAs. 
 
 
 
 
 
Unspecific activity (mU/ml) when adding Specific  
activity 
(mU/ml) 
NADPH 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(DHAP) 
0.12mM (#149) 0 97 113 16 
1.2mM (#140)  8  81  347 258  
6mM (# 143)  24 105 1016 887 
12mM (#150) 8 97 1427 1322 
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Table # 33
 
: Activity of glycerol-1-phosphate dehydrogenase (GPDH) in cell- free extract 
from Halo medium vs synthetic medium without AroAAs. 
 
 
 
 
 
 
 
8.10.1.6 Activity assay for GPDH from cell-free extract in 2.8M KCl 
825µl 3.4M KCl + 10mM NaCl + 25mM Tris pH=7.2 
15µl 10mM NADPH   (0.15mM) 
20µl cell extract (1mg total protein according to BCA assay) 
100µl 120mM DHAP (12mM) 
Total volume: 1000µl (RT) 
 
8.10.1.7 Aldolase activity in cell free extract of H. salinarum 
In the current study, aldolase activity was detected in pure preparations of proteins 
OE1472F and OE2019F, so it was of interest to see if aldolase activity could be 
detected directly in cell extracts of H. salinarum, using a spectrometric assay. To 
check this, a coupled enzyme assay was performed, where the formation of DHAP 
was detected by the disappearance of NADPH. DHAP, one of the products obtained 
after the cleavage of F-1,6-P is converted to glycerol-1-P by glycerol-1-phosphate 
dehydrogenase (GPDH, OE1602F, EC 1.1.1.261), as shown in the reaction below.  
F-1,6-P  GAP + DHAP 
DHAP + NADPH  Glycerol-1-P + NADP+ 
The aldolase activity in cell-free extracts of R1 grown in complex medium, was 
measured using the coupled enzyme assay with GPDH in basal salt and 2.8M KCl and 
1.2mM F-1,6-P. Very low activity (8mU/ml) was detected when the buffer was basal 
 
Unspecific activity (mU/ml) when adding Specific 
activity 
(mU/ml) 
NADH 
(0.15mM) 
Cell extract 
(20µl) 
Precursor 
(12mM DHAP) 
Halo medium (# 150)  
 
8  
 
96  1427  1322  
Synthetic WO AroAAs  
(# 174)  10 80  
 
940 
 
850  
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salt (table #34, sample #94 pink), but no activity was detected when the assay was 
preformed in 2.8M KCl (table #34). That may be due to low turnover number of the 
Aldolase, thus lower amounts of DHAP were released. As indicated from sample 169 
(bottom row of table #33), GPDH was still active in cell-free extracts, when aldolase 
activity was measured.  
 
Table # 34
 
: Aldolase activity in cell free-extracts of H. salinarum  
 
 
 
 
 
 
 
 
(a)- The activity after each addition was calculated after adding NADPH, cell-free extract, and  
     precursor, in the concentrations indicated in the table. 
(b)-The specific activity of GPDH in the cell-free extracts was calculated by subtracting the 
     unspecific activities (after adding NADPH, after adding cell-free extract, respectively) 
     from the activity calculated after adding the precursor. 
 
 
 
 
 
 
 
 
 
 
 
Figure # 104
 
: Aldolase activity in H. salinarum cell free-extracts as detected by the coupled 
enzyme assay coupled with GDPH. 2.8M KCl, NADPH, cell free-extracts, and precursors 
were added at the indicated times and the decrease in absorbance at 340nm followed at RT. 
Red- 1.2mM F-1,6-P, Blue-without precursor, Green-positive control for the activity of 
GDPH using 1.2mM DHAP.  Arrows indicates the addition time point. 
 
Substrates 
(a)Unspecific activity (mU/ml) when adding (b)Specifi
c activity 
(mU/ml) 
NADPH 
(0.15mM) 
Cell extract 
(20µl) 
Precursors 
(1.2mM each) 
1.2mM F-1,6-P (# 94) 0 mU/ml 72 mU/ml 80 mU/ml 8 
1.2mM F-1,6-P (# 166) 8 mU/ml 113mU/ml 97mU/ml 0 
WO F-1,6-P (# 168) 2.5 mU/ml 137 mU/ml 97 mU/ml 0 
1.2mM DHAP (# 169)  
7 days after cell extract 
preparation 
48 mU/ml 121 mU/ml 395 mU/ml 226  
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